Sentence,class,file
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/5d/opth-8-2425.PMC4259508.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/64/opth-8-2441.PMC4259510.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2441–2447Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2441Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7513 0Comparison study of OCT, HRT and VF findings  among normal controls and patients with  pseudoexfoliation, with or without increased iOP Fryni riga ilias georgalas Panagiotis Tsikripis Dimitrios Papaconstantinou Department of Ophthalmology,   University of athens, athens, greecePurpose:  To compare and evaluate optic nerve head (ONH) and retinal nerve fiber layer  (RNFL) measurements obtained with the optical coherence tomography (OCT) and the  Heidelberg retina tomography (HRT) to visual field (VF) parameters in normal and in patients  with pseudoexfoliation with or without increased intraocular pressure (IOP).",Non-OADS,/arxiv_data1/oa_pdf/05/64/opth-8-2441.PMC4259510.pdf
"In 2003, Ritch et  al  explained the relation between glaucoma and pseudoexfoliation.1,2,4 In the early 1980s  though, Roth and Epstein reported that glaucoma was present in patients with pseudo - exfoliation syndrome.3 The prevalence of pseudoexfoliation syndrome in glaucomatous Correspondence: Panagiotis Tsikripis Department of Ophthalmology,  University of athens, leoforos Mesogion  154, athens 115 27, greece email ptsikripis@gmail.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Riga et al Running head recto: Comparison study of OCT, HRT, and VF findings DOI: http://dx.doi.org/10.2147/OPTH.S75130",Non-OADS,/arxiv_data1/oa_pdf/05/64/opth-8-2441.PMC4259510.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/05/64/opth-8-2441.PMC4259510.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/64/opth-8-2441.PMC4259510.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/0a/opth-8-2415.PMC4259511.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2415–2423Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2415Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7205 3evaluation of actual retinal images produced  by misaligned aspheric intraocular lenses  in a model eye  Takashi Fujikado1 Makoto saika2 1Department of applied Visual science,   Osaka University graduate school of  Medicine, Osaka, Japan; 2research and  Development Department of T opcon  Corporation, T okyo, JapanPurpose:  To examine the effect of misalignment (decentration and tilt) of intraocular lenses  (IOLs) on retinal image quality using a water-immersed model eye with corneal spherical  aberration adjusted to the values found in normal human eyes (spherical aberration 0.25 µm;  pupil diameter 6 mm).",Non-OADS,/arxiv_data1/oa_pdf/b3/0a/opth-8-2415.PMC4259511.pdf
"Removal  of the crystalline lens followed by insertion of an intraocular lens (IOL) during cataract  surgery provides an opportunity to modify the spherical aberration of the eye, thereby  improving visual function.4–6 To do this, aspherical IOLs have been designed that either:  1) nullify the spherical aberration of the whole eye, thereby focusing an image at the  plane of focus with good contrast; 2) reduce the spherical aberration of the whole eye  to approximately 0.1 µm (pupil diameter 6 mm; a value typically found in healthy  young people); or 3) decrease the spherical aberration of the IOL to approximately  zero, thereby retaining the spherical aberration of the cornea.7–9Correspondence: Takashi Fujikado Department of applied Visual science,  Osaka University graduate school  of Medicine, 2-2 Yamadaoka, suita,  Osaka 565-0871, Japan Tel +81 6 6879 3941 Fax +81 6 6879 3948 email fujikado@ophthal.med.osaka-u.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Fujikado and Saika Running head recto: Intraocular lens misalignment DOI: http://dx.doi.org/10.2147/OPTH.S72053",Non-OADS,/arxiv_data1/oa_pdf/b3/0a/opth-8-2415.PMC4259511.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b3/0a/opth-8-2415.PMC4259511.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/0a/opth-8-2415.PMC4259511.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/61/opth-8-2403.PMC4259512.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2403–2407Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2403Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7399 0Isolated posterior capsular rupture following  blunt head trauma ahmad M Mansour Mahmoud O Jaroudi rola N Hamam Fadi C Maalouf Department of Ophthalmology,   american University of Beirut,   Beirut, LebanonAbstract:  Closed-globe traumatic cataract is not uncommon in males in the pediatric age  group.",Non-OADS,/arxiv_data1/oa_pdf/40/61/opth-8-2403.PMC4259512.pdf
"After aspiration of two-thirds of the lens content, Correspondence: ahmad M Mansour Department of Ophthalmology,  american University of Beirut,  pO Box 1136044, Beirut, Lebanon email ammansourmd@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Mansour et al Running head recto: Posterior capsular rupture DOI: http://dx.doi.org/10.2147/OPTH.S73990",Non-OADS,/arxiv_data1/oa_pdf/40/61/opth-8-2403.PMC4259512.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/40/61/opth-8-2403.PMC4259512.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/61/opth-8-2403.PMC4259512.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/fa/ott-7-2237.PMC4259513.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 2237–2248OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2237Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OTT .S6828 6Angiogenesis and antiangiogenic agents in cervical  cancer Federica T omao1 Anselmo Papa2 Luigi Rossi2 eleonora Zaccarelli2 Davide Caruso2 Federica Zoratto2 Pierluigi Benedetti Panici1 Silverio T omao2 1Department of Gynecology and  Obstetrics, Sapienza University of  Rome, Policlinico Umberto i, Rome,   2Department of Medico-Surgical  Sciences and Biotechnologies,   Sapienza University of Rome,   Oncology Unit, iCOT, Latina, italy Correspondence: Federica Tomao   via Baldovinetti  83, 00142 Rome, italy   Tel +39 06 503 5826   email federica.tomao@uniroma1.i tAbstract:  Standard treatment of cervical cancer (CC) consists of surgery in the early stages  and of chemoradiation in locally advanced disease.",Non-OADS,/arxiv_data1/oa_pdf/73/fa/ott-7-2237.PMC4259513.pdf
Available from:  http://clinicaltrials.gov/show/NCT00369122 .,Non-OADS,/arxiv_data1/oa_pdf/73/fa/ott-7-2237.PMC4259513.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/73/fa/ott-7-2237.PMC4259513.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/fa/ott-7-2237.PMC4259513.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/98/opth-8-2461.PMC4259514.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2461–2465Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2461Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7555 8Clinical course of focal choroidal excavation  in Vogt–Koyanagi–Harada disease Yuko Nishikawa1–3,* Kaoru Fujinami1,2,4,5,* Ken Watanabe1,2 T oru Noda1,2 Kazushige Tsunoda1,2 Kunihiko akiyama1,2 1Department of Ophthalmology,   National Hospital Organization,   T okyo Medical Center, T okyo, Japan;   2Laboratory of Visual Physiology,   National institute of sensory Organs,   National T okyo Medical Center, T okyo,   Japan; 3Department of Ophthalmology,   Osaka Medical College, Takatsuki,   Osaka, Japan; 4Department of  Ophthalmology, Keio University  school of Medicine, T okyo, Japan;   5UCL institute of Ophthalmology,   London, UK *These authors contributed equally  to this workAbstract:  We describe focal choroidal excavation (FCE) in a case of Vogt–Koyanagi–Harada  (VKH) disease and compare the findings with different chorioretinal conditions.",Non-OADS,/arxiv_data1/oa_pdf/4a/98/opth-8-2461.PMC4259514.pdf
"SD-OCT obtained 1 year before Correspondence: Kaoru Fujinami Laboratory of Visual Physiology,  National institute of sensory Organs,  National Tokyo Medical Center,  2-5-1 Higashigaoka, Meguro-ku,  Tokyo 152-8902, Japan Tel +81 3 3411 0111 Fax +81 3 3411 0185 email kfj21kfj21kfj21@kmf.biglobe.ne.j p Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Nishikawa et al Running head recto: Focal choroidal excavation in Vogt–Koyanagi–Harada disease DOI: http://dx.doi.org/10.2147/OPTH.S75558",OADS,/arxiv_data1/oa_pdf/4a/98/opth-8-2461.PMC4259514.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4a/98/opth-8-2461.PMC4259514.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/98/opth-8-2461.PMC4259514.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/9b/clep-6-441.PMC4259550.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2014:6 441–449Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  441Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S6547 6self-reported health following percutaneous  coronary intervention: results from a cohort  followed for 3 years with multiple measurements Karin Biering1,2 Morten Frydenberg3 niels henrik hjollund4,5 1Department of Occupational  Medicine, regional hospital West  Jutland, herning, Denmark; 2Danish  ramazzini Centre, regional hospital  West Jutland, herning, Denmark;   3section of Biostatistics, Department  of Public health, aarhus University,   aarhus, Denmark; 4WestChronic,   regional hospital West Jutland,   herning, Denmark; 5Department  of Clinical Epidemiology, aarhus  University hospital, aarhus, Denmark Correspondence: Karin Biering   Department of Occupational Medicine,  regional hospital West Jutland,   DK-7400 herning, Denmark   Tel +45 7843 3518   Email k arin.biering@vest.rm.d kObjective:  Improvements in the treatment of coronary heart disease have increased the   number of patients living with a chronic heart disease.",Non-OADS,/arxiv_data1/oa_pdf/5b/9b/clep-6-441.PMC4259550.pdf
"Additional information is available at The  National  Committee on Health Research Ethics’ webpage in the  “Act on Research Ethics Review of Health Research  Projects” § 14,2. available from: http://www.cvk.sum.dk/ English/actonabiomedicalresearch.asp x.",Non-OADS,/arxiv_data1/oa_pdf/5b/9b/clep-6-441.PMC4259550.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/5b/9b/clep-6-441.PMC4259550.pdf
"Available from: http://www.ssi.dk/  Sundhedsdataogit.asp x. Accessed September 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/9b/clep-6-441.PMC4259550.pdf
"Available from: http://www.kea.au.dk/ file/pdf/43.pd f. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/9b/clep-6-441.PMC4259550.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/05/cia-9-2103.PMC4259551.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/34/05/cia-9-2103.PMC4259551.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/34/05/cia-9-2103.PMC4259551.pdf
"Clinical Interventions in Aging 2014:9 2103Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2103CorrIgendumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S7447 7A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman  with a previous history of negative Pap cytology [corrigendum]Journal name: Clinical Interventions in Aging Article Designation: Corrigendum Y ear: 2014 Volume: 9 Running head verso: Zappacosta et al Running head recto: A very rare case of HPV -53-related cervical cancer DOI: http://dx.doi.org/10.2147/CIA.S74477 Zappacosta R, Lattanzio G, Viola P, Ianieri MM, Gatta DMP,  Rosini S. Clin Interv Aging .",Non-OADS,/arxiv_data1/oa_pdf/34/05/cia-9-2103.PMC4259551.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/b5/jaa-7-165.PMC4259552.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Asthma and Allergy 2014:7 165–167Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  165CAse Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JAA.S6854 8Rituximab therapy in a patient with low grade   B-cell lymphoproliferative disease and  concomitant acquired angioedema Ravdeep Kaur Aerik Anthony Williams Catherine Baker swift Jason W Caldwell Wake Forest University school of  Medicine, Wake Forest University,   Winston-salem, NC, UsA Correspondence: Aerik Anthony  Williams   Wake Forest University Medical  Center, 2311 Lewisville Clemmons Rd,  Clemmons, NC  27012, UsA   tel +1 614 506 4374  Fax +1 336 716 4734  email aerikwilliams@hotmail.co mAbstract:  Acquired angioedema is often associated with significant morbidity.",Non-OADS,/arxiv_data1/oa_pdf/e0/b5/jaa-7-165.PMC4259552.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/e0/b5/jaa-7-165.PMC4259552.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/b5/jaa-7-165.PMC4259552.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/96/ijwh-6-989.PMC4259553.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 989–998International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  989OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org /10.2147/IJWH.S70935Does the presence of coexisting diseases modulate  the effectiveness of a low-dose estrogen/progestin,  ethinylestradiol/drospirenone combination tablet  in dysmenorrhea?",Non-OADS,/arxiv_data1/oa_pdf/4d/96/ijwh-6-989.PMC4259553.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/4d/96/ijwh-6-989.PMC4259553.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/96/ijwh-6-989.PMC4259553.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/de/ndt-10-2291.PMC4259554.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2291–2297Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2291Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7055 5The clinical psychologist and the management  of inpatient pain: a small case series Correspondence: Carsten Bantel Department of surgery and Cancer,  anaesthetics section, imperial  College London, Chelsea and  Westminster Campus, 369 Fulham road,  London sW10 9NH, UK Tel +44 20 3315 8897 Fax +44 20 3315 5109 email c.bantel@imperial.ac.u k susan r Childs1,* emma M Casely2,* Bianca M Kuehler1 stephen Ward1 Charlotte L Halmshaw1 sarah e Thomas1 ian D Goodall1 Carsten Bantel1,3 1Pain Medicine, Chelsea  and Westminster Hospital  NHs Foundation Trust, London,   2anaesthetic Department, Hillingdon  Hospital, Uxbridge, 3section of  anaesthetics, Department of surgery  and Cancer, Faculty of Medicine,   imperial College London, Chelsea  and Westminster Hospital Campus,   London, UK *These authors contributed equally  to this manuscriptAbstract:  Recent research has confirmed that between 25% and 33% of all hospitalized patients  experience unacceptable levels of pain.",Non-OADS,/arxiv_data1/oa_pdf/5c/de/ndt-10-2291.PMC4259554.pdf
"A recent  analysis of an American database including more than 100,000 patients with chronic  low back pain for instance revealed a prevalence of depression in 13%, anxiety in 8%,  and sleep disorders in 10% of patients, respectively.1 Further, a recent European study  in neuropathic pain described a prevalence of 42% for anxiety and 35% for depression  in these patients.2 Anger (with a prevalence of 37%) is also common in chronic pain  patients, as is borderline personality disorder (BPD), which occurs in 30% of cases.3,4  For acute perioperative pain anxiety, low mood, catastrophizing, and depression have  been identified as predictors of pain intensity and analgesic consumption.5,6 They also  constitute risk factors for developing persistent post-surgical pain.7,8 In the current economic climate, with its constraints on health care budgets,  services are faced with increasing demands and declining resources.9 Consequently,  many patients are being navigated to “fast track” or “enhanced recovery” pathways,  which were developed to assist early discharge after routine procedures.10 How - ever, to be able to facilitate mobilization, rehabilitation, and prompt discharge, all Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case Series Y ear: 2014 Volume: 10 Running head verso: Childs et al Running head recto: Clinical psychologist in inpatient pain management DOI: http://dx.doi.org/10.2147/NDT.S70555",Non-OADS,/arxiv_data1/oa_pdf/5c/de/ndt-10-2291.PMC4259554.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5c/de/ndt-10-2291.PMC4259554.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/de/ndt-10-2291.PMC4259554.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307.PMC4259555.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2307–2312Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2307OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7192 2Remediation of context-processing deficits in  schizophrenia: preliminary data with ambiguous  sentences chrystel Besche-richard1,2 sarah T errien1 Marion lesgourgues3,4 célia Béchiri-Payet5 Fabien gierski1,3 Frédéric limosin6–8 1laboratory cognition, santé,   socialisation, University of reims  champagne-ardenne, France; 2institut  Universitaire de France, Paris, France;   3centre hospitalier Universitaire,   Pôle de Psychiatrie des adultes,   reims, France; 4service Universitaire  de Médecine Préventive et de  Promotion de la santé, University  of reims champagne-ardenne,   reims, France; 5etablissement Public  de santé mentale départemental  de l’aisne, Prémontré, France;   6Department of adult and geriatric  Psychiatry, hôpitaux Universitaires  Paris, Ouest (assistance publique- hôpitaux de Paris), hôpital corentin- celton, issy-les-Moulineaux, France;   7Faculty of  Medicine, University  Paris Descartes, sorbonne Paris  cité, Paris, France; 8Psychiatry  and Neurosciences center, French  National institute of health and  Medical research, institut National de  la santé et de la recherche Médicale  U894,  Paris,  FranceBackground:  Processing of contextual information is essential for the establishment of good inter - personal relations and communicational interactions.",Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307.PMC4259555.pdf
"Moreover, correspondence: chrystel Besche- richard laboratory cognition, santé,  socialisation, c2s, ea6291, Université  de reims champagne-ardenne,  57 rue Pierre Taittinger, 51096  reims, cedex, France Tel +33 3 2691 3776 Fax +33 3 2691 3719 email chrystel.besche@univ-reims.f r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Besche-Richard et al Running head recto: Remediation of context-processing deficits in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S71922",Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307.PMC4259555.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307.PMC4259555.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307.PMC4259555.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/34/clep-6-451.PMC4259556.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2014:6 451–460Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  451Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S6966 0Bias in identification of the best treatment   in a Bayesian network meta-analysis   for binary outcome: a simulation study Taddele Kibret1 Danielle Richer2 Joseph Beyene1,2 1Department of Mathematics and  statistics,  2Department of Clinical  Epidemiology and Biostatistics,   McMaster University, Hamilton,    On, Canada Correspondence: Joseph Beyene   1280 Main Street West, MDCL  3211,  hamilton, On l8s  4K1, Canada   Tel +1 905 525 9140 ext  21333  Fax +1 905 528 2814  Email beyene@mcmaster.c aAbstract:  Network meta-analysis (NMA) has emerged as a useful analytical tool allowing  comparison of multiple treatments based on direct and indirect evidence.",Non-OADS,/arxiv_data1/oa_pdf/3a/34/clep-6-451.PMC4259556.pdf
"In this study, the package gemtc  (http://cran.r-proct.org/web/packages/gemtc/index.htm l)  from the R library, was used to implement the Bayesian  NMA through MCMC simulation nicely, and is compat - ible with other packages that can conduct convergence  diagnostics.",OADS,/arxiv_data1/oa_pdf/3a/34/clep-6-451.PMC4259556.pdf
"Available  from: http://www.cadth.ca/media/pdf/H0462_itc_tr_e.pd f. Accessed  September  15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3a/34/clep-6-451.PMC4259556.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/3a/34/clep-6-451.PMC4259556.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/e1/jpr-7-707.PMC4259557.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 707–716Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  707ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7134 4Proinflammatory cytokines and DHEA-S in  women with fibromyalgia: impact of psychological  distress and menopausal status John A Sturgeon1 Beth D Darnall1 Heather L Zwickey2 lisa J Wood3 Douglas A Hanes2 David T Zava4 Sean C Mackey1 1Stanford University School of Medicine,  Department of Anesthesiology,  Perioperative and Pain Medicine, Palo  Alto, CA, USA; 2Helfgott Research  Institute, National College of Natural  Medicine, Portland, OR, USA; 3Mgh  Institute of Health Professions, Boston,  MA, USA; 4ZRT Laboratories, Beaverton,  OR, USA Correspondence: John A Sturgeon   Stanford University School of Medicine,  Department of Anesthesiology,  Perioperative and Pain Medicine,  Stanford Systems Neuroscience and Pain  Laboratory, 1070 Arastradero, Suite 200,  MC 5596, Palo Alto, CA 94304, USA   email jasturge@stanford.ed uAbstract:  Though fibromyalgia is not traditionally considered an inflammatory disorder, evi - dence for elevated inflammatory processes has been noted in this disorder in multiple  studies.",Non-OADS,/arxiv_data1/oa_pdf/4c/e1/jpr-7-707.PMC4259557.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/4c/e1/jpr-7-707.PMC4259557.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/e1/jpr-7-707.PMC4259557.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/ea/nss-6-149.PMC4259558.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2014:6 149–156Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  149OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NSS.S7385 6Pulsing blue light through closed eyelids: effects  on acute melatonin suppression and phase   shifting of dim light melatonin onset Mariana g Figueiro Barbara Plitnick Mark S rea lighting research center, rensselaer  Polytechnic institute, Troy, NY, USa correspondence: Mariana g Figueiro   lighting research center, rensselaer  Polytechnic institute,  21 Union Street,  Troy, NY  12180, USa   Tel +1 518 687 7100  Fax +1 518 687 7120  email figuem@rpi.ed uAbstract:  Circadian rhythm disturbances parallel the increased prevalence of sleep disorders  in older adults.",Non-OADS,/arxiv_data1/oa_pdf/45/ea/nss-6-149.PMC4259558.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/45/ea/nss-6-149.PMC4259558.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/ea/nss-6-149.PMC4259558.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/67/jpr-7-699.PMC4259559.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 699–705Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  699Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S4561 5Provocative diskography: safety and predictive  value in the outcome of spinal fusion or pain  intervention for chronic low-back pain Paul C willems Department of Orthopedic Surgery,   CAPHRi Research School, Maastricht  University Medical Center, Maastricht,   the Netherlands Correspondence: Paul C willems   Department of Orthopedic Surgery,  CAPHRi Research School, Maastricht  University Medical Center, PO Box 5800,  Maastricht 6202 AZ, the Netherlands   Tel +31 43 387 5038   email p.willems@mumc.n lAbstract:  There is still no clear definition of diskogenic low-back pain and no consensus on a  generally agreed test, such as provocative diskography (PD), to diagnose painful disk degenera - tion, and probably more importantly, to predict the outcome of therapy intended to reduce pain  that is presumed to be diskogenic in nature.",Non-OADS,/arxiv_data1/oa_pdf/34/67/jpr-7-699.PMC4259559.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/34/67/jpr-7-699.PMC4259559.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/67/jpr-7-699.PMC4259559.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/a3/cia-9-2087.PMC4259560.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2087–2095Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2087OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7200 6Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Liu et al Running head recto: Olive oil in the prevention and treatment of osteoporosis DOI: http://dx.doi.org/10.2147/CIA.S72006 Olive oil in the prevention and treatment  of osteoporosis after artificial menopause Purpose:  The goal of this study was to investigate the anti-osteoporosis effect of extra virgin  olive oil (EVOO) in vivo, and explore its antioxidant, anti-inflammatory properties in Sprague  Dawley rats and its anticancer properties in patients.",Non-OADS,/arxiv_data1/oa_pdf/d9/a3/cia-9-2087.PMC4259560.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d9/a3/cia-9-2087.PMC4259560.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d9/a3/cia-9-2087.PMC4259560.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/d1/ndt-10-2285.PMC4259561.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2285–2290Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2285OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7118 4Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Zenthöfer et al Running head recto: Older people in nursing homes and dental treatments needs DOI: http://dx.doi.org/10.2147/NDT.S71184 increasing dependency of older people in nursing  homes is associated with need for dental treatments Abstract:  To determine relationships between the need for dental treatments of institutionalized  elderly people and cognitive impairment and the general level of care needed.,Non-OADS,/arxiv_data1/oa_pdf/a4/d1/ndt-10-2285.PMC4259561.pdf
Available from: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/ KE-ET-10-001/EN/KE-ET-10-001-EN.PDF.,Non-OADS,/arxiv_data1/oa_pdf/a4/d1/ndt-10-2285.PMC4259561.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a4/d1/ndt-10-2285.PMC4259561.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/d1/ndt-10-2285.PMC4259561.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/b5/jir-7-159.PMC4259568.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2014:7 159–167Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  159ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S7503 7Inhibiting TnF- α signaling does not attenuate  induction of endotoxin tolerance christopher loosbroock Kenneth W hunter Department of Microbiology and  Immunology, University of nevada  school of Medicine, Reno, nV, Usa correspondence: Kenneth W hunter   University of nevada, Reno, applied  Research Facility M/s199, 1664 n.  Virginia street, Reno, nV 89557, Usa   Tel +1 775 327 5255   Fax +1 775 784 1142   email khunter@medicine.nevada.ed uAbstract:  Tumor necrosis factor-alpha (TNF- α) is a central mediator of inflammatory responses  elicited by Toll-like receptor agonists, such as the Gram-negative bacterial outer membrane  antigen lipopolysaccharide (LPS).",Non-OADS,/arxiv_data1/oa_pdf/6b/b5/jir-7-159.PMC4259568.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/6b/b5/jir-7-159.PMC4259568.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/b5/jir-7-159.PMC4259568.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 469–482Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  469REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S4741 2Learning lessons from operational research   in infectious diseases: can the same model   be used for noncommunicable diseases   in developing countries?,Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
Or use: http://dvpr.es/1rPARC z,Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
"Seattle,  Washington, USA: University of Washington; 2014 [updated September  15, 2014; cited August 30, 2014]; Available from: http://www.healthdata.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
"2009. http://www.who.int/chp/steps/esteps/e n. Accessed  September 15 , 2014.",OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
"Available from: http://www.mrc.ac.za/researchdevelopment/ ISHReCAbrochure.pd f. Accessed September 14 , 2014.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
"Available from: http://www.cohred.org/westafric a. Accessed  September  14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
Available  from: http://www.wahooas.org/spip.php?article512&lang =en.,Non-OADS,/arxiv_data1/oa_pdf/71/d5/amep-5-469.PMC4259801.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/   10.1016/j.devcel.2005.03.01 6 Duquet, A., A. Melotti, S. Mishra, M. Malerba, C. Seth, A. Conod, and A. Ruiz  i Altaba.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1074/jbc   .M112.41337 7 Guo, X., T.F.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1101/gad.123070 4 Harada, N., Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and M.M.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10   .1093/emboj/18.21.593 1 Hernández, A.R., A.M. Klein, and M.W.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1126/science.122873 4 Hill, T.P., D. Später, M.M.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1016/   j.devcel.2005.02.01 3 Hill, T.P., M.M.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1242/dev.0229 8 Hoser, M., M.R.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"28:4675– 4687. http://dx.doi.org/10.1128/MCB.00338-0 8 Ikeda, T., S. Kamekura, A. Mabuchi, I. Kou, S. Seki, T. Takato, K. Nakamura,  H. Kawaguchi, S. Ikegawa, and U.I.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi   .org/10.1242/dev.09179 3 Kan, A., T. Ikeda, A. Fukai, T. Nakagawa, K. Nakamura, U.I.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"13:4. http://dx.doi.org/10.1186/   1471-213X-13- 4 Kawanami, A., T. Matsushita, Y.Y.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2009.06.05 9 Kim, S.E., H. Huang, M. Zhao, X. Zhang, A. Zhang, M.V.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1126/   science .123238 9 Kist, R., H. Schrewe, R. Balling, and G. Scherer.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1002/gene.1005 0 Kormish, J.D., D. Sinner, and A.M. Zorn.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1016/S0070-2153(10)90008- 2 Li, V.S., S.S. Ng, P.J.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1016/   j.cell.2012.05.00 2 Logan, M., J.F.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
http://dx.doi.org/10.1002/   gene.1009 2primary and HRP-conjugated secondary antibodies (Table S3) diluted in  blocking solution containing 5% nonfat dry milk.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
Online sup - plemental material is available at http://www.jcb.org/cgi/content/full/jcb   .201405098/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi   .org/10.1101/gad.101780 2 Akiyama, H., J.P. Lyons, Y. Mori-Akiyama, X. Yang, R. Zhang, Z. Zhang,  J.M.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1101/gad.117110 4 Albrecht, U., G. Eichele, J.A.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1101/gad.40340 6 Bergsland, M., D. Ramsköld, C. Zaouter, S. Klum, R. Sandberg, and J. Muhr.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1101/gad   .176008.11 1 Bhattaram, P., A. Penzo-Méndez, E. Sock, C. Colmenares, K.J.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/   10.1038/ncomms100 8 Brault, V., R. Moore, S. Kutsch, M. Ishibashi, D.H. Rowitch, A.P.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1016/j.cell.2012.05.01 2 Day, T.F., X. Guo, L. Garrett-Beal, and Y .",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1101/ cshperspect.a00833 4 Nissen-Meyer, L.S., R. Jemtland, V.T.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi   .org/10.1242/jcs.00385 5 Paul, M.H., R.P.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10   .1007/s00018-013-1523- x Penzo-Méndez, A., P. Dy, B. Pallavi, and V. Lefebvre.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1242/dev.04210 1 Ramezani-Rad, P., H. Geng, C. Hurtz, L.N.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"121:148– 155. http://dx.doi.org/10.1182/blood-2012-05-42893 8 Regard, J.B., Z. Zhong, B.O.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1101/   cshperspect.a00799 7 Saegusa, M., M. Hashimura, and T. Kuwata.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"92:511– 521. http://dx.doi.org/10.1038/labinvest.2011.19 6 Semënov, M.V., K. Tamai, B.K.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00290- 1 Sinner, D., J.J. Kordich, J.R. Spence, R. Opoka, S. Rankin, S.C. Lin, D. Jonatan,  A.M. Zorn, and J.M.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1128/MCB   .02179-0 6 Sock, E., S.D.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"24:6635– 6644. http://dx.doi.org/10.1128/MCB.24.15.6635-6644.200 4 Später, D., T.P.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi   .org/10.1242/dev.0247 1 Thein, D.C., J.M.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1111/j.1471- 4159.2010.06910. x Tiwari, N., V.K.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1016/j.ccr.2013.04.02 0 Topol, L., W. Chen, H. Song, T.F.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1074/jbc.M80804820 0 Valenta, T., G. Hausmann, and K. Basler.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1038/emboj   .2012.15 0 Vervoort, S.J., R. van Boxtel, and P.J.",OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
"http://dx.doi.org/10.1038/   onc.2012.50 6 Vinyoles, M., B. Del Valle-Pérez, J. Curto, R. Viñas-Castells, L. Alba-Castellón,  A. García de Herreros, and M. Duñach.",Non-OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
http://dx.doi.org/10   .1016/j.molcel.2013.12.01 0,OADS,/arxiv_data1/oa_pdf/8f/4a/JCB_201405098.PMC4259807.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"Single-particle tracking Single-particle tracking was performed using a custom-written plugin for Im - ageJ (Abràmoff et al., 2004), which is available from http://www.smal   .ws/home/software.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
Online supplemental material is available at http://www.jcb.,Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"Additional data are available  in the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201405014.d v. We thank H. Sanchez, E. Peterman, S. Uphoff, A. Kapanidis, and B. Eppink  for discussions; J. Kerssemakers for sharing MATLAB bleaching step analysis; I.  Grigoriev and G. Kremers for technical microscopy help; N. van Vliet and  M.Schoonakker for technical assistance in cell biology; N. van den Tempel for  help with engineering HeLa cell lines; J. Stark for sharing reagents; and the  Erasmus Optical Imaging Center and Proteomics Center for providing facilities  and technical support.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10   .1093/emboj/21.8.203 0 Essers, J., A.B.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/S0076-   6879(06)08029- 3 Gibson, D.G., L. Young, R.-Y.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/   nmeth.131 8 Grünwald, D., R.M.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10   .1073/pnas.92.6.229 8 Haupts, U., S. Maiti, P. Schwille, and W.W. Webb.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi   .org/10.1146/annurev-genet-051710-15095 5 Hockemeyer, D., F. Soldner, C. Beard, Q. Gao, M. Mitalipova, R.C.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/   10.1038/nbt.156 2 Hoogstraten, D., A.L.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10   .1016/S1097-2765(02)00709- 8 Jaqaman, K., D. Loerke, M. Mettlen, H. Kuwata, S. Grinstein, S.L.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/   nmeth.123 7 Jensen, R.B., A. Carreira, and S.C. Kowalczykowski.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"467:678– 683. http://dx.doi.org/10.1038/nature0939 9 Jeyasekharan, A.D., N. Ayoub, R. Mahen, J. Ries, A. Esposito, E. Rajendra,  H. Hattori, R.P.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/   10.1073/pnas.100957710 7 Jeyasekharan, A.D., Y. Liu, H. Hattori, V. Pisupati, A.B.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/nsmb.266 6 Katagiri, T., H. Saito, A. Shinohara, H. Ogawa, N. Kamada, Y. Nakamura,  and Y. Miki.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"21:217–   222. http://dx.doi.org/10.1002/(SICI)1098-2264(199803)21:3<217:: AID-GCC5>3.0.CO;2- 2 Kerssemakers, J.W., E.L. Munteanu, L. Laan, T.L.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/nature0492 8 Krawczyk, P .M., B. Eppink, J. Essers, J. Stap, H. Rodermond, H. Odijk, A. Zelensky,  C. van Bree, L.J.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/nsmb.190 4References Abraham, J., B. Lemmers, M.P.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/   10.1093/emboj/cdg58 0 Abràmoff, M.D., P.J.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/j.ygeno   .2005.08.00 3 Agarwal, S., W.A.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1083/jcb.20101102 5 Anastassiadis, K., J. Fu, C. Patsch, S. Hu, S. Weidlich, K. Duerschke, F.  Buchholz, F. Edenhofer, and A.F.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/   10.1242/dmm.00308 7 Brugmans, L., N.S.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi   .org/10.1016/j.dnarep.2009.09.00 2 Cadiñanos, J., and A. Bradley.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi   .org/10.1093/nar/gkm44 6 Carreira, A., and S.C. Kowalczykowski.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10   .1074/jbc.274.46.3293 1 Chenouard, N., I. Smal, F. de Chaumont, M. Maška, I.F.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/nmeth.280 8 Cox, J., and M. Mann.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/   10.1038/nbt.151 1 Cox, J., N. Neuhauser, A. Michalski, R.A. Scheltema, J.V.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi   .org/10.1021/pr101065 j Davies, A.A., J.-Y.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/S1097-2765(01)00175- 7 Dickson, R.M., A.B.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/4104 8 Duong, T., B. Goud, and K. Schauer.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1007/s10577-   010-9155- 6 Essers, J., R.W.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80199- 3 Essers, J., R.W.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
http://dx.doi.org/10.1016/S1568-7864(02)00110- 6,OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
http://dx.doi   .org/10.1046/j.1365-2818.2002.01066.,Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"82:2775– 2783. http://dx.doi.org/10.1016/S0006-3495(02)75618- X Thorslund, T., M.J. McIlwraith, S.A. Compton, S. Lekomtsev, M. Petronczki,  J.D.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/   nsmb.190 5 Tokunaga, M., N. Imamoto, and K. Sakata-Sogawa.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/nmeth117 1 Ulbrich, M.H., and E.Y.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"95:312– 321. http://dx.doi.org/10.1002/bip.2158 5 van Royen, M.E., S.M.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1083/jcb   .20060917 8 Van Royen, M.E., W.A.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1242/jcs.13522 8 van Veelen, L.R., J. Essers, M.W.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi   .org/10.1016/j.mrfmmm.2005.01.02 0 Vaughn, J.P., F.D.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/S0960-9822(02)00763- 7 Xie, X.S., P .J.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/S1097-2765(03)00394- 0 Zhang, B., J. Zerubia, and J.C. Olivo-Marin.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1364/AO.46.00181 9Löbrich, M., A. Shibata, A. Beucher, A. Fisher, M. Ensminger, A.A. Goodarzi,  O. Barton, and P.A.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.4161/cc.9.4.1076 4 Magwood, A.C., M.J. Malysewich, I. Cealic, M.M.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/   j.dnarep.2013.10.00 6 Mazza, D., A. Abernathy, N. Golob, T. Morisaki, and J.G.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1093/nar/gks70 1 Meijering, E., O. Dzyubachyk, and I. Smal.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10   .1016/B978-0-12-391857-4.00009- 4 Mizuta, R., J.M.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10   .1073/pnas.94.13.692 7 Montenegro Gouveia, S., K. Leslie, L.C.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/j.cub.2010.08.02 0 Nagai, T., K. Ibata, E.S.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/   10.1093/nar/gkp87 3 Roy, R., J. Chun, and S.N.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/nrc318 1 Saeki, H., N. Siaud, N. Christ, W.W. Wiegant, P.P.W.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi   .org/10.1073/pnas.060029810 3 Sanchez, H., M. Reuter, M. Yokokawa, K. Takeyasu, and C. Wyman.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/j.dnarep.2014.02.01 2 Schlacher, K., N. Christ, N. Siaud, A. Egashira, H. Wu, and M. Jasin.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/j.cell.2011.03.04 1 Schütz, G.J., H. Schindler, and T. Schmidt.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/S0006-3495(97)78139- 6 Schwille, P., S. Kummer, A.A. Heikal, W.E.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"21:962– 968. http://dx.doi.org/10.1038/nsmb.289 9 Sharan, S.K., M. Morimatsu, U. Albrecht, D.S.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1038/386804a 0 Siaud, N., M.A.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1371/journal.pgen.100240 9 Speil, J., and U. Kubitscheck.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/10.1016/j.bbamcr.2009.10.01 0 Stark, J.M., P. Hu, A.J.",OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"http://dx.doi.org/   10.1074/jbc.M11213220 0 Tan, T.L., J. Essers, E. Citterio, S.M.",Non-OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
http://dx.doi.org/10.1016/S0960-9822(99)80142- 0,OADS,/arxiv_data1/oa_pdf/de/eb/JCB_201405014.PMC4259808.pdf
"In  cancer, these anti-oncogenic effects of CDK5 can provide  selective pressure for the down-regulation of DLC1, which  occurs frequently in tumors, and can contribute to the pro- oncogenic activity of CDK5 in lung adenocarcinoma.CDK5 is a major regulator of the tumor   suppressor DLC1 Brajendra K. Tripathi,1* Xiaolan Qian,1* Philipp Mertins,2 Dunrui Wang,1 Alex G. Papageorge,1 Steven A. Carr,2   and Douglas R. Lowy1 1Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda 20892, MD 2The Broad Institute of MIT and Harvard, Cambridge 02142, MA This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress   .org/terms).",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
Publicly available microarray data analysis The gene expression microarray analyses reported in this study used data  from caArray (https://array.nci.nih.gov/caarray/home.action) of the NCI.,OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/   full/jcb.201405105/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1186/1476-4598-9-20 4 Arif, A.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1016/j.bcp.2012.06.02 7 Cao, X., C. Voss, B. Zhao, T. Kaneko, and S.S. Li.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1773-05.200 5 Contreras-Vallejos, E., E. Utreras, and C. Gonzalez-Billault.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1016/j.cellsig.2011.08.02 2 Cox, J., and M. Mann.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/   nbt.151 1 Cox, J., N. Neuhauser, A. Michalski, R.A. Scheltema, J.V.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1021/pr101065 j Director’s Challenge Consortium for the Molecular Classification of Lung  Adenocarcinoma, Shedden, K., J.M.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/nm.179 0 Durkin, M.E., M.R.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1016/j.febslet.2004.12.09 0 Durkin, M.E., V. Ullmannova, M. Guan, and N.C. Popescu.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"26:4580– 4589. http://dx.doi.org/10.1038/sj.onc.121024 4 Elias, J.E., and S.P.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
http://dx.doi   .org/10.1007/s10585-007-9119- 1buffer.,Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1074/jbc   .M80904020 0 Ponting, C.P., and L. Aravind.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1016/S0968-0004(99)01362- 6 Pozo, K., E. Castro-Rivera, C. Tan, F. Plattner, G. Schwach, V. Siegl, D. Meyer,  A. Guo, J. Gundara, G. Mettlach, et al.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/   10.1016/j.ccr.2013.08.02 7 Qian, X., G. Li, H.K.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/   10.1073/pnas.070303310 4 Qian, X., G. Li, W.C. Vass, A. Papageorge, R.C.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-12-236 8 Qiao, F., and J.U.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/   nprot.2007.26 1 Rathinam, R., A. Berrier, and S.K.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"16:2561– 2571. http://dx.doi.org/10.2741/387 2 Sabbir, M.G., N. Wigle, S. Loewen, Y. Gu, C. Buse, G.G.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1186/1741-7007-8-1 7 Sato, Y., M. Taoka, N. Sugiyama, K. Kubo, T. Fuchigami, A. Asada, T. Saito, K.  Nakajima, T. Isobe, and S. Hisanaga.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1111/j.1365- 2443.2007.01139. x Shevchenko, A., H. Tomas, J. Havlis, J.V .",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/nprot.2006.46 8 Su, S.C., and L.H.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1146/annurev-cellbio-092910-15402 3 Tripathi, B.K., and P.S.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1128/MCB.01098-0 9 Tripathi, B.K., M.A.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1016/j.febslet.2008.04.03 9 Vigil, D., J. Cherfils, K.L.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/nrc296 0 Vogelstein, B., and K.W.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/nm108 7 Wong, C.M., J.M.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-05-285 0 Yang, Y., H. Wang, J. Zhang, F. Luo, K. Herrup, J.A.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"378:94– 106. http://dx.doi.org/10.1016/j.ydbio.2013.03.02 3 Yau, T.O., T.H.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1371/journal   .pone.000656 6Feldmann, G., A. Mishra, S.M.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-110 7 Healy, K.D., L. Hodgson, T.Y.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1002/mc.2038 9 Huber, R.J., and D.H. O’Day.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1002/jcb.2341 7 Katz, M., I. Amit, A. Citri, T. Shay, S. Carvalho, S. Lavi, F. Milanezi, L. Lyass,  N. Amariglio, J. Jacob-Hirsch, et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/ncb162 2 Kawauchi, T., K. Chihama, Y. Nabeshima, and M. Hoshino.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10   .1038/ncb133 8 Kim, T.Y., K.D.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1074/jbc.M80061720 0 Kim, T.Y., D. Vigil, C.J.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1007/s10555-008-9167- 2 Kim, T.Y., S. Jackson, Y. Xiong, T.G.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1002/ijc.2850 5 Levacque, Z., J.L.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.4161/cc.2188 6 Li, G., X.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1073/   pnas.111212210 8 Liao, Y.C., L. Si, R.W.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1083/jcb.20060801 5 Lin, H., M.C.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1074/jbc   .M60723420 0 Lin, Y., N.T.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1038/onc.2010.5 4 Liu, J.L., X.Y.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/   10.1007/s12032-010-9510- 7 Lukasik, D., E. Wilczek, A. Wasiutynski, and B. Gornicka.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1038/nrm343 4 Miyamoto, Y., J. Yamauchi, J.R. Chan, A. Okada, Y. Tomooka, S. Hisanaga,  and A. Tanoue.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi.org/10.1242/jcs.01821 8 Ohshima, T., J.M.",OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
http://dx.doi   .org/10.1046/j.1471-4159.2002.00824.,Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
"http://dx.doi   .org/10.1242/jcs.02748 2 Zukerberg, L.R., G.N.",Non-OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
http://dx.doi   .org/10.1016/S0896-6273(00)81200- 3,OADS,/arxiv_data1/oa_pdf/7a/3f/JCB_201405105.PMC4259810.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201406135/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"142:1105– 1119. http://dx.doi.org/10.1083/jcb.142.4.110 5 Benjamin, J.M., A.V.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1083/jcb.20091004 1 Brugnera, E., L. Haney, C. Grimsley, M. Lu, S.F.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1038/   nrm252 3 Burridge, K., and K. Wennerberg.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)00003- 0 Côté, J.-F., and K. Vuori.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1016/S1534-   5807(02)00216- 2Materials and methods Cell culture MDCK G type II cells were grown in DMEM with 1 g/liter sodium bicar - bonate, 10% fetal bovine serum (Atlas Biologicals), penicillin, streptomy - cin, and kanamycin.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"Raichu   FRET probes for Rac1 (1,026×; a sequential fusion of four proteins), YFP-CRIB   (Cdc42/Rac interactive binding) domain [p21-activated kinase]-Rac1-CFP,  expressed from a cytomegalovirus [CMV] promoter in a pCAGGS back - bone), and RhoA (1,298×; a sequential fusion of four proteins, YFP-RBD  domain[PKN]-RhoA-CFP, expressed from a CMV promoter in a pCAGGS  backbone) were variants of published probes that contained Venus instead  of YFP (http://www.fret.lif.kyoto-u.ac.jp/e-phogemon/vector.htm) and were  gifts from M. Matsuda (Kyoto University, Kyoto, Japan).",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1083/jcb.147.5.100 9 Santy, L.C., K.S.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1016/   j.cub.2005.08.05 2 Tapon, N., and A.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1038/ncb266 3 Yamada, S., and W.J.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1083/jcb.20070105 8 Yoshizaki, H., Y. Ohba, K. Kurokawa, R.E.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1083/jcb.20021204 9 Zhang, J., M. Betson, J. Erasmus, K. Zeikos, M. Bailly, L.P. Cramer, and V.M.M.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10   .1242/jcs.0263 9Feige, J.N., D. Sage, W. Wahli, B. Desvergne, and L. Gelman.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi   .org/10.1002/jemt.2021 5 Hodgson, L., F. Shen, and K. Hahn.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1128/   MCB.22.18.6582-6591.200 2 Katoh, H., and M. Negishi.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi   .org/10.1038/nature0181 7 Kitt, K.N., and W.J.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1371/journal.pone.001784 1 Malliri, A., S. van Es, S. Huveneers, and J.G.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi   .org/10.1074/jbc.M40119220 0 Margaron, Y., N. Fradet, and J.-F. Côté.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1083/jcb.20010313 4 McCormack, J., N.J. Welsh, and V.M.M.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1074/jbc.M30027720 0 Meller, N., S. Merlot, and C. Guda.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1242/jcs.0267 1 Nayal, A., D.J.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1083/jcb.20050907 5 Nelson, W.J.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1101/cshperspect.a00051 3 Niessen, C.M.C., D. Leckband, and A.S.A.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10   .1038/ncb93 8 O’Toole, T.E., K. Bialkowska, X. Li, and J.E.B.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/10.1016/j.cub.2010.10.02 8 Patel, M., T.-C. Chiang, V. Tran, F.-J.S.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi   .org/10.1074/jbc.M111.27419 1 Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
"http://dx.doi.org/   10.1038/nmeth.122 0 Rosenberger, G., I. Jantke, A. Gal, and K. Kutsche.",OADS,/arxiv_data1/oa_pdf/8f/f1/JCB_201406135.PMC4259811.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi   .org/10.1016/j.bpj.2011.08.04 8 Bakolitsa, C., J.M.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)81549- 4 Bakolitsa, C., D.M.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1038/nature0261 0 Bois, P.R., B.P.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1074/jbc.M51039720 0 Borgon, R.A., C. Vonrhein, G. Bricogne, P.R.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi   .org/10.1016/j.str.2004.05.00 9 Bricogne, G., E. Blanc, M. Brandl, C. Flensburg, P. Keller, P. Paciorek, P.  Roversi, A. Sharff, O.S.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1242/   jcs.0173 4 Chen, H., D.M.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1074/jbc.M60732420 0 Davis, I.W., L.W.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1093/nar/gkh39 8 Di Paolo, G., and P. De Camilli.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1038/   nature0518 5 Diez, G., F. List, J. Smith, W.H.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/   10.1016/j.bbrc.2008.05.18 2 Diez, G., P. Kollmannsberger, C.T.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"314:2163) http://dx.doi.org/10   .1006/excr.1996.345 1Immunoblotting Cells showing stable and comparable levels of expression of vinculin or  vinculin mutants were cultured to 70–80% confluency on gelatin-coated  10-cm Petri dishes in media supplemented with 200 µg/ml Zeocin, and  were collected through trypsinization.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201404128/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"17:781– 783. http://dx.doi.org/10.1016/j.str.2009.05.00 4 Matthews, B.W.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"33:491– 497. http://dx.doi.org/10.1016/0022-2836(68)90205- 2 McLaughlin, S., J. Wang, A. Gambhir, and D. Murray.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1146/annurev   .biophys.31.082901.13425 9 Milam, L.M.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10   .1016/0022-2836(85)90301- 8 Molony, L., and K. Burridge.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/   10.1002/jcb.24029010 4 Palmer, S.M., M.D.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1021/bi801764 a Palmer, S.M., M.P.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi   .org/10.1074/jbc.M80784220 0 Peng, X., E.S.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/B978-0-12-386043-9.00005- 0 Poon, I.Kh., A.A. Baxter, F.T.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.7554/eLife.0180 8 Ramarao, N., C. Le Clainche, T. Izard, R. Bourdet-Sicard, E. Ageron, P.J.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10   .1016/j.febslet.2007.01.05 7 Rangarajan, E.S., and T. Izard.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi   .org/10.1074/jbc.M112.35102 3 Rangarajan, E.S., J.H.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1371/journal.pone.001067 9 Rangarajan, E.S., J.H.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi   .org/10.1002/pro.66 4 Saad, J.S., J. Miller, J. Tai, A. Kim, R.H. Ghanam, and M.F.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/j.ejcb.2006.01.01 4 Shen, K., C.E.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10   .1074/jbc.M111.24429 3 Steimle, P .A., J.D.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1074/jbc.274.26.1841 4 Thievessen, I., P.M. Thompson, S. Berlemont, K.M.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/   10.1083/jcb.20130312 9 Thompson, P.M., C.E.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/j.febslet.2013.02.04 2 Thompson, P.M., C.E.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.4161/cam.2318 4 Vagin, A., and A. Teplyakov.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1083/jcb.20020415 3 George, E.M., T. Izard, S.D.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1074/jbc.M110.10863 9 Giannone, G., G. Jiang, D.H. Sutton, D.R.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1083/jcb.20030200 1 Gilmore, A.P., and K. Burridge.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"381:531– 535. http://dx.doi.org/10.1038/381531a 0 Grashoff, C., B.D.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/   10.1038/nature0919 8 Hansen, S.B., X. Tao, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"477:495– 498. http://dx.doi.org/10.1038/nature1037 0 Hüttelmaier, S., P. Bubeck, M. Rüdiger, and B.M.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
http://dx.doi.org/10.1111/ j.1432-1033.1997.01136.,Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/S0960-9822(98)70199- X Izard, T., G. Evans, R.A. Borgon, C.L.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1038/nature0228 1 Janssen, M.E., E. Kim, H. Liu, L.M.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/   j.molcel.2005.11.02 0 Janssen, M.E., H. Liu, N. Volkmann, and D. Hanein.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1083/jcb.20111104 6 Jockusch, B.M., and G. Isenberg.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1038/373261a 0 Johnson, R.P., and S.W.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1126/   science.121823 1 Kono, N., U. Ohto, T. Hiramatsu, M. Urabe, Y. Uchida, Y. Satow, and H.  Arai.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1126/   science.123350 8 Le Clainche, C., S.P.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1074/jbc   .M110.10283 0 Lee, J.H., E.S.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/   10.1016/j.str.2009.04.01 0 Lee, J.H., E.S.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/   10.1016/j.jmb.2012.06.01 5 Ling, K., R.L.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1038/nature0108 2 Ling, K., N.J. Schill, M.P.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
http://dx.doi.org/10.1016/j.tcb.2006.03.00 7,OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1107/S090744491100777 3 Weekes, J., S.T.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/0092-   8674(82)90377- 4 Wirth, V.F., F. List, G. Diez, and W.H.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1016/j.bbrc.2010.06.09 4 Witt, S., A. Zieseniss, U. Fock, B.M.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"279:31533– 31543. http://dx.doi.org/10.1074/jbc.M31424520 0 Xu, W., H. Baribault, and E.D.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1146/   annurev.physiol.65.092101.14251 7 Zaidel-Bar, R., C. Ballestrem, Z. Kam, and B. Geiger.",OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
"http://dx.doi.org/10.1242/   jcs.0079 2 Ziegler, W.H., R.C.",Non-OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
http://dx.doi.org/   10.1016/j.tcb.2006.07.00 4,OADS,/arxiv_data1/oa_pdf/8b/d6/JCB_201404128.PMC4259812.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201408090/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1189/jlb.080954 9 Sindrilaru, A., and K. Scharffetter-Kochanek.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1089/wound.2012.040 7 Starnes, T.W., and A. Huttenlocher.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1155/2012/39864 0 Stasia, M.J., and X.J.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1007/s00281-008-0121- 8 Stramer, B., S. Moreira, T. Millard, I. Evans, C.Y .",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1083/jcb.20091213 4 Theveneau, E., B. Steventon, E. Scarpa, S. Garcia, X. Trepat, A. Streit, and R.  Mayor.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1038/ncb277 2 Woodfin, A., M.B.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1189/jlb.101056 7 Yoo, S.K., T.W.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1038/nature1063 2 Yoo, S.K., C.M.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1083/jcb.20120315 4 Zhu, J.W., T. Brdicka, T.R.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1016/j.immuni.2007.11.02 4References Abercrombie, M. 1967.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.2741/   3015 Abtin, A., R. Jain, A.J.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1038/ni.276 9 Baruzzi, A., E. Caveggion, and G. Berton.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"65:2175– 2190. http://dx.doi.org/10.1007/s00018-008-8005- 6 Bratton, D.L., and P.M. Henson.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/   10.1016/j.it.2011.04.00 9 Brüne, B., N. Dehne, N. Grossmann, M. Jung, D. Namgaladze, T. Schmid, A. von  Knethen, and A. Weigert.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1089/   ars.2012.478 5 Byeon, S.E., Y.S.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1155/2012/51292 6 Chaubey, S., G.E.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1371/journal.pone.005486 9 Ellett, F., L. Pase, J.W.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1182/blood-   2010-10-31412 0 Fredman, G., and C.N.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1042/BJ2011032 7 Gurskaya, N.G., V .V .",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1038/nbt119 1 Holmes, G.R., G. Dixon, S.R.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi   .org/10.1155/2012/79216 3 Li, L., H. Jin, J. Xu, Y. Shi, and Z. Wen.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1182/blood-2010-06-29070 0 Li, L., B. Yan, Y.Q.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1074/jbc   .M112.34912 6 Mathias, J.R., B.J.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10   .1189/jlb.050634 6 Meng, F., and C.A.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1093/emboj/17   .15.439 1 Nathan, C. 2006.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1038/nri178 5 Nathan, C., and A. Ding.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.02 9 Niethammer, P., C. Grabher, A.T. Look, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1038/nature0811 9 Ortega-Gómez, A., M. Perretti, and O. Soehnlein.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10   .1002/emmm.20120238 2 Robertson, A.L., G.R.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
"http://dx.doi.org/10.1126/scitranslmed.300767 2 Silva, M.T.",Non-OADS,/arxiv_data1/oa_pdf/8f/fe/JCB_201408090.PMC4259815.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201404127/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201404127.d v. We thank Dr. Sarah Murdoch (Dundee) for valuable help and constant techni - cal advice throughout the course of this project.,Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi   .org/10.1099/00221287-141-1-12 3 Brurberg, M.B., I.F.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1099/13500872-142-7-158 1 Cox, J., and M. Mann.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/   10.1038/nbt.151 1 de Lorenzo, V ., M. Herrero, U. Jakubzik, and K.N.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1111/j.1365- 2958.2006.05377. x English, G., K. Trunk, V.A.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1111/mmi.1202 8 Flyg, C., K. Kenne, and H.G.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi   .org/10.1128/JB.183.24.7044-7052.200 1 Francetic, O., D. Belin, C. Badaut, and A.P.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1093/   emboj/19.24.669 7 Frederiksen, R.F., D.K.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1099/mic.0.051839- 0 Fukushima, T., Y. Yao, T. Kitajima, H. Yamamoto, and J. Sekiguchi.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1007/s00438-007-0255- 8 Goemans, C., K. Denoncin, and J.F.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi   .org/10.1016/j.bbamcr.2013.10.01 4 Govind, R., and B. Dupuy.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1074/jbc.275.2.76 9Guzman, L.M., D. Belin, M.J. Carson, and J. Beckwith.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1099/00222615-46-11-90 3 Hines, D.A., P.N.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"EMBO Rep.  14:95– 102. http://dx.doi.org/10.1038/embor.2012.18 6 Iguchi, A., Y. Nagaya, E. Pradel, T. Ooka, Y. Ogura, K. Katsura, K. Kurokawa,  K. Oshima, M. Hattori, J. Parkhill, et al.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10   .1093/gbe/evu16 0 Jack, R.L., G. Buchanan, A. Dubini, K. Hatzixanthis, T. Palmer, and F. Sargent.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1038/sj.emboj.760040 9 Javelle, A., E. Severi, J. Thornton, and M. Merrick.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi   .org/10.1074/jbc.M31239920 0 Kaniga, K., I. Delor, and G.R.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1007/s00018-003-3056- 1 Korotkov, K.V., M. Sandkvist, and W.G.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
http://dx.doi   .org/10.1111/j.1365-2958.2011.07803.,Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1146/annurev-physiol-012110-14225 0 Mahlen, S.D.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1128/   CMR.00017-1 1 Manza, L.L., S.L.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1002/pmic.20040106 3 Marlow, V.L., M. Porter, L. Hobley, T.B.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1128/JB.00930-1 3 Olling, A., S. Seehase, N.P.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1016/   j.micpath.2011.10.00 9 Palmer, T., and B.C.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1021/   bi010505 h Reddy, B.L., and M.H.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1016/j.bbamem.2013.07.00 4 Ritorto, M.S., K. Cook, K. Tyagi, P.G.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"12:2449– 2457. http://dx.doi.org/10.1021/pr301011 r Scheurwater, E., C.W.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1016/j.biocel.2007.03.01 8 Shcherbo, D., E.M. Merzlyak, T.V.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
http://dx.doi   .org/10.1038/nmeth108 3,Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1099/   13500872-145-5-120 9 Summer, E.J., J. Berry, T.A.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1016/j.jmb.2007.08.04 5 Suzuki, K., M. Taiyoji, N. Sugawara, N. Nikaidou, B. Henrissat, and T. Watanabe.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1042/0264-6021:343058 7 Suzuki, K., T. Uchiyama, M. Suzuki, N. Nikaidou, M. Regue, and T. Watanabe.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi   .org/10.1271/bbb.65.33 8 Tran, H.T., N. Barnich, and E. Mizoguchi.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1002/pmic.20040102 4 Vaaje-Kolstad, G., D.R.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi   .org/10.1016/j.bbapap.2003.09.01 4 Vaaje-Kolstad, G., S.J.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"280:28492– 28497. http://dx.doi.org/10.1074/jbc.M50446820 0 Vaaje-Kolstad, G., D.R.",OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"280:11313– 11319. http://dx.doi.org/10.1074/jbc.M40717520 0 White, R., T.A.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
"http://dx.doi.org/10.1128/   JB.01263-0 9 Wiśniewski, J.R., A. Zougman, N. Nagaraj, and M. Mann.",Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
http://dx.doi.org/10.1038/nmeth.132 2,Non-OADS,/arxiv_data1/oa_pdf/40/05/JCB_201404127.PMC4259817.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/ce/hmer-6-113.PMC4259863.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHepatic Medicine: Evidence and Research 2014:6 113–118Hepatic Medicine: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  113REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S6008 3Metabolic syndrome in chronic hepatitis C  infection: does it still matter in the era   of directly acting antiviral therapy?,Non-OADS,/arxiv_data1/oa_pdf/37/ce/hmer-6-113.PMC4259863.pdf
"Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hepatic-medicine-evidence-and-research-journa lHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pedi - atric hepatology in the clinic and laboratory including the following  topics: Pathology, pathophysiology of hepatic disease; Investigation  and treatment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/37/ce/hmer-6-113.PMC4259863.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/ce/hmer-6-113.PMC4259863.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/34/ceor-6-523.PMC4259865.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2014:6 523–530ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  523REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CEOR.S3069 7Different strategies and cost-effectiveness   in the treatment of primary open angle glaucoma Naomi SJ Ting1 James FT Li Yim2 Jia Y Ng2,3 1Hull Royal infirmary, Hull, UK;   2Department of Ophthalmology,   University Hospital Ayr, South  Ayrshire, UK; 3Faculty of Medicine,   University of Glasgow, Glasgow, UK Correspondence: Jia Y Ng   Department of Ophthalmology,   Third Floor, Ayr Hospital, Dalmellington  Road, South Ayrshire, KA6  6DX,  Scotland, United Kingdom   Tel +44 12 9261 4843  Fax +44 12 9261 4646  Email j iayung@nhs.",Non-OADS,/arxiv_data1/oa_pdf/ad/34/ceor-6-523.PMC4259865.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/ad/34/ceor-6-523.PMC4259865.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/34/ceor-6-523.PMC4259865.pdf
Available  from http://hdr.undp.org/en/content/human-development-report-200 6.,Non-OADS,/arxiv_data1/oa_pdf/ad/34/ceor-6-523.PMC4259865.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/2f/clep-6-433.PMC4259866.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2014:6 433–440Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  433Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7203 2aspirin overutilization for the primary   prevention of cardiovascular disease Jeffrey J VanWormer1 aaron W Miller2 shereif h rezkalla3 1Center for Clinical Epidemiology  and Population health,  2Biomedical  informatics research Center,   Marshfield Clinic research  Foundation, Marshfield, Wi, Usa;   3Department of Cardiology, Marshfield  Clinic, Marshfield, Wi, Usa Correspondence: Jeffrey J VanWormer   Center for Clinical Epidemiology and  Population Health, Marshfield Clinic  research Foundation,  1000 north Oak  Avenue, Marshfield, WI  54449, Usa   Tel +1 715 221 6484  Fax +1 715 389 3880  Email vanwormer.jeffrey@mcrf.mfldclin.ed uBackground:  Aspirin is commonly used for the primary prevention of cardiovascular disease  (CVD) in the US.",Non-OADS,/arxiv_data1/oa_pdf/f9/2f/clep-6-433.PMC4259866.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/f9/2f/clep-6-433.PMC4259866.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/4f/ijgm-7-525.PMC4259867.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 525–529International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  525OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7164 4effect of acetylsalicylic acid on thalassemia   with pulmonary arterial hypertension nonlawan  chueamuangphan1,2 Wattana Wongtheptian2 Jayanton Patumanond3 apichard sukonthasarn4 suporn chuncharunee5 chamaiporn Tawichasri6 Weerasak nawarawong4 1clinical epidemiology Program,   Faculty of Medicine, chiang Mai  University, chiang Mai, Thailand;   2Department of Medicine, chiang rai  hospital, chiang rai, Thailand; 3clinical  epidemiology Program, Faculty of  Medicine, Thammasat University,   Bangkok, Thailand; 4Department of  Medicine, Faculty of Medicine, chiang  Mai University, chiang Mai, Thailand;   5Department of Medicine, Faculty  of Medicine, ramathibodi hospital,   Mahidol University, Bangkok, Thailand;   6clinical epidemiology society at  chiang Mai, chiang Mai, Thailand correspondence: nonlawan  chueamuangphan   Department of Medicine, chiang rai  hospital, chiang rai 57000, Thailand   Tel +66 53 711 300   Fax +66 53 713 044   email nonlawanbim@gmail.co mObjective:  To compare pulmonary artery systolic pressure (PASP) between thalassemic  patients with pulmonary arterial hypertension (PAH) for whom acetylsalicylic acid (ASA) was  and was not prescribed after 1 year.",Non-OADS,/arxiv_data1/oa_pdf/44/4f/ijgm-7-525.PMC4259867.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/44/4f/ijgm-7-525.PMC4259867.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/4f/ijgm-7-525.PMC4259867.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/74/dmso-7-587.PMC4259868.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 587–591Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  587Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6740 0Mechanism linking diabetes mellitus and obesity Abdullah S Al-Goblan1 Mohammed A Al-Alfi1 Muhammad Z Khan2 1Diabetes Center, King Fahad  Specialist Hospital, Buraidah,    Qassim, Kingdom of Saudi Arabia;   2Sulaiman AlRajhi Colleges,   Al Bukairiyah, Kingdom   of Saudi Arabia Correspondence: Abdullah S Al-Goblan   Diabetes Center, King Fahad Specialist  Hospital, Buraidah, Qassim,   PO Box 2290, Buraidah 81999,   Kingdom of Saudi Arabia   Fax +966 063 250 870   email agoblan@yahoo.co mAbstract:  Body mass index has a strong relationship to diabetes and insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/29/74/dmso-7-587.PMC4259868.pdf
Or use: http://dvpr.es/1rSdsl 0,Non-OADS,/arxiv_data1/oa_pdf/29/74/dmso-7-587.PMC4259868.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/29/74/dmso-7-587.PMC4259868.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/74/dmso-7-587.PMC4259868.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/ce/ijgm-7-513.PMC4259869.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 513–524International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  513OrIGInal rESEarCHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJGM.S7273 6analysis of the presence or absence of atrophy   of the subgenual and subcallosal cingulate   cortices using voxel-based morphometry   on MrI is useful to select prescriptions   for patients with depressive symptoms akira niida1 richi niida2 Hiroshi Matsuda3 Makoto Motomura4 akihiko Uechi5 1Department of radiology, nanbu  Hospital, Itoman City, Okinawa, Japan;   2Department of Psychiatry, nanto  Clinic, Urasoe City, Okinawa, Japan;   3Integrative Brain Imaging Center,   national Center of neurology and  Psychiatry, Kodaira City, T okyo, Japan;   4Department of Human Sciences,   University of the ryukyus, nakagami  County, Okinawa, Japan;  5Cognitive  neuroscience research Project,   Kansai Gaidai University, Hirakata  City, Osaka, Japan Correspondence: akira niida   Department of radiology, nanbu  Hospital,  870 Maezato, Itoman City,  Okinawa,  901-0362, Japan   Tel +81 98 994 0501  Fax +81 98 994 0525  Email aniida@nirai.ne.j pObjective:  We objectively evaluated the presence or absence of atrophy of the subgenual  anterior cingulate cortex (sgACC) and the subcallosal anterior cingulate cortex (scACC), using  new voxel-based morphometry (VBM) software employing Statistical Parametric Mapping  software v8 and diffeomorphic anatomic registration through an exponentiated lie algebra.",Non-OADS,/arxiv_data1/oa_pdf/3f/ce/ijgm-7-513.PMC4259869.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/3f/ce/ijgm-7-513.PMC4259869.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/ce/ijgm-7-513.PMC4259869.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/85/ceor-6-505.PMC4259870.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2014:6 505–514ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  505ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/CEOR.S7130 1seriousness, preventability, and burden impact   of reported adverse drug reactions in lombardy  emergency departments: a retrospective 2-year  characterization Valentina Perrone1,* Valentino Conti2,* Mauro Venegoni2 stefania scotto2 luca Degli Esposti3 Diego sangiorgi3 lucia Prestini4 sonia Radice1 Emilio Clementi5,6 giuseppe Vighi2,4 1Unit of Clinical Pharmacology,   Department of Biomedical and  Clinical sciences, University hospital  luigi sacco, Università di Milano,   Milan, italy; 2Regional Centre for  Pharmacovigilance, lombardy, Milan,   italy; 3CliCon srl, health, Economics  and Outcomes Research, Ravenna,   italy; 4Unit of Clinical Pharmacology  and Pharmacovigilance, niguarda  Ca’granda hospital, Milan, italy;   5Unit of Clinical Pharmacology,   CnR institute of neuroscience,   Department of Biomedical and  Clinical sciences, University hospital  luigi sacco, Università di Milano,   Milan, italy; 6scientific institute, iRCC s  Eugenio Medea, lecco, italy *These authors contributed equally  to the work Correspondence: Emilio Clementi   Unit of Clinical Pharmacology, luigi sacco  University hospital, University of Milano,  Via gB grassi, 74 – 20157 Milan, italy   Tel +39 02 5031 9643   Fax +39 02 5031 9646   Email emilio.clementi@unimi.i tObjective:  The purpose of this study was to determine the prevalence of adverse drug reactions  (ADRs) reported in emergency departments (EDs) and carry out a thorough characterization  of these to assess preventability, seriousness that required hospitalization, subsequent 30-day  mortality, and economic burden.",Non-OADS,/arxiv_data1/oa_pdf/4b/85/ceor-6-505.PMC4259870.pdf
"Available from: http://www.who-umc.org/graphics/25301.pd f.  Accessed February 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/85/ceor-6-505.PMC4259870.pdf
"Available from:  http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri =OJ:L:2010:3 48:0074:0099:EN:PD F. Accessed October 19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/85/ceor-6-505.PMC4259870.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/4b/85/ceor-6-505.PMC4259870.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/85/ceor-6-505.PMC4259870.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/40/cia-9-2065.PMC4259871.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2065–2077Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2065RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7272 8Efficacy and tolerability of Ginkgo biloba  extract EGb 761® in dementia: a systematic  review and meta-analysis of randomized  placebo-controlled trials Serge Gauthier1  Sandra Schlaefke2 1Alzheimer Disease Research Unit,  Memory Clinic, McGill Centre for  Studies in Aging, McGill University,  Verdun, QC, Canada; 2Clinical Research  Department, Dr Willmar Schwabe  GmbH & Co. KG, Karlsruhe, GermanyAbstract:  The objective of this systematic review was to evaluate current evidence for the  efficacy of Ginkgo biloba extract EGb 761 in dementia.",Non-OADS,/arxiv_data1/oa_pdf/cd/40/cia-9-2065.PMC4259871.pdf
"It restores impaired mitochondrial function, thereby improving  neuronal energy supply,4 improves compromised hippocampal neurogenesis and  neuroplasticity,5 inhibits the aggregation and toxicity of A β protein,6 decreases blood  viscosity, and enhances microperfusion.7 In a recent study, EGb 761 specifically Correspondence: Serge Gauthier Alzheimer Disease Research Unit,  Memory Clinic, McGill Centre for Studies  in Aging, 6825 LaSalle Boulevard, Verdun,  QC, Canada, H4H 1R3 Tel +1 514 766 2010 Fax +1 514 888 4050 email serge.gauthier@mcgill.c a Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2014 Volume: 9 Running head verso: Gauthier and Schlaefke Running head recto: Meta-analysis of EGb 761® in dementia DOI: http://dx.doi.org/10.2147/CIA.S72728",Non-OADS,/arxiv_data1/oa_pdf/cd/40/cia-9-2065.PMC4259871.pdf
Available from: http://handbook.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/cd/40/cia-9-2065.PMC4259871.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/cd/40/cia-9-2065.PMC4259871.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/cd/40/cia-9-2065.PMC4259871.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/c4/ceor-6-515.PMC4259872.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2014:6 515–521ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  515ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S6742 4level, pattern, and determinants of polypharmacy  and inappropriate use of medications by village  doctors in a rural area of Bangladesh Rafia s Rasu1 Mohammad iqbal2 sMa hanifi2 ariful Moula2 shahidul hoque2 sabrina Rasheed2 abbas Bhuiya2 1school of Pharmacy, University of  Missouri-Kansas City, Kansas City,   MO, Usa; 2Centre for Equity and  health system, international Centre  for Diarrhoeal Disease Research  (iCDDR,B), Dhaka, Bangladesh Correspondence: Rafia S Rasu   school of Pharmacy, Doctoral Faculty   of henry W Bloch school of  Management, University of Missouri- Kansas City, 2464 Charlotte street,  Kansas City, MO, Usa   Tel +1 816 235 5498   Email rafiarasu@gmail.co mObjective:  Village doctors, informal health care providers practicing modern medicine, are  dominant health care providers in rural Bangladesh.",Non-OADS,/arxiv_data1/oa_pdf/2f/c4/ceor-6-515.PMC4259872.pdf
Or use: http://dvpr.es/1td9A2 Q,Non-OADS,/arxiv_data1/oa_pdf/2f/c4/ceor-6-515.PMC4259872.pdf
Available from: http://www.gov.cn/zwgk/2011-07/14/ content_1906244.htm.,Non-OADS,/arxiv_data1/oa_pdf/2f/c4/ceor-6-515.PMC4259872.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/2f/c4/ceor-6-515.PMC4259872.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/c4/ceor-6-515.PMC4259872.pdf
Available from:   http://www.fpnotebook.com/geri/Pharm/Plyphrmcy.htm.,Non-OADS,/arxiv_data1/oa_pdf/2f/c4/ceor-6-515.PMC4259872.pdf
Available at http://www.who.int//mediacentre/factsheets/ fs311/en (accessed 9 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/dc/fb/nutd201439a.PMC4259904.pdf
Available at http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/pof/2008_2009/.,Non-OADS,/arxiv_data1/oa_pdf/dc/fb/nutd201439a.PMC4259904.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Lycopene reduces TNF- αvia RAGE in kidney DT Pierine et al 6 Nutrition & Diabetes (2014) 1 –6 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/dc/fb/nutd201439a.PMC4259904.pdf
2012. http://www.ahrq.gov/research/findings/nhqrdr/nhqrdr11/qrdr11.,OADS,/arxiv_data1/oa_pdf/a0/13/10.1177_2150131914546325.PMC4259917.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/C/EBP βin breast cancer E Kurzejamska et al 11 © 2014 Macmillan Publishers Limited Oncogenesis (2014), 1 –11",Non-OADS,/arxiv_data1/oa_pdf/f1/c3/oncsis201438a.PMC4259962.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Class I HDAC inhibitors attenuate MLL-AF4 activity K Ahmad et al 11 © 2014 Macmillan Publishers Limited Oncogenesis (2014), 1 –11",Non-OADS,/arxiv_data1/oa_pdf/1a/2a/oncsis201439a.PMC4259963.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/EBAG9 as a modulator of antitumor immunity T Miyazaki et al 8 Oncogenesis (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/66/bf/oncsis201440a.PMC4259964.pdf
The lengths of red (Cy3) or green (AF 488) labeled patches were measured using the ImageJ software (National Institutes of Health; http://rsbweb.nih.gov/ij/) and arbitrary length values were converted into micrometers using the scale bars created bythe microscope.,OADS,/arxiv_data1/oa_pdf/29/9b/oncsis201442a.PMC4259965.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)Abasic site accumulation in H. pyloric infection D Kidane et al 12 Oncogenesis (2014), 1 –12 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/29/9b/oncsis201442a.PMC4259965.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)KLF4 regulates ﬁbrocyte generation from MDSCs Y Shi et al 7 © 2014 Macmillan Publishers Limited Oncogenesis (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/d6/16/oncsis201444a.PMC4259966.pdf
"The protein acronyms were as provided by the ProteinPilot software,which uses the gene symbol nomenclature based on the Guidelines for Human Gene Nomenclature 36and http://www.genenames.org/ guidelines.html.",OADS,/arxiv_data1/oa_pdf/be/d6/tp2014114a.PMC4259987.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Quantitative proteomics of delirium A Poljak et al 10 Translational Psychiatry (2014), 1 –10 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/be/d6/tp2014114a.PMC4259987.pdf
All calculations were performed under the R statistical environment(http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/56/08/tp2014116a.PMC4259988.pdf
Pathway analysis was conducted using Meta- boAnalyst online pathway tool (http://www.metaboanalyst.ca).,OADS,/arxiv_data1/oa_pdf/56/08/tp2014116a.PMC4259988.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Fluoxetine response metabolite pro ﬁle YH e et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/56/08/tp2014116a.PMC4259988.pdf
"Zones extending 2 cm from each novel object or novel mouse enclosure (inverted wire cup, GalaxyCup, Kitchen Plus, http://www.kitchen-plus.com), and direction of the head, body and tail de ﬁned sniff time.",Non-OADS,/arxiv_data1/oa_pdf/69/cf/tp2014117a.PMC4259989.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Intranasal oxytocin in BTBR mice KL Bales et al 10 Translational Psychiatry (2014), 1 –10 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/69/cf/tp2014117a.PMC4259989.pdf
"Pathway analyses were performed for each time point using MetaboAnalyst (http://www.metaboanalyst.ca) applying a hypergeometric algorithm for over- representation analysis and relative-betweeness centrality for pathway topology analysis.43,45,46Pathways were considered affected if they were signiﬁcantly enriched ( PHolm-corrected ⩽0.1) for all signi ﬁcantly altered metabolites of an individual time point.",OADS,/arxiv_data1/oa_pdf/9c/1f/tp2014119a.PMC4259990.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Time-dependent metabolomic pro ﬁling of Ketamine drug action K Weckmann et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/9c/1f/tp2014119a.PMC4259990.pdf
"16,18 Statistical analyses Statistical analyses and graphs were performed using JMP Pro 9 (SAS, Toronto, ON, Canada), R-statistical software (http://www.r-project.org/) and Stata 11.0 (StataCorp, College Station, TX, USA).",OADS,/arxiv_data1/oa_pdf/fe/42/tp2014120a.PMC4259991.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)The serotonin-NAS –melatonin pathway as autism biomarker C Pagan et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/fe/42/tp2014120a.PMC4259991.pdf
"R Foun- dation for Statistical Computing: Vienna, Austria, 2013; http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/5a/f1/tp2014121a.PMC4259992.pdf
R package version 1.0-5 2013; http://CRAN.R-project.org/package =lme4.,Non-OADS,/arxiv_data1/oa_pdf/5a/f1/tp2014121a.PMC4259992.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Codeine-induced hyperalgesia and allodynia JL Johnson et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/5a/f1/tp2014121a.PMC4259992.pdf
"(https://surfer.nmr.mgh.harvard.edu).27In brief, after removal of non-brain tissue via a hybrid watershed algorithm/surface deformation, the image then underwent an automated Talairach transformation and whole-brain segmentation.",Non-OADS,/arxiv_data1/oa_pdf/32/f6/tp2014124a.PMC4259994.pdf
(040.98).29The data were despiked (analysis of functional neuroimages 3dDespike (http://afni.nimh.nih.gov)) and then were band-pass ﬁltered (0.008 –0.09 Hz).,OADS,/arxiv_data1/oa_pdf/32/f6/tp2014124a.PMC4259994.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Agomelatine prevents chronic stress-evoked dysfunctions F Boulle et al 10 Translational Psychiatry (2014), 1 –10",Non-OADS,/arxiv_data1/oa_pdf/9a/f6/tp2014125a.PMC4259995.pdf
The data and Matlab code for our subnetwork detection algorithm are freely available from http://bioinfo.au.tsinghua.edu.cn/software/DGPsubNet and http://doc.aporc.org/wiki/DGPsubNet.,OADS,/arxiv_data1/oa_pdf/ea/03/psp201444a.PMC4259999.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/ea/03/psp201444a.PMC4259999.pdf
<http://www.who.int/ ipcs/methods/harmonization/areas/pbpk_models.pdf> (2010).,OADS,/arxiv_data1/oa_pdf/09/49/psp201445a.PMC4260000.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/09/49/psp201445a.PMC4260000.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/5f/88/psp201446a.PMC4260001.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/9d/25/psp201447a.PMC4260002.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr B Lajin; E-mail: BassamL7@yahoo.co.uk; Published online 28 October 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/bjc2014106a.PMC4260011.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2202 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/bjc2014106a.PMC4260011.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Professor Z Lu; E-mail: zuxunlu @yahoo.com Published online 25 February 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/bjc2014106a.PMC4260011.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2203,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/bjc2014106a.PMC4260011.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Professor Z Lu; E-mail: zuxunlu @yahoo.com Published online 25 February 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/ce/45/bjc2014107a.PMC4260012.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2203,Non-OADS,/arxiv_data1/oa_pdf/ce/45/bjc2014107a.PMC4260012.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr MA Malik; E-mail: maliksgpgi@gmail.com Published online 15 April 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/63/a5/bjc2014184a.PMC4260013.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2200 www.bjcancer.comLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/63/a5/bjc2014184a.PMC4260013.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2201,Non-OADS,/arxiv_data1/oa_pdf/bf/0e/bjc2014186a.PMC4260014.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2201,Non-OADS,/arxiv_data1/oa_pdf/e7/79/bjc2014212a.PMC4260015.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr B Lajin; E-mail: BassamL7@yahoo.co.uk; Published online 28 October 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/e7/79/bjc2014212a.PMC4260015.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2202 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/e7/79/bjc2014212a.PMC4260015.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr B Lajin; E-mail: BassamL7@yahoo.co.uk; Published online 28 October 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/c1/3b/bjc2014295a.PMC4260016.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2202 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/c1/3b/bjc2014295a.PMC4260016.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2199LETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/bjc2014334a.PMC4260017.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr MA Malik; E-mail: maliksgpgi@gmail.com Published online 15 April 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/bjc2014334a.PMC4260017.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2200 www.bjcancer.comLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/bjc2014334a.PMC4260017.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Serum micronutrients, liver cancer, and liver disease BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.365 2171",Non-OADS,/arxiv_data1/oa_pdf/21/bb/bjc2014365a.PMC4260018.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Professor Z Lu; E-mail: zuxunlu @yahoo.com Published online 25 February 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/f2/86/bjc2014401a.PMC4260019.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2203,Non-OADS,/arxiv_data1/oa_pdf/f2/86/bjc2014401a.PMC4260019.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2204 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/f2/86/bjc2014401a.PMC4260019.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2198 www.bjcancer.comLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/e8/df/bjc2014440a.PMC4260021.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2198 www.bjcancer.comLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/2e/86/bjc2014441a.PMC4260022.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2199LETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/2e/86/bjc2014441a.PMC4260022.pdf
Available at http://www.ons.gov.uk/ons/search/index.html?newquery=cancerþregistrations.,Non-OADS,/arxiv_data1/oa_pdf/19/f2/bjc2014480a.PMC4260024.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Aspirin use and colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.481 2179,Non-OADS,/arxiv_data1/oa_pdf/3d/5a/bjc2014481a.PMC4260025.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Dosing to rash: erlotinib in pancreatic cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.494 2075,Non-OADS,/arxiv_data1/oa_pdf/fa/45/bjc2014494a.PMC4260026.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)SERPINE1 and SMA expression in OSCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.500 2121,Non-OADS,/arxiv_data1/oa_pdf/0d/fa/bjc2014500a.PMC4260028.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Bevacizumab in mBC: TURANDOT risk factor analyses BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.504 2057,Non-OADS,/arxiv_data1/oa_pdf/79/f7/bjc2014504a.PMC4260030.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Predictors of adherence to repeat FOBT BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.507 2155,Non-OADS,/arxiv_data1/oa_pdf/cd/7d/bjc2014507a.PMC4260031.pdf
Available at http://hematologia-h12.com/onewebmedia/NCCN%20LMC%202014.pdfAccessed on 24 February 2014.,Non-OADS,/arxiv_data1/oa_pdf/6e/26/bjc2014508a.PMC4260032.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Bosutinib þcapecitabine in advanced solid tumours 2066 www.bjcancer.com | DOI:10.1038/bjc.2014.508,Non-OADS,/arxiv_data1/oa_pdf/6e/26/bjc2014508a.PMC4260032.pdf
"2014) http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf, accessed 20March 2014.Histological categorisation of EMT status in CRC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.509 2089",Non-OADS,/arxiv_data1/oa_pdf/0a/90/bjc2014509a.PMC4260033.pdf
11.http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/55/bc/bjc2014510a.PMC4260034.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Self-sampling increase cervical screening uptake 2196 www.bjcancer.com | DOI:10.1038/bjc.2014.510,Non-OADS,/arxiv_data1/oa_pdf/55/bc/bjc2014510a.PMC4260034.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)The lncRNA that suppress tumour invasion BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.520 2141,Non-OADS,/arxiv_data1/oa_pdf/42/06/bjc2014520a.PMC4260035.pdf
"To date, more than 1500 human miRNAs are known to exist and over half of all human genes are predicted to be repressed by miRNAs (miRBase;http://www.mirbase.org/).",Non-OADS,/arxiv_data1/oa_pdf/bb/df/bjc2014524a.PMC4260036.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Excess miRNA-378a-5p causes chromosome instability BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.524 2151,Non-OADS,/arxiv_data1/oa_pdf/bb/df/bjc2014524a.PMC4260036.pdf
"Ministry of Health and Welfare (2012) Statistical Annual Report of Medical Care: National Health Insurance, 2012. http://www.mohw.gov.tw/EN/Ministry/Statistic.aspx?f_list_no=474.",Non-OADS,/arxiv_data1/oa_pdf/fe/b5/bjc2014525a.PMC4260037.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER SOX2’s role in maintaining stemness of HNSCC stem-like cells 2130 www.bjcancer.com | DOI:10.1038/bjc.2014.528,Non-OADS,/arxiv_data1/oa_pdf/b0/ec/bjc2014528a.PMC4260038.pdf
http://clinicaltrials.gov(accessed 25 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/7b/72/bjc2014534a.PMC4260039.pdf
http://clinicaltrials.gov/ct2/results?term=NCT01186705 (accessed 25 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/7b/72/bjc2014534a.PMC4260039.pdf
http://clinicaltrials.gov/ct2/results?term=NCT01306045 (accessed 25 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/7b/72/bjc2014534a.PMC4260039.pdf
http://clinicaltrials.gov/ct2/results?term=NCT01312753 (accessed 25 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/7b/72/bjc2014534a.PMC4260039.pdf
"http://clinicaltrials.gov/ct2/results?term=NCT01277757 (accessed 25 September 2014).von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P,Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF,Tomlin I, Visseren-Grul CM, Conte PF (2000) Gemcitabine andcisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatinin advanced or metastatic bladder cancer: results of a large, randomized,multinational, multicenter, phase III study.",OADS,/arxiv_data1/oa_pdf/7b/72/bjc2014534a.PMC4260039.pdf
http://cancer.sanger.ac.uk/cancergenome/projects/ cell_lines (accessed 25 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/7b/72/bjc2014534a.PMC4260039.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)PIK3CA/DUSP1/ERK 1/2 regulate AKT therapy response BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.534 2113,Non-OADS,/arxiv_data1/oa_pdf/7b/72/bjc2014534a.PMC4260039.pdf
Normalised miRNAs with o20% missing values were included for Significance Analysis of Microarrays (SAM) (http://www-stat.stanford.edu/Btibs/SAM/) and clustering analysis.,OADS,/arxiv_data1/oa_pdf/82/ca/bjc2014548a.PMC4260040.pdf
"Functional annotation and gene ontology analyses were performed by GeneCodis3 (http://genecodis.cnb.csic.es/), using a combination of GO biological process and molecular function parameters.",OADS,/arxiv_data1/oa_pdf/82/ca/bjc2014548a.PMC4260040.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER microRNAs in imatinib resistance of GIST 2102 www.bjcancer.com | DOI:10.1038/bjc.2014.548,Non-OADS,/arxiv_data1/oa_pdf/82/ca/bjc2014548a.PMC4260040.pdf
"EXPERIMENTAL PROCEDURES Plant material and growth condition T-DNA tagged (pGPTV-Bar (http://biotech.unl.edu/pgptv-bar)) mutant population of Arabidopsis thaliana , ecotype Col0, were used in the screen.",OADS,/arxiv_data1/oa_pdf/7a/e7/tpj0078-0916.PMC4260087.pdf
Available at: http://dx.doi.org/ 10.1038/nprot.2007.287.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/tpj0078-0031.PMC4260089.pdf
"One report showed that endo - scopic ultrasound can predict large vessel which is located  within submucosal area and this can reduce immediate bleed - ing during endoscopic resection.13 The postoperative bleed - ing, which is defined as delayed bleeding in this article, can be  though as more important complication, especially in setting  of one day procedure, because endoscopists can not control Open Access Received:  November 14, 2014    Accepted:  November 14, 2014 Correspondence:  Hwoon-Y ong Jung Department of Gastroenterology, Asan Digestive Disease Research Institute, Asan  Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3180, Fax: +82-2-476-0824 E-mail:  hwoonymd@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Endoscopic Submucosal Dissection for Gastric Neoplasm   at an Outpatient Clinic: Efficacy and Safety Hwoon-Yong Jung and Ji Yong Ahn Department of Gastroenterology, Asan Digestive Disease Research Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea See “Gastric Endoscopic Submucosal Dissection Is Safe for Day Patients” by Sun Y oung Ahn, Sun Ik Jang, Dong Wook Lee,  et al., on page 538-543Clin Endosc  2014 ;47:473-475COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.473",Non-OADS,/arxiv_data1/oa_pdf/48/ff/ce-47-473.PMC4260092.pdf
"A cutoff value of 3.8 mg/dL dis - tinguished IgG4-SC from PSC and cholangiocarcinoma with Open Access Received:  October 14, 2014    Accepted:  October 17, 2014 Correspondence:  Ji Kon Ryu Division of Gastroenterology, Department of Internal Medicine and Liver Re - search Institute, Seoul National University College of Medicine, 101 Daehak-ro,  Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-1962, Fax: +82-2-762-9662 E-mail:  jkryu@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Diagnosis of Immunoglobulin G4-Related Sclerosing Cholangitis Ji Kon Ryu Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea See “IgG4 Levels in Bile for Distinguishing IgG4-Associated Cholangiopathy from Other Biliary Disorders: A Single Blind - ed Pilot Study) by Udayakumar Navaneethan, Norma G. Gutierrez, Ramprasad Jegadeesan, et al., on page 555-559Clin Endosc  2014 ;47:476-477COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.476",Non-OADS,/arxiv_data1/oa_pdf/ad/64/ce-47-476.PMC4260093.pdf
"Key Words :  Stomach neoplasms; Prevention; Mass screeningOpen Access Received:  November 3, 2014    Revised:  November 11, 2014 Accepted:  November 11, 2014 Correspondence:  Rolando Herrero Prevention and Implementation Group, Section of Early Detection and Pre - vention, International Agency for Research on Cancer, 150 Cours Albert Thom - as, 69372 Lyon Cedex 08, France Tel: +33-4-7273-8683, Fax: +33-4-7273-8518, E-mail:  herreror@iarc.fr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.478 INTRODUCTION In spite of declining incidence in recent years, gastric can - cer is still one of the most frequently occurring cancers.",Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
Available from: http://ci5.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
Available from: http://www.iarc.fr/en/publications/pdfs-online/ wrk/wrk8/index.php.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
Available from: http://www.iarc.fr/en/publications/pdfs-on - line/wrk/wrk8/index.php.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
Available  from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
Available from: http://www.iarc.fr/ en/publications/pdfs-online/wrk/wrk8/index.php.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/ wrk8/index.php.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/ce-47-478.PMC4260094.pdf
"Key Words :  Stomach neoplasms; Screening; Endoscopy; Upper gastrointestinal seriesOpen Access Received:  July 3, 2014    Revised:  July 18, 2014 Accepted:  July 23, 2014 Correspondence:  Kui Son Choi Graduate School of Cancer Science and Policy, National Cancer Center, 323  Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea Tel: +82-31-920-2184, Fax: +82-31-920-2189, E-mail:  kschoi@ncc.re.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.490 INTRODUCTION Until recently, gastric cancer comprised the second most  common type of cancer worldwide.",Non-OADS,/arxiv_data1/oa_pdf/19/46/ce-47-490.PMC4260095.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/19/46/ce-47-490.PMC4260095.pdf
"Key Words :  Stomach neoplasms; Endoscopy; Screening; SurveillanceOpen Access Received:  November 10, 2014    Accepted:  November 10, 2014 Correspondence:  Il Ju Choi Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel: +82-31-920-2282, Fax: +82-31-920-2799, E-mail:  cij1224@ncc.re.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.497FOCUSED REVIEW SERIES:  Endoscopic Screening and Surveillance for Gastrointestinal Cancer",Non-OADS,/arxiv_data1/oa_pdf/89/9d/ce-47-497.PMC4260096.pdf
DOI: http://dx.doi.org/10.1002/ ijc.29210.,Non-OADS,/arxiv_data1/oa_pdf/89/9d/ce-47-497.PMC4260096.pdf
DOI: http://dx.doi.org/10.1016/j.gie.2014.07.047.,OADS,/arxiv_data1/oa_pdf/89/9d/ce-47-497.PMC4260096.pdf
"Key Words :  Image enhancement; Screening colonoscopy; Adenoma detection rateOpen Access Received:  October 27, 2014    Revised:  November 18, 2014 Accepted:  November 18, 2014 Correspondence:  Bong Min Ko Division of Gastroenterology, Department of Internal Medicine, Soonchun - hyang University College of Medicine, 170 Jomaru-ro, Wonmi-gu, Bucheon  420-767, Korea Tel: +82-32-621-5096, Fax: +82-32-621-5080, E-mail:  kopa9445@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Clin Endosc  2014 ;47:504-508Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.504FOCUSED REVIEW SERIES:  Endoscopic Screening and Surveillance for Gastrointestinal Cancer",Non-OADS,/arxiv_data1/oa_pdf/b4/76/ce-47-504.PMC4260097.pdf
"Key Words :  Inflammatory bowel diseases; Colonic neoplasms; Surveillance colonoscopy; ChemopreventionOpen Access Received:  July 3, 2014    Accepted:  August 5, 2014 Correspondence:  Y ou Sun Kim Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje Uni - versity College of Medicine, 9 Mareunnae-ro, Jung-gu, Seoul 100-032, Korea Tel: +82-2-2270-0012, Fax: +82-2-2270-0257, E-mail:  yousunk69@korea.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.509FOCUSED REVIEW SERIES:  Endoscopic Screening and Surveillance for Gastrointestinal Cancer",Non-OADS,/arxiv_data1/oa_pdf/ec/05/ce-47-509.PMC4260098.pdf
"Key Words :  Stricture; Esophagus; Stomach; Endoscopic submucosal dissectionOpen Access Received:  June 4, 2013    Accepted:  July 16, 2013 Correspondence:  Sam Ryong Jee Department of Internal Medicine, Inje University Busan Paik Hospital, Inje  University College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 614-735, Korea Tel: +82-51-890-6401, Fax: +82-51-892-0273, E-mail:  srjee@inje.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.516 INTRODUCTION The number of patients with early esophageal and gastric  cancer who undergo endoscopic resection is increasing be - cause of the improvement in diagnostic techniques such as  narrow-band imaging and the development of various devic -es, including knives and accessories.1 In particular, endoscop - ic submucosal dissection (ESD) is a useful, minimally invasive  procedure for the management of early esophageal and gas - tric neoplasms and enables the en bloc  resection of large le - sions.",Non-OADS,/arxiv_data1/oa_pdf/bc/6b/ce-47-516.PMC4260099.pdf
"Key Words :  Esophageal neoplasms; Lymph node metastasis; Endoscopic resectionOpen Access Received:  June 19, 2013    Revised:  August 28, 2013 Accepted:  October 5, 2013 Correspondence:  Suck Chei Choi Department of Internal Medicine, Digestive Disease Research Institute, Wonk - wang University School of Medicine, 460 Iksan-daero, Iksan 570-974, Korea Tel: +82-63-850-2563, Fax: +82-63-855-2025,   E-mail:  medcsc@wmc.wonkwang.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Clin Endosc  2014 ;47:523-529REVIEW Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.523",Non-OADS,/arxiv_data1/oa_pdf/1a/86/ce-47-523.PMC4260100.pdf
"Key Words :  Percutaneous endoscopic gastrostomy; Pull type; Introducer type; Complication; Indication for PEGOpen Access Received:  June 28, 2013    Revised:  September 19, 2013 Accepted:  November 12, 2013 Correspondence:  Jeong Hoon Lee Department of Internal Medicine, Asan Medical Center, University of Ulsan  College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3180, Fax: +82-2-476-0824, E-mail:  jhlee.gi@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.530 INTRODUCTION Percutaneous endoscopic gastrostomy (PEG) is a technique  that creates a route for providing enteral nutrition using an  endoscopic approach.1,2 PEG is a safe and effective procedure  for patients who require enteral tube feeding for longer than 1  month.3,4 It was introduced in 1980 as an alternative operative  gastrostomy procedure.5 More patients require PEG insertion  as a feeding intervention, because life expectancies and the  incidence of senile diseases have increased in recent times.",Non-OADS,/arxiv_data1/oa_pdf/da/a3/ce-47-530.PMC4260101.pdf
"Key Words :  Endoscopic submucosal dissection; Hemorrhage; Perforation; OutpatientsOpen Access Received:  July 25, 2013    Revised:  October 18, 2013 Accepted:  November 28, 2013 Correspondence:  Seong Woo Jeon Division of Gastroenterology and Hepatology, Department of Internal Medi - cine, Kyungpook National University Medical Center, Kyungpook National  University School of Medicine, 807 Hoguk-ro, Buk-gu, Daegu 702-210, Korea Tel: +82-53-200-3517, Fax: +82-53-426-8773, E-mail:  swjeon@knu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Clin Endosc  2014 ;47:538-543ORIGINAL ARTICLE Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.538 See commentary on page 473-475",Non-OADS,/arxiv_data1/oa_pdf/2c/a9/ce-47-538.PMC4260102.pdf
"cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.544",Non-OADS,/arxiv_data1/oa_pdf/ab/0b/ce-47-544.PMC4260103.pdf
"1, Supplementary Video 1 [avail - able online at http://www.e-ce.org/]) is capable of performing  several steps of ESD (including marking, circumferential in - cision and cutting, dissection, vessel coagulation, and water  injection) without the need to change the instrument.",Non-OADS,/arxiv_data1/oa_pdf/ab/0b/ce-47-544.PMC4260103.pdf
"ESD technique Two experienced endoscopists (IKC and CIK) performed  all procedures (Supplementary Videos 2,3 [available online  at http://www.e-ce.org/]); both had performed many ESDs in  clinical settings and conducted several teaching programs for  ex vivo  and in vivo  ESD training.",Non-OADS,/arxiv_data1/oa_pdf/ab/0b/ce-47-544.PMC4260103.pdf
"Key Words :  Cholangiopancreatography, endoscopic retrograde; Immunoglobulin G; BileOpen Access Received:  June 12, 2013    Revised:  August 29, 2013 Accepted:  October 4, 2013 Correspondence:  Mansour A. Parsi Department of Gastroenterology, Digestive Disease Institute, Cleveland Clin - ic, Desk A30, 9500 Euclid Ave, Cleveland, OH 44195, USA Tel: +1-216-444-4880, Fax: +1-216-444-6305, E-mail:  parsim@ccf.org cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.555 INTRODUCTION Immunoglobulin G4 (IgG4)-associated cholangiopathy  (IAC) is an inflammatory systemic disease characterized by  IgG4-positive lymphoplasmocytic infiltration of the biliary tract.1-4 IAC is part of a systemic process in which IgG4 infil - tration in the biliary tract is accompanied by infiltration in  other organs, such as the pancreas (autoimmune pancreatitis  [AIP]), salivary glands (chronic sclerosing sialadenitis), lacri - mal glands (Mikulicz’s disease), retroperitoneum (retroperi - toneal fibrosis), kidneys, and many others.5 IAC is associated with pancreas involvement in approxi - mately 90% of patients.6 However, biliary involvement may  also be seen without pancreatic involvement.6 Although the  most commonly involved part of the biliary tree in IAC is the  intrapancreatic segment of the common bile duct, multifocal  intrahepatic biliary strictures similar to those seen in primary  sclerosing cholangitis (PSC) may occur.6,7 IAC can also pres -See commentary on page 476-477",Non-OADS,/arxiv_data1/oa_pdf/b4/4d/ce-47-555.PMC4260104.pdf
"Key Words :  Gastroesophageal reflux; Transoral incisionless fundoplication; Esophageal perforation; Empyema; PneumothoraxOpen Access Received:  October 14, 2013    Revised:  October 17, 2013 Accepted:  October 19, 2013 Correspondence:  Kenneth Nugent Department of Internal Medicine, Texas Tech University Health Sciences Cen - ter, 3601 4th St, Lubbock, TX 79430, USA Tel: +1-806-743-3155, Fax: +1-806-743-3148 E-mail:  kenneth.nugent@ttuhsc.edu cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.560",Non-OADS,/arxiv_data1/oa_pdf/4d/6b/ce-47-560.PMC4260105.pdf
"Key Words :  Endoscopic submucosal dissection; Gastric plasmacytoma; Extramedullary plasmacytomasOpen Access Received:  October 31, 2013    Revised:  December 28, 2013 Accepted:  January 13, 2014 Correspondence:  Hee Seok Moon Department of Internal Medicine, Chungnam National University School of  Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 301-747, Korea Tel: +82-42-280-7164, Fax: +82-42-254-4553, E-mail:  mhs1357@cnuh.co.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Clin Endosc  2014 ;47:564-567CASE REPORT Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.564",Non-OADS,/arxiv_data1/oa_pdf/7a/fd/ce-47-564.PMC4260106.pdf
"Key Words :  Duodenal obstruction; Down syndrome; HematemesisOpen Access Received:  November 5, 2013    Revised:  December 5, 2013 Accepted:  December 9, 2013 Correspondence:  Michael J. Rosen Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s  Hospital Medical Center, 3333 Burnet Avenue, MLC 2010, Cincinnati, OH  45229, USA  Tel: +1-513-803-5008, Fax: +1-513-803-2785 E-mail:  michael.rosen@cchmc.org cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.568",Non-OADS,/arxiv_data1/oa_pdf/8e/01/ce-47-568.PMC4260107.pdf
"Key Words :  Papilloma; Stomach; Endoscopic resection; PolypsOpen Access Received:  November 5, 2013    Revised:  December 6, 2013 Accepted:  December 28, 2013 Correspondence:  Hyung Wook Kim Department of Internal Medicine and Medical Research Institute, Pusan Na - tional University Y angsan Hospital, Pusan National University School of Medi - cine, 20 Geumo-ro, Y angsan 626-787, Korea  Tel: +82-55-360-1535, Fax: +82-55-360-1536 E-mail:  mdkhwook@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.571",Non-OADS,/arxiv_data1/oa_pdf/97/66/ce-47-571.PMC4260108.pdf
"Key Words :  Abdominal pain; Arteriovenous malformations; Jejunum; Intussusception; Polypoid arteriovenous malformationOpen Access Received:  October 12, 2013    Revised:  November 18, 2013 Accepted:  December 28, 2013 Correspondence:  Ji Y ong Ahn Department of Gastroenterology, Asan Digestive Disease Research Institute,  Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic- ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-5667, Fax: +82-2-476-0824, E-mail:  ji110@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.575 INTRODUCTION Vascular malformations of the gastrointestinal tract can oc - cur at any age, and patients may present with a variety of  symptoms.",Non-OADS,/arxiv_data1/oa_pdf/8e/30/ce-47-575.PMC4260109.pdf
"Key Words :  Duodenum; Ulcer; Scar; Pancreatitis; StentOpen Access Received:  January 4, 2014    Revised:  February 17, 2014 Accepted:  March 31, 2014 Correspondence:  Jong Ho Hwang Department of Internal Medicine, Busan Medical Center, 359 Worldcup-daero,  Y eonje-gu, Busan 611-706, Korea Tel: +82-51-607-2285, Fax: +82-51-607-2473, E-mail:  asluke@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.579 INTRODUCTION Duodenal ulcer is one of the most commonly encountered  gastrointestinal diseases.",Non-OADS,/arxiv_data1/oa_pdf/3e/e6/ce-47-579.PMC4260110.pdf
"Scand J Gastroenterol 2013;48:101-110.Pro: Propofol in EndoscopyOpen AccessClin Endosc  2014 ;47:584-585LETTER TO THE EDITOR Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.6.584 Received:  June 19, 2014    Accepted:  October 9, 2014 Correspondence:  Alexandre Oliveira Ferreira Department of Gastroenterology, Algarve Hospital Center-Portimão, Sítio do  Poço Seco 8500 Portimão, Portugal Tel: +351-965-389-966, Fax: +351-282-450-390 E-mail:  alex.gastrohep@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/6c/ce-47-584.PMC4260111.pdf
Availablefrom http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Memo-Contract-Year-2014-Medication-Therapy-Manageme nt-MTM-Program-Submission- v040513 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/15/phar0034-0826.PMC4260116.pdf
Available from http://www.cms.gov/Medicare/Prescription-Drug-Cover-age/PrescriptionDrugCovGenIn/D ownloads/2014-Draft-Tech-Notes.,Non-OADS,/arxiv_data1/oa_pdf/7b/15/phar0034-0826.PMC4260116.pdf
Available from http://www.fda.gov/down-loads/Drugs/GuidanceComplianceRegulatoryInformation/ Guid-ances/ucm071185.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/64/phar0034-0891.PMC4260119.pdf
Available from http://www.fda.gov/ohrms/dock- ets/ac/06/briefing/2006-4266b1-01- 11-Ketek-appendix-h.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/d2/phar0034-0336.PMC4260122.pdf
"Available from http://www.accessda-ta.fda.gov/drugsatfda_docs/appletter/2007/021085s036,021277s030ltr.pdf.",Non-OADS,/arxiv_data1/oa_pdf/fb/d2/phar0034-0336.PMC4260122.pdf
2008.Available from http://ec.europa.eu/health/documents/commu-nity-register/2008/2008071446252/anx_46252_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/d2/phar0034-0336.PMC4260122.pdf
Available from http://ec.europa.eu/health/documents/community-regis ter/2008/2008071446252/anx_46252_ en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/d2/phar0034-0336.PMC4260122.pdf
Available from http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/ucm091457.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/d2/phar0034-0336.PMC4260122.pdf
Available from http://www.fda.-gov/downloads/Safety/MedWatch/SafetyInformation/SafetyAlert-sforHumanMedicalProducts/UCM154544.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/d2/phar0034-0336.PMC4260122.pdf
"The brain of each allografted mouse was sliced into several coronal sections; the section withthelargesttumourdiameterwasmeasuredusingImageJ(http://rsbweb.nih.gov/ij/; NIH, Bethesda, MD, USA) [21].",Non-OADS,/arxiv_data1/oa_pdf/b8/cc/path0234-0011.PMC4260128.pdf
"cPRI collection – the collection of Plant Research International, Wageningen, The Netherlands; SCRI collection – The James Hutton Institute bacteri al collection, Dundee, Scotland; IPP collection – the collection of the Department of the Virology and Bacteriology of the Institute of Plant Protection – National Research Institute, Pozna ´n, Poland; CCM – the Czech Collection of Microorganisms, http://www.sci.muni.cz/ccm/index.html.",Non-OADS,/arxiv_data1/oa_pdf/37/9a/aab0165-0474.PMC4260167.pdf
Availablefrom http://www.etikkom.no/retnin-gslinjer/helsinkideklarasjonen (last accessed 13 July 2008).,OADS,/arxiv_data1/oa_pdf/22/89/scs0028-0741.PMC4260168.pdf
"PSII photochemical quan-tum yield (Fv/Fm: measured in dark-adapted state;Fv ′/Fm′: measured in light-adapted state) and func- tional absorption cross section of PSII ( 𝜎)a sw e l la sQA re-oxidation time ( 𝜏) were assessed by analysis of the single turnover ﬂash response using the Fireworx matlabcode (http://sourceforge.net/projects/ﬁreworx, writtenby Audrey Barnett).",OADS,/arxiv_data1/oa_pdf/c0/ab/ppl0152-0316.PMC4260171.pdf
Available: http://www.herbicideresistanceconference.com.au/Program.,Non-OADS,/arxiv_data1/oa_pdf/ac/f5/ps0070-1367.PMC4260172.pdf
"2011) and of hundreds of other accessions potentiated by theMedicago hapmap project (http://www.medicagohapmap.org), resources for transcriptomics, proteomics,metabolomics and for forward- and reverse-genetics make M. truncatula ideal for legume functional genomics (Young & Udvardi 2009).",OADS,/arxiv_data1/oa_pdf/ed/26/pce0037-2553.PMC4260174.pdf
"Relative water content (RWC) of leaveswas calculated using the formula [(FW-DW):(TW-DW)] × 100, where FW corresponds to the fresh weight of leafsamples, TW the turgid weight after 24 h rehydrating ofleaf samples at 4 °C in the dark and DW, the dry weight ofleaf samples after 24 h at 85 °C Gene expression analysis Total RNAs were isolated with TRIzol®Reagent (Invitrogen, Carlsbad, CA, USA; http://www.lifetechnologies.com/us/en/home.html) following the manufacturer’s guide.",Non-OADS,/arxiv_data1/oa_pdf/ed/26/pce0037-2553.PMC4260174.pdf
"Sampleswere evaluated for purity with a Bioanalyzer 2100 (AgilentTechnologies, Santa Clara, CA, USA; http://www.home.agilent.com/).",OADS,/arxiv_data1/oa_pdf/ed/26/pce0037-2553.PMC4260174.pdf
"The Affymetrix GeneChip® – MedicagoGenome Array (Affymetrix, Santa Clara, CA, USA; http://www.affymetrix.com/) was used for expression analysis.Probelabelling, array hybridization and scanning were performedaccording to the manufacturer’s instructions (Affymetrix) foreukaryotic RNA, using a one-cycle protocol for cDNA syn-thesis.The RNAs from all drought treatment/time points andtwo well-watered controls were analysed as showed in theSupporting information (Supporting Information Fig.",OADS,/arxiv_data1/oa_pdf/ed/26/pce0037-2553.PMC4260174.pdf
"These included threeferritin-encoding genes, two legume-speciﬁc genes withunknown function, one histidine-containing phosphotransferprotein gene (with two probe sets), a small signal peptidasegene, a protein kinase gene and a cation transporter gene.Interestingly, gene corresponding to eight probe sets in thisgroup were previously found to be expressed mainly inﬂower tissues (Medicago Gene Expression Atlas, http://bioinfo.noble.org/gene-atlas/v2/).",Non-OADS,/arxiv_data1/oa_pdf/ed/26/pce0037-2553.PMC4260174.pdf
"They are, however, induced in shootsand/or roots by exogenous application of phytohormones,salt stress, nodulation or mycorrhizal inoculation (http://mtgea.noble.org).",Non-OADS,/arxiv_data1/oa_pdf/ed/26/pce0037-2553.PMC4260174.pdf
"With this work, we provide a thorough characterization of the transcriptomic variationinduced by different stages of progressive drought stress,which has been included in the Medicago Gene Atlas server(http://mtgea.noble.org).",OADS,/arxiv_data1/oa_pdf/ed/26/pce0037-2553.PMC4260174.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/da/1a/srep07391.PMC4260214.pdf
The results were visualized with the BrainNet Viewer (http://www.nitrc.org/projects/bnv/).,OADS,/arxiv_data1/oa_pdf/51/52/srep07376.PMC4260215.pdf
"Data preprocessing .Functional images were preprocessed using the Data Processing Assistant for Resting-state fMRI (DPARSF 2.2, http://restfmri.net/forum/DPARSF).",OADS,/arxiv_data1/oa_pdf/51/52/srep07376.PMC4260215.pdf
"After that, signals at the neural level were recovered by Wiener deconvolution (http://users.ugent.be/ ,dmarinaz/HRF_ deconvolution.html)16.",OADS,/arxiv_data1/oa_pdf/51/52/srep07376.PMC4260215.pdf
Resting and the HRF effect were tested by the paired-sample t-test embedded in the SPM8 software (http://www.fil.ion.ucl.ac.uk/spm).,OADS,/arxiv_data1/oa_pdf/51/52/srep07376.PMC4260215.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7376 | DOI: 10.1038/srep07376 7",Non-OADS,/arxiv_data1/oa_pdf/51/52/srep07376.PMC4260215.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ba/e1/srep07384.PMC4260216.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2a/40/srep07374.PMC4260218.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7377 | DOI: 10.1038/srep07377 6",Non-OADS,/arxiv_data1/oa_pdf/ee/2a/srep07377.PMC4260219.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7375 | DOI: 10.1038/srep07375 12",Non-OADS,/arxiv_data1/oa_pdf/3f/1d/srep07375.PMC4260220.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/24/srep07378.PMC4260221.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Little, W. et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/f1/srep07372.PMC4260222.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2b/ae/srep07392.PMC4260227.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c7/f1/srep07388.PMC4260228.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7381 | DOI: 10.1038/srep07381 6",Non-OADS,/arxiv_data1/oa_pdf/ac/d6/srep07381.PMC4260229.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: T.V., C.D., M.C.",Non-OADS,/arxiv_data1/oa_pdf/88/18/srep07389.PMC4260230.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Zhou, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/13/32/srep07382.PMC4260231.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7382 | DOI: 10.1038/srep07382 9",Non-OADS,/arxiv_data1/oa_pdf/13/32/srep07382.PMC4260231.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bf/6e/srep07383.PMC4260232.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7383 | DOI: 10.1038/srep07383 6",Non-OADS,/arxiv_data1/oa_pdf/bf/6e/srep07383.PMC4260232.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/10/TOORTHJ-8-442.PMC4260234.pdf
Available from: http://hdl.handle.net/1822/3463.,Non-OADS,/arxiv_data1/oa_pdf/4d/75/ABR-3-231.PMC4260286.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/03/d4/IJA-58-511.PMC4260294.pdf
http://www.nejm.org/doi/ full/10.1056/NEJMoa1406617 accessed on 2/10/2014.,OADS,/arxiv_data1/oa_pdf/cd/ab/IJA-58-538.PMC4260298.pdf
Available  from: http://www.ihn- org.com/wp-content/uploads/2011/06/ ISBT -definitions-for -non-infectious-transfusion-reactions.,Non-OADS,/arxiv_data1/oa_pdf/18/82/IJA-58-543.PMC4260299.pdf
Available from: http://www.who.int/bloodsafety/ clinical-use/en/manual-EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/82/IJA-58-543.PMC4260299.pdf
Available from http://www.indiankanoon.org/ doc/1449517/?type=print/.,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from http://www.cdsco.nic.,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
"Available from http://naco.gov.in/upload/Policies%20 and %20 Guidelines/29,%20voluntary%20blood%20donation.pdf [Last  accessed on 2014 Aug 08].",Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from http://www.hsph.,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from  http://www.naco.gov.in/upload/final%20publications/ blood%20safety/standards%20for%20blood%20banks%20 and%20blood%20transfusion%20services.pdf [Last accessed  on 2014 Aug 08].,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from http://www.mciindia.org/for -colleges/ Minimum%20Standard%20Requirements%20for%2050%20 Admissions.pdf [Last accessed on 2014 Aug 08].,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from: http://www.cdsco.nic.in/writereaddata/ GSR_218(E).pdf [Last accessed on 2014 Aug 08].,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from http://www.who.int/ bloodsafety/Screening Donated Blood for Transfusion.pdf  [Last accessed on 2014 Aug 08].,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from http://www.indiankanoon.,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
Available from http://www.bcshguidelines.com/ documents/Admin_blood_components_bcsh_05012010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/e6/IJA-58-558.PMC4260301.pdf
"[6] Patient blood management is currently defined by the  Society for the Advancement of Blood Management (available at http://www.sabm.org) as “the timely  application of evidence based medical and surgical  concepts designed to maintain haemoglobin (Hb),  optimize haemostasis and minimise blood loss in  an effort to improve patient outcome.”[7] Reduction  in allogenic BT (ABT) for each individual patient to  the level of as low as reasonably achievable risk by  providing alternatives to transfusion as outlined in the  matrix of PBM [Figure 1] goals are as follows.",Non-OADS,/arxiv_data1/oa_pdf/b2/d0/IJA-58-573.PMC4260303.pdf
Available from: http://www.en.wikipedia.org/w/index.,Non-OADS,/arxiv_data1/oa_pdf/35/15/IJA-58-581.PMC4260304.pdf
Available from: http://www.aabb.org/pbm/Documents/ msbos.pdf .,Non-OADS,/arxiv_data1/oa_pdf/35/15/IJA-58-581.PMC4260304.pdf
Available from: http://www.pulmccm.org/ main/2014/review-articles/bleeding-and-coagulation-disorders- in-the-icu.,Non-OADS,/arxiv_data1/oa_pdf/ed/6d/IJA-58-596.PMC4260306.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ed/6d/IJA-58-596.PMC4260306.pdf
Available from: http://www.usaisr.amedd.army.mil/ cpgs/DmgCntrlResus0903.pdf.,OADS,/arxiv_data1/oa_pdf/12/e0/IJA-58-609.PMC4260308.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/12/e0/IJA-58-609.PMC4260308.pdf
Available from: http://www.mail.,Non-OADS,/arxiv_data1/oa_pdf/70/e7/IJA-58-629.PMC4260311.pdf
Available from: http://www.rcog.org.uk/files/rcog-corp/ uploadedfiles/GT47BloodTransfusions1207amended.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/e7/IJA-58-629.PMC4260311.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/6a/7c/IJA-58-643.PMC4260313.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/6a/7c/IJA-58-643.PMC4260313.pdf
Available from: http://www.britannica.com/ EBchecked/topic/302393/Jehovahs- Witness.,Non-OADS,/arxiv_data1/oa_pdf/da/dc/IJA-58-658.PMC4260316.pdf
"Anticoagulation Task Force, Guidelines for Neuraxial  Anesthesia and Anticoagulation:, Intermountain Health Care,  Salt lake City, Utah, USA , P and T Approved February; 2014.,  https://kr.ihc.com/ext/Dcmnt.",Non-OADS,/arxiv_data1/oa_pdf/ea/e5/IJA-58-665.PMC4260317.pdf
Available from: http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/bb/71/IJA-58-672.PMC4260318.pdf
"Production and hosting by Elsevier B.V. http://dx.doi.org/10.1016/j.jpha.2013.11.004 nCorresponding author at: Department of Pharmaceutical Sciences, Pharmacy Hall, Room N521, 20 N. Pine St., Baltimore, MD 21201, USA.",Non-OADS,/arxiv_data1/oa_pdf/29/b5/main.PMC4260322.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/43/145731 Abstract Guidelines for validating whole slide imaging (WSI) for primary diagnosis in surgical  pathology have been recommended by an expert panel commissioned by the College  of American Pathologists.,Non-OADS,/arxiv_data1/oa_pdf/98/34/JPI-5-43.PMC4260323.pdf
"J Pathol Inform 2014, 1:43  http://www.jpathinformatics.org/content/5/1/43MATERIALS AND METHODS Our laboratory utilizes an Aperio AT T urbo scanner,  Spectrum Version 11.2.0.780 slide manager software,  ImageScope Version 11.2.0.780 digital slide viewer and  a Microsoft Windows 7 platform.",Non-OADS,/arxiv_data1/oa_pdf/98/34/JPI-5-43.PMC4260323.pdf
Statistical  P values (Fisher‑exact test) were determined  utilizing 2014  GraphPad software (http://graphpad.com).,OADS,/arxiv_data1/oa_pdf/98/34/JPI-5-43.PMC4260323.pdf
"J Pathol Inform 2014, 1:43  http://www.jpathinformatics.org/content/5/1/43were tabulated in a spreadsheet and compared to the  initial interpretations.",OADS,/arxiv_data1/oa_pdf/98/34/JPI-5-43.PMC4260323.pdf
"J Pathol Inform 2014, 1:43  http://www.jpathinformatics.org/content/5/1/43There were 1522 parts in agreement (98.5%) with  13 minor discordances and 10 major discordances for  a combined discordance rate of 1.5% [Table 2].",OADS,/arxiv_data1/oa_pdf/98/34/JPI-5-43.PMC4260323.pdf
"J Pathol Inform 2014, 1:43  http://www.jpathinformatics.org/content/5/1/43the scroll feature on the mouse for magnification while  several relied on the Image Scope magnification bar.",Non-OADS,/arxiv_data1/oa_pdf/98/34/JPI-5-43.PMC4260323.pdf
"J Pathol Inform 2014, 1:43  http://www.jpathinformatics.org/content/5/1/43REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/98/34/JPI-5-43.PMC4260323.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/44/145733 Abstract Digital pathology is rapidly developing, but early systems have been slow to gain traction  outside of niche applications such as: Second‑opinion telepathology, immunostain  interpretation, and intraoperative telepathology.",Non-OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
"J Pathol Inform 2014, 1:44  http://www.jpathinformatics.org/content/5/1/44better integration with APLIS data.",OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
"J Pathol Inform 2014, 1:44  http://www.jpathinformatics.org/content/5/1/44for tumor in the lymph node.",Non-OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
"J Pathol Inform 2014, 1:44  http://www.jpathinformatics.org/content/5/1/44If no ROIs were positive, then the ROIs should be  ranked or triaged based on risk and/or atypia assessment.",Non-OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
"J Pathol Inform 2014, 1:44  http://www.jpathinformatics.org/content/5/1/44review data, then this should be straightforward.",Non-OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
"J Pathol Inform 2014, 1:44  http://www.jpathinformatics.org/content/5/1/44of grossing so that most specimens do not demand a  pathologist’s personal intervention.",Non-OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
"J Pathol Inform 2014, 1:44  http://www.jpathinformatics.org/content/5/1/44systems are available, but in the author’s experience  clinical image analysis has thus far failed to provide  meaningful automation of daily work.",Non-OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
Available  from: http://teleconference.upmc.edu/2011/0317b2011/0317b2011.html   [Last accessed on 2014 Oct 27].,Non-OADS,/arxiv_data1/oa_pdf/3a/ec/JPI-5-44.PMC4260324.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/68/main.PMC4260341.pdf
URL:http://www.rockefeller.edu/labheads/mcewen/mcewen-lab.php Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.09.001 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/68/main.PMC4260341.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Neurobiology of Stress 1 (2015) 1 e11,Non-OADS,/arxiv_data1/oa_pdf/b7/68/main.PMC4260341.pdf
the Developing Child ( http://developingchild.harvard.edu/ activities/council/ ) and Frameworks Institute ( http://www.,Non-OADS,/arxiv_data1/oa_pdf/b7/68/main.PMC4260341.pdf
Psychiatry 2. http://dx.doi.org/ 10.1038/mp.2014.96 advance online publication.,Non-OADS,/arxiv_data1/oa_pdf/b7/68/main.PMC4260341.pdf
http://www.pymol.org 2002  (Supplementary information is linked to the online version of the paper  on the Cell Research website.),OADS,/arxiv_data1/oa_pdf/72/dc/cr2014144a.PMC4260346.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/f9/main.PMC4260357.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.09.004 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/40/f9/main.PMC4260357.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Neurobiology of Stress 1 (2015) 66 e79,Non-OADS,/arxiv_data1/oa_pdf/40/f9/main.PMC4260357.pdf
http://dx.doi.org/10.1073/ pnas.1415191111 .,Non-OADS,/arxiv_data1/oa_pdf/40/f9/main.PMC4260357.pdf
Available from: http://www.purebrush.com/clinical.,Non-OADS,/arxiv_data1/oa_pdf/a8/47/IJDENT-5-183.PMC4260383.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/0a/main.PMC4260408.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.09.006 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/0a/main.PMC4260408.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Neurobiology of Stress 1 (2015) 23 e32,Non-OADS,/arxiv_data1/oa_pdf/25/0a/main.PMC4260408.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/99/main.PMC4260418.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.09.007 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/main.PMC4260418.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Neurobiology of Stress 1 (2015) 33 e43,Non-OADS,/arxiv_data1/oa_pdf/9e/99/main.PMC4260418.pdf
http://dx.doi.org/10.1038/nnp.2014.200 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/9e/99/main.PMC4260418.pdf
Available from: http://clinicaltrials.gov/show/ NCT00748956 NLM Identi ﬁ er: NCT00748956.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/main.PMC4260418.pdf
Available from: http://clinicaltrials.gov/show/ NCT01533519 NLM Identi ﬁer: NCT01533519.,Non-OADS,/arxiv_data1/oa_pdf/9e/99/main.PMC4260418.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/37/main.PMC4260419.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.09.003 2352-2895/ ©2014 The Author.,Non-OADS,/arxiv_data1/oa_pdf/4b/37/main.PMC4260419.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Neurobiology of Stress 1 (2015) 12 e22,Non-OADS,/arxiv_data1/oa_pdf/4b/37/main.PMC4260419.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"Direct link to deposited data Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE46154Experimental design, materials and methods Drosophila strains and genetics Drosophila melanogaster strains were raised on standard cornmeal – molasses –agar media at 25 °C.",OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
Consent n/a http://dx.doi.org/10.1016/j.gdata.2014.10.011 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
This database (dros.db) was created using the AnnotationForge [12]package of the Bioconductor suite of tools derived from Agilent's annotation ﬁle for 4x44K oligonucleotide microarrays (https://earray.chem.agilent.com/earray/ ).,OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"Supplementary data To run the R code package analyses, download the microarray data ﬁles extracted by the Agilent Feature Extractor ( http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.gdata.2014.10.011 .,OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"Development 134 (2007) 55 –64,http://dx.doi.org/10.1242/ dev.02666 .",Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"13 (2003) 1557 –1563, http://dx.doi.org/10.1016/S0960-9822(03)00596-7 .",Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"Neuron 61 (2009) 519 –526, http://dx.doi.org/10.1016/j.neuron.2008.12.021 .",OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"PLoSONE 8 (8) (2013) e72434, http://dx.doi.org/10.1371/journal.pone.0072434 .",Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"(2009), http://dx.doi.org/ 10.3791/1599 .",Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"PLoS ONE 7 (2012) e33634, http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"PLoS ONE 6 (2011) e22611, http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
(URL http://www.R-project.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
R package version 1.22.0. http://www.bioconductor.org/packages//2.11/bioc/html/ Agi4x44PreProcess.html .,Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
R package version 1.4.4. http://www.bioconductor.org/packages/release/bioc/ html/AnnotationForge.html .,Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
"4 (2009) 44–57, http://dx.doi.org/10.1038/nprot.2008.211 .",Non-OADS,/arxiv_data1/oa_pdf/f0/11/main.PMC4260420.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/0e/srep07380.PMC4260466.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7380 | DOI: 10.1038/srep07380 10",Non-OADS,/arxiv_data1/oa_pdf/92/0e/srep07380.PMC4260466.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/5a/btt-8-281.PMC4260520.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2014:8 281–291Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  281Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5761 9Multikinase inhibitors use in differentiated   thyroid carcinoma Sina Jasim1,* Levent Ozsari2,* Mouhammed Amir Habra2 1Division of endocrinology, Diabetes,   Metabolism, and Nutrition, Mayo  Clinic, Rochester, MN, USA;   2Department of endocrine Neoplasia  and Hormonal Disorders, The  University of Texas MD Anderson  Cancer Center, Houston, TX, USA *These authors contributed equally in  this work Correspondence: Mouhammed   Amir Habra   Department of endocrine Neoplasia  and Hormonal Disorders, Unit  1461,  The University of Texas MD Anderson  Cancer Center,  1515 Holcombe  Boulevard, Houston, TX  77030, USA   Tel +1 713 792 2841  Fax +1 713 794 4065  email mahabra@mdanderson.or gAbstract:  Thyroid cancer is the most common endocrine malignancy, and its incidence is  increasing.",Non-OADS,/arxiv_data1/oa_pdf/30/5a/btt-8-281.PMC4260520.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/30/5a/btt-8-281.PMC4260520.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/30/5a/btt-8-281.PMC4260520.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dc/3f/ijn-9-5627.PMC4260657.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5627–5637International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5627OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6685 2similar healthy osteoclast and osteoblast  activity on nanocrystalline hydroxyapatite  and nanoparticles of tri-calcium phosphate  compared to natural bone adam K MacMillan1 Francis V lamberti1 Julia N Moulton2 Benjamin M geilich2  Thomas J Webster2,3 1rTI surgical, alachua, Fl, Usa;  2Department of chemical engineering,  Northeastern University, Boston,  Ma, Usa; 3center of excellence  for advanced Materials research,  King abdulaziz University, Jeddah,  saudi arabiaAbstract:  While there have been numerous studies to determine osteoblast (bone forming cell)  functions on nanocrystalline compared to micron crystalline ceramics, there have been few  studies which have examined osteoclast activity (including tartrate-resistant acid phosphatase,  formation of resorption pits, size of resorption pits, and receptor activator of nuclear factor κB  [RANK]).",Non-OADS,/arxiv_data1/oa_pdf/dc/3f/ijn-9-5627.PMC4260657.pdf
"In these conventional implants, alumina and zirconia (ZrO2) monoliths have been the correspondence: Thomas J Webster  Department of chemical engineering,  Northeastern University, 313 snell  engineering center, Boston,   Ma 02115, Usa Tel +1 617 373 6586 email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: MacMillan et al Running head recto: Similar healthy osteoclast and osteoblast activity DOI: http://dx.doi.org/10.2147/IJN.S66852",Non-OADS,/arxiv_data1/oa_pdf/dc/3f/ijn-9-5627.PMC4260657.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/dc/3f/ijn-9-5627.PMC4260657.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/3f/ijn-9-5627.PMC4260657.pdf
Available from: http://www.raybiotech.com /.,Non-OADS,/arxiv_data1/oa_pdf/dc/3f/ijn-9-5627.PMC4260657.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/25/ijn-9-5619.PMC4260658.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5619–5626International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5619OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7475 1rapid and quantitative detection of c-reactive   protein using quantum dots and  immunochromatographic test strips Xianglin cheng1,* Xu Pu2,* Pen Jun3 XiaoBo Zhu3 Di Zhu4 Ming chen1 1Department of laboratory Medicine,   First affiliated hospital of Yangtze  University, Jingzhou, 2Department  of laboratory Medicine, renMin  hospital of Wuhan University,   Wuhan, 3Key laboratory of analytical  chemistry for Biology and Medicine  (Ministry of education), college  of chemistry and Molecular  sciences, Wuhan University, Wuhan,   hubei, People’s republic of china;   4Department of Medical Oncology,   Dana-Farber cancer Institute,   harvard Medical school, Boston,   Ma, Usa *These authors contributed  equally to this study and share  first authorshipBackground:  Rapid immunochromatographic tests can detect disease markers in 10–15 minutes,  which facilitates clinical diagnosis and treatment programs.",Non-OADS,/arxiv_data1/oa_pdf/b7/25/ijn-9-5619.PMC4260658.pdf
"These tests are simple to use, provide rapid results, and are referred to as correspondence: Ming chen Department of laboratory Medicine,  First Affiliated Hospital of Yangtze  University, Jingzhou, hubei, 434000,  People’s republic of china Tel +86 189 7216 1770 email chenmingbox@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Cheng et al Running head recto: Novel probes for detection of CRP DOI: http://dx.doi.org/10.2147/IJN.S74751",Non-OADS,/arxiv_data1/oa_pdf/b7/25/ijn-9-5619.PMC4260658.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b7/25/ijn-9-5619.PMC4260658.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/25/ijn-9-5619.PMC4260658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/e6/ijgm-7-531.PMC4260659.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 531–538International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  531OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7101 5effects and tolerability of betahistine in patients  with vestibular vertigo: results from the romanian  contingent of the OsValD study Ovidiu Băjenaru1 adina Maria roceanu2 silviu albu3 Viorel Zainea4 alexandru Pascu4 Mădălina Gabriela  Georgescu4 sebastian cozma5 Luigi Mărceanu6 Dafin Fior Mureşanu7 1Department of neurology, carol  Davila University of Medicine and  Pharmacy, 2Department of neurology,   University hospital, Bucharest, 3IInd  Department of Otolaryngology, Iuliu  hatieganu University of Medicine  and Pharmacy, Cluj-Napoca, 4Institute  of Phono-Audiology and ENT  Functional surgery Prof Dr Dorin  hociota, carol Davila University of  Medicine and Pharmacy, Bucharest,   5enT Department, University of  Medicine and Pharmacy Grigore  T Popa, audiology and Vestibulogy  Department, rehabilitation clinical  hospital, Iasi, 6Transilvania University,   Faculty of Medicine, Department:   Doctoral Program (PhD), Brasov,   7“roneuro” Institute for neurological  Research and Diagnostic Cluj-Napoca,   University of Medicine and Pharmacy  “Iuliu Haţieganu”, Department of  Clinical Neurosciences, Cluj-Napoca,   romania correspondence: adina M roceanu   University emergency hospital Bucharest,   169th splaiul Independentei street,   050098-Bucharest, Romania   Tel +402 1312 8102 ext  280  Fax +402 1318 0502  email amr2012mar@gmail.co mBackground and methods:  An efficacy population of  245 patients with vertigo of peripheral  vestibular origin was recruited in Romania as part of a  3-month multinational, post-marketing  surveillance study of open-label betahistine  48 mg/day (OSVaLD).",Non-OADS,/arxiv_data1/oa_pdf/d7/e6/ijgm-7-531.PMC4260659.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/d7/e6/ijgm-7-531.PMC4260659.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/e6/ijgm-7-531.PMC4260659.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/ed/ijn-9-5575.PMC4260660.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5575–5590International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5575ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7281 9Noninvasive detection of macrophages in  atherosclerotic lesions by computed tomography  enhanced with PEGylated gold nanoparticles Jinbao Qin1,* Chen Peng2,* Binghui Zhao2,* Kaichuang Ye1 Fukang Yuan1 Zhiyou Peng1 Xinrui Yang1 Lijia Huang1 Mier Jiang1 Qinghua Zhao3 Guangyu Tang2 Xinwu Lu1,4 1Department of Vascular Surgery,   Shanghai Ninth People’s Hospital  Affiliated to Shanghai JiaoTong  University, School of Medicine;   2Department of Radiology, Shanghai  Tenth People’s Hospital Affiliated  to T ongji University, School  of Medicine; 3Department of  Orthopaedics, Shanghai First People’s  Hospital, School of Medicine, Shanghai  Jiao T ong University; 4Vascular Center  of Shanghai JiaoT ong University,   Shanghai, People’s Republic of China *These authors contributed equally  to this workAbstract:  Macrophages are becoming increasingly significant in the progression of  atherosclerosis (AS).",Non-OADS,/arxiv_data1/oa_pdf/8a/ed/ijn-9-5575.PMC4260660.pdf
"Molecular imaging profoundly influences preclinical research and future clinical  cardiovascular medicine in many ways, such as in the early diagnosis and assessment  of chronic diseases.9–11 Promising molecular imaging instruments such as computed  tomography (CT) have high spatial and high density resolutions, which have great  potential for the risk-stratified detection of atherosclerotic lesions and may be used Correspondence: Xinwu Lu   Email luxinwu@aliyun.co m     Guangyu Tang   Email tgy17@126.co m     Qinghua Zhao   Email sawboneszhao@163.co mJournal name: International Journal of Nanomedicine Article Designation: ORIGINAL RESEARCH Y ear: 2014 Volume: 9 Running head verso: Qin et al Running head recto: Macrophage detection in atherosclerotic lesions with Au nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S72819",Non-OADS,/arxiv_data1/oa_pdf/8a/ed/ijn-9-5575.PMC4260660.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8a/ed/ijn-9-5575.PMC4260660.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ed/ijn-9-5575.PMC4260660.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/04/ijn-9-5603.PMC4260661.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5603–5618International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5603OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7231 8Induction of mucosal immune responses and  protection of cattle against direct-contact challenge  by intranasal delivery with foot-and-mouth disease  virus antigen mediated by nanoparticles li Pan1,2 Zhongwang Zhang1,2 Jianliang lv1,2 Peng Zhou1,2 Wenfa hu1,2 Yuzhen Fang1,2 haotai chen1,2 Xinsheng liu1,2 Junjun shao1,2 Furong Zhao1,2 Yaozhong Ding1,2 T ong lin1,2 huiyun chang1,2 Jie Zhang1,2 Y ongguang Zhang1,2 Y onglu Wang1,2 1state Key laboratory of Veterinary  etiological Biology, National Foot-and- Mouth Disease reference laboratory,  lanzhou Veterinary research Institute,  chinese academy of  agricultural  sciences (caas), lanzhou, gansu,  People’s republic of china; 2Jiangsu  co-innovation center for Prevention  and control of Important animal  Infectious Diseases and Zoonoses,  Yangzhou, People’s republic of chinaAbstract:  The aim of this study was to enhance specific mucosal, systemic, and cell-mediated  immunity and to induce earlier onset of protection against direct-contact challenge in cattle by  intranasal delivery of a nanoparticle-based nasal vaccine against type A foot-and-mouth disease  (FMD).",Non-OADS,/arxiv_data1/oa_pdf/6b/04/ijn-9-5603.PMC4260661.pdf
"Keywords:  FMDV, nanoparticles, chitosan, trehalose, poly(lactic-co-glycolic acid), PLGAcorrespondence: Yongguang Zhang Xujiaping 1, lanzhou, gansu 730046,  People’s republic of china Tel +86 931 834 2537 Fax +86 931 834 0977 email zhangyongguang@caas.c n Yonglu Wang Xujiaping 1, lanzhou, gansu 730046,  People’s republic of china Tel +86 931 834 3796 Fax +86 931 834 0977 email wangyonglu@caas.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Pan et al Running head recto: Intranasal delivery of foot-and-mouth disease vaccine DOI: http://dx.doi.org/10.2147/IJN.S72318",Non-OADS,/arxiv_data1/oa_pdf/6b/04/ijn-9-5603.PMC4260661.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6b/04/ijn-9-5603.PMC4260661.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/04/ijn-9-5603.PMC4260661.pdf
2002) [Research Collaboratory for Structural Bioinfor-matics (RCSB) Protein Data Bank (PDB) (http://www.rcsb.org/pdb/home/home.do) ID: 1KPX].,OADS,/arxiv_data1/oa_pdf/bc/ec/mec0023-1799.PMC4260670.pdf
"Filtering of reads, map-ping and generation of consensus sequences were car-ried out using the FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit), BWA (Li & Durbin 2009), SAM-tools v1.4 (Li et al.",OADS,/arxiv_data1/oa_pdf/80/51/mec0023-1124.PMC4260671.pdf
"In each run, we sampledgenealogies every 1000 steps to produce 90 000 trees thatwere analysed with the program Tracer v.1.5 (http://beast.bio.ed.ac.uk/Tracer).",OADS,/arxiv_data1/oa_pdf/80/51/mec0023-1124.PMC4260671.pdf
Acknowledgements We thank all the members of the ‘Isolation with Migration Discussion Group’ (https://groups.google.com/forum/?from- groups#!forum/Isolation-with-Migration) for tireless and help- ful advice.,Non-OADS,/arxiv_data1/oa_pdf/80/51/mec0023-1124.PMC4260671.pdf
ﬁl.ion.ucl.ac.uk/spm/) and home- made programs under the environment of MATLAB (http://www.mathworks.com).,Non-OADS,/arxiv_data1/oa_pdf/e9/c6/nbm0027-0444.PMC4260672.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/99/sccaa-7-101.PMC4260682.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pStem Cells and Cloning: Advances and Applications 2014:7 101–108Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  101Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S5051 4Some aspects of allogeneic stem cell  transplantation in patients with myelodysplastic  syndrome: advances and controversy Olga Blau igor wolfgang Blau Department of Hematology,    Oncology and T umor immunology,   Charité – Universitätsmedizin   Berlin, Berlin, Germany Correspondence: Olga Blau   Charité Universitätsmedizin Berlin,   30 Hindenburgdamm,   Berlin 12200, Germany   Tel +49 30 4050 26492   Fax +49 30 4050 26618   email olga.blau@charite.d eAbstract:  Myelodysplastic syndrome (MDS) is a heterogeneous group of myeloid disorders.",Non-OADS,/arxiv_data1/oa_pdf/45/99/sccaa-7-101.PMC4260682.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/45/99/sccaa-7-101.PMC4260682.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/99/sccaa-7-101.PMC4260682.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/d9/sccaa-7-089.PMC4260683.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pStem Cells and Cloning: Advances and Applications 2014:7 89–99Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  89Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S5100 9From regenerative dentistry to regenerative  medicine: progress, challenges, and potential  applications of oral stem cells Li Xiao1 Masanori Nasu2 1Department of Pharmacology,   2Research Center, The Nippon   Dental University, T okyo, Japan Correspondence: Li Xiao   Department of Pharmacology, The  Nippon Dental University, School of  Life Dentistry at Tokyo,  1-9-20 Fujimi,  Chiyoda-ku, Tokyo  102-8159, Japan   Tel +81 3 3261 8772  Fax +81 3 3264 8399  email xiaoli@tky.ndu.ac.j pAbstract:  Adult mesenchymal stem cells (MSCs) and epithelial stem cells play essential roles  in tissue repair and self-healing.",Non-OADS,/arxiv_data1/oa_pdf/a3/d9/sccaa-7-089.PMC4260683.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/a3/d9/sccaa-7-089.PMC4260683.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/d9/sccaa-7-089.PMC4260683.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/88/ijnrd-7-447.PMC4260684.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 447–455International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  447RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S5052 7Evaluating the benefits of home-based   peritoneal dialysis Karlien François Joanne M Bargman Division of Nephrology, University  Health Network Toronto General  Hospital, University of T oronto,   T oronto, ON, Canada Correspondence: Karlien François   Division of Nephrology, University  Health NetworkToronto General  Hospital,  200 elizabeth Street,   Toronto, ON, M5G  2C4, Canada   email karlien.francois@uzbrussel.b eAbstract:  Peritoneal dialysis (PD) is an effective renal replacement strategy for patients  suffering from end-stage renal disease.",Non-OADS,/arxiv_data1/oa_pdf/95/88/ijnrd-7-447.PMC4260684.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/95/88/ijnrd-7-447.PMC4260684.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/88/ijnrd-7-447.PMC4260684.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-9-5683.PMC4260685.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5683–5700International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5683OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7365 1Immunoliposome co-delivery of bufalin   and anti-cD40 antibody adjuvant induces  synergetic therapeutic efficacy against melanoma Ying li1,* Jiani Yuan1,* Qian Yang1 Wei cao1 Xuanxuan Zhou1 Yanhua Xie1 honghai T u2 Ya Zhang1 siwang Wang1 1Department of Natural Medicine and  Institute of Materia Medica, school  of Pharmacy, Fourth Military Medical  University, Xi’an, People’s republic  of china; 2Institute for Drug and  Instrument control, Xinjiang Military  area command, Urumqi, Xinjiang,   People’s republic of china *These authors contributed equally  to this workAbstract:  Liposomes constitute one of the most popular nanocarriers for improving the delivery  and efficacy of agents in cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-9-5683.PMC4260685.pdf
"The overall goal of immunotherapy is the induction and amplification of functional correspondence: Wei cao Department of Natural Medicine and  Institute of Materia Medica, school  of Pharmacy, Fourth Military Medical  University, 169 West changle road,  Xi’an, 710032, People’s republic of china Tel +86 29 8477 3752 Fax +86 29 8322 4790 email caowei@fmmu.edu.c n  si-Wang Wang Department of Natural Medicine and  Institute of Materia Medica, school  of Pharmacy, Fourth Military Medical  University, 169 West changle road,  Xi’an, 710032, People’s republic of china Tel +86 29 8477 4748 Fax +86 29 8322 4790 email wangsiw@fmmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Li et al Running head recto: Immunoliposome co-delivery of bufalin and anti-CD40 antibody DOI: http://dx.doi.org/10.2147/IJN.S73651",Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-9-5683.PMC4260685.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-9-5683.PMC4260685.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-9-5683.PMC4260685.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/ff/ijn-9-5701.PMC4260686.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5701–5710International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5701OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7430 6In vitro antioxidant activity and in vivo antifatigue  effect of layered double hydroxide nanoparticles  as delivery vehicles for folic acid lili Qin1,* Wenrui Wang2,* songhui Y ou1  Jingmei Dong1  Yunhe Zhou1 Jibing Wang1 1Department of Physical education,   2school of life science and  T echnology, T ongji University, shanghai,   People’s republic of china *These authors contributed equally  to this workAbstract:  Folic acid antioxidants were successfully intercalated into layered double hydroxides  (LDH) nanoparticles according to a previous method with minor modification.",Non-OADS,/arxiv_data1/oa_pdf/67/ff/ijn-9-5701.PMC4260686.pdf
"correspondence: lili Qin Department of Physical education, Tongji  University, 1239 siping road, shanghai  200092, People’s republic of china  Tel +86 21 659 81711 Fax +86 21 659 83777 email qinlili@tongji.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Qin et al Running head recto: Layered double hydroxide nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S74306",Non-OADS,/arxiv_data1/oa_pdf/67/ff/ijn-9-5701.PMC4260686.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/67/ff/ijn-9-5701.PMC4260686.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/ff/ijn-9-5701.PMC4260686.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/cf/ijn-9-5667.PMC4260688.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5667–5682International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5667OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7059 3Fluorescence tomographic imaging of sentinel  lymph node using near-infrared emitting  bioreducible dextran nanogels Jiejing li1* Beiqi Jiang1* chao lin2 Zhigang Zhuang1 1Department of Breast surgery,   shanghai First Maternity and Infant  hospital, 2The Institute for Biomedical  engineering and Nanoscience, T ongji  University school of Medicine,   Tongji  University, shanghai, People’s  republic of china *These authors contributed equally   to this workAbstract:  Sentinel lymph node (SLN) mapping is a critical procedure for SLN biopsy and  its diagnosis as tumor metastasis in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/8f/cf/ijn-9-5667.PMC4260688.pdf
"Generally, the nanoparticles with correspondence: chao lin room 222, shixun Building, Tongji  University, shanghai, 200092,  People’s republic of china email chaolin@tongji.edu.c n   Zhigang Zhuang shanghai First Maternity and Infant  hospital, 536 changle road, shanghai,  200040, People’s republic of china Tel +86 21 6598 8029 Fax +86 21 6598 3706 email 137ljj_zzg@tongji.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Li et al Running head recto: NIR-emitting nanogels for sentinel lymph node imaging DOI: http://dx.doi.org/10.2147/IJN.S70593",Non-OADS,/arxiv_data1/oa_pdf/8f/cf/ijn-9-5667.PMC4260688.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8f/cf/ijn-9-5667.PMC4260688.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/cf/ijn-9-5667.PMC4260688.pdf
"Accessed at http://apps.leg.wa.gov/wac/default.aspx?cite¼296-27-00105 on March 20, 2013.",OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
"Accessed at http://apps.leg.wa.gov/rcw/default.aspx?cite ¼51.28.020 on March 20, 2013.",OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
Link Plus Accessed at http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
"Accessed at http://www.osha.gov/OshDoc/Directive_pdf/ CPL_02_09-08.pdf on March 20, 2013.",OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
"Accessed at http://www.bls.gov/opub/hom/pdf/homch9.pdfon March 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
"Accessed athttp://www.gao.gov/products/GAO-10-10 on March 20, 2013.",OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
"Accessed at http://www.gao.gov/assets/590/589961.pdf on March 20, 2013.",OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
"Accessed at http://apps.leg.wa.gov/wac/default.aspx?cite ¼296-27-00105 on March 20, 2013.",OADS,/arxiv_data1/oa_pdf/1a/0f/ajim0057-1133.PMC4260691.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/Ecological theory to avoid pathogenic invasion P De Schryver and O Vadstein 2368 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/08/9a/ismej201484a.PMC4260705.pdf
The CCHI website is http://www.cchi.gov.sa/ Pages/default.aspxe76 A. ALKHAMIS ET AL .,OADS,/arxiv_data1/oa_pdf/c6/d9/hpm0029-0e64.PMC4260721.pdf
"Retrieved 6-8-2012, 2012, from http://www.alrazzi.com/AxCMSwebLive/EnAlRazziEconomic.cms.",Non-OADS,/arxiv_data1/oa_pdf/c6/d9/hpm0029-0e64.PMC4260721.pdf
"Retrieved 13 June, 2012, from http://www.alarabiya.net/articles/2012/05/02/211651.html.",Non-OADS,/arxiv_data1/oa_pdf/c6/d9/hpm0029-0e64.PMC4260721.pdf
"Retrieved 22/ 09/2010, 2010, from http://data.worldbank.org/country/saudi-arabia.The World Bank, WHO, et al.",OADS,/arxiv_data1/oa_pdf/c6/d9/hpm0029-0e64.PMC4260721.pdf
"The images or other third partymaterial in this article are included in the article ’sC r e a t i v eC o m m o n s license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PKC ηpromotes senescence U Zurgil et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/57/a2/cddis2014481a.PMC4260739.pdf
Published online 11 September 2014; http://dx.doi.org/10.1016/j.simyco.2014.07.004 .,OADS,/arxiv_data1/oa_pdf/bc/68/main.PMC4260807.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).Studies in Mycology available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 78: 141 –173.,Non-OADS,/arxiv_data1/oa_pdf/bc/68/main.PMC4260807.pdf
"This option was cho- sen by ICPA on April 11, 2012 ( http://www.aspergilluspenicillium.",Non-OADS,/arxiv_data1/oa_pdf/bc/68/main.PMC4260807.pdf
"In a step towards cleaning up misidenti ﬁed GenBank sequences, the RefSeq initiative was launched ( http://www.ncbi.nlm.nih.gov/refseq/ ), which contains only veri ﬁed ITS sequences ( Schoch et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/68/main.PMC4260807.pdf
"As the taxonomy keeps evolving in fungi, this list will be kept up to date on http://www.aspergilluspenicillium.org from where comments can be sent to curators of the list.",Non-OADS,/arxiv_data1/oa_pdf/bc/68/main.PMC4260807.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.simyco.2014.07.004 .,OADS,/arxiv_data1/oa_pdf/bc/68/main.PMC4260807.pdf
Bioinformatics .http://dx.doi.org/10.1093/bio- informatics/btu033 .,OADS,/arxiv_data1/oa_pdf/bc/68/main.PMC4260807.pdf
http://dx.doi.org/10.1016/j.jare.2012.03.003,OADS,/arxiv_data1/oa_pdf/66/f8/main.PMC4260886.pdf
http://dx.doi.org/10.1016/j.jare.2012.05.001,OADS,/arxiv_data1/oa_pdf/7f/ea/main.PMC4260887.pdf
http://dx.doi.org/10.1016/j.jare.2012.04.003,OADS,/arxiv_data1/oa_pdf/14/c8/main.PMC4260888.pdf
http://dx.doi.org/10.1016/j.jare.2012.05.003,OADS,/arxiv_data1/oa_pdf/61/f3/main.PMC4260906.pdf
"Proof of principle for epitope-focused vaccine design Bruno E. Correia1,2,3, John T. Bates4, Rebecca J. Loomis5, Gretchen Baneyx1, Christopher  Carrico6, Joseph G. Jardine1,7,8,9, Peter Rupert6, Colin Correnti6, Oleksandr  Kalyuzhniy1,8,9, Vinayak Vittal1, Mary J. Connell5, Eric Stevens1, Alexandria Schroeter1,  Man Chen10, Skye MacPherson1,7,8,9, Andreia M. Serra1,8,9, Yumiko Adachi1,8,9, Margaret A.  Holmes6,*, Yuxing Li7,8,9, Rachel E. Klevit1, Barney S. Graham10, Richard T. Wyatt7,8,9,  David Baker1, Roland K. Strong6, James E. Crowe Jr4,11,12, Philip R. Johnson5, and William  R. Schief1,7,8,9,† 1Department of Biochemistry, University of Washington, Seattle, WA 98195, USA 2PhD Program in Computational Biology, Instituto Gulbenkian Ciência and Instituto de Tecnologia  Química e Biológica, Universidade Nova de Lisboa, Oeiras, 2780-157 Portugal 3Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, 92037 USA 4The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, 37232 USA 5The Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, 19104 USA 6Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024,  USA 7Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla,  California 92037, USA 8IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California 92037,  USA 9Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research  Institute, La Jolla, California 92037, USA 10Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National  Institutes of Health, Bethesda, MD 20892, USA 11Department of Pathology, Microbiology and Immunology, Vanderbilt Medical Center, Nashville,  TN, USA 12Department of Pediatrics, Vanderbilt Medical Center, Nashville, TN, 37232 USA Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research,  subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms †To whom correspondence should be addressed: schief@scripps.edu.",Non-OADS,/arxiv_data1/oa_pdf/e2/b2/nihms551111.PMC4260937.pdf
[PubMed: 23598484]  11. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ .,Non-OADS,/arxiv_data1/oa_pdf/e2/b2/nihms551111.PMC4260937.pdf
http://dx.doi.org/10.1016/j.fob.2014.11.007 2211-5463/ /C2112013 The Authors.,OADS,/arxiv_data1/oa_pdf/ff/d9/main.PMC4261070.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.fob.2013.11.001 ⇑Corresponding authors at: Department of Neurology, Nagoya University Grad- uate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.",Non-OADS,/arxiv_data1/oa_pdf/ff/d9/main.PMC4261070.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/d1/d0/ajg2014323a.PMC4261138.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2014; 109:1942–1952; doi: 10.1038/ajg.2014.331; published online 28 October 2014     1   Department of Medicine, Division of Gastroenterology and Hepatology, Indiana University School of Medicine ,  Indianapolis ,  Indiana ,  USA   ;     2   Department of  Medicine, Division of Endocrinology, Biochemistry and Molecular Biology, and the Pancreatic Cancer Signature Center at the IU S imon Cancer Center, Indiana  University School of Medicine ,  Indianapolis ,  Indiana ,  USA   ;     3   Department of Biostatistics, Indiana University School of Medicine ,  Indianapolis ,  Indiana ,  USA   ;     4   The  ﬁ  rst two authors contributed equally to this work   .",Non-OADS,/arxiv_data1/oa_pdf/1b/77/ajg2014331a.PMC4261139.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/                        29.",Non-OADS,/arxiv_data1/oa_pdf/1b/77/ajg2014331a.PMC4261139.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/89/99/srep07411.PMC4261161.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7411 | DOI: 10.1038/srep07411 6",Non-OADS,/arxiv_data1/oa_pdf/89/99/srep07411.PMC4261161.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7409 | DOI: 10.1038/srep07409 5",Non-OADS,/arxiv_data1/oa_pdf/32/52/srep07409.PMC4261162.pdf
"DTZ Staining .A DTZ (Merck; Whitehouse Station, NJ; http://www.merck.com) stock solution was prepared with 50 mg of DTZ in 5 ml of dimethyl sulfoxide (DMSO) and stored briefly at 215uC.",Non-OADS,/arxiv_data1/oa_pdf/60/9f/srep07402.PMC4261164.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/srep07402.PMC4261164.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7402 | DOI: 10.1038/srep07402 11",Non-OADS,/arxiv_data1/oa_pdf/60/9f/srep07402.PMC4261164.pdf
"2013, Vegan: Community Ecology Package 2.0-10. http://cran.r-project.org/web/packages/vegan/ index.html).",Non-OADS,/arxiv_data1/oa_pdf/da/9c/srep07417.PMC4261165.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/da/9c/srep07417.PMC4261165.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/1c/srep07418.PMC4261166.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/08/srep07400.PMC4261168.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7400 | DOI: 10.1038/srep07400 5",Non-OADS,/arxiv_data1/oa_pdf/56/08/srep07400.PMC4261168.pdf
All of the authors discussed the results and commented on the manuscripts.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/77/srep07395.PMC4261170.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7419 | DOI: 10.1038/srep07419 6",Non-OADS,/arxiv_data1/oa_pdf/51/32/srep07419.PMC4261173.pdf
More details are at http://www.pmel.noaa.,Non-OADS,/arxiv_data1/oa_pdf/14/d9/srep07412.PMC4261176.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/d9/srep07412.PMC4261176.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7412 | DOI: 10.1038/srep07412 6",Non-OADS,/arxiv_data1/oa_pdf/14/d9/srep07412.PMC4261176.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/46/b2/srep07396.PMC4261178.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7396 | DOI: 10.1038/srep07396 10",Non-OADS,/arxiv_data1/oa_pdf/46/b2/srep07396.PMC4261178.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/10/srep07350.PMC4261179.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b3/3f/srep07404.PMC4261180.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a5/47/srep07399.PMC4261181.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7399 | DOI: 10.1038/srep07399 7",Non-OADS,/arxiv_data1/oa_pdf/a5/47/srep07399.PMC4261181.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e6/de/srep07403.PMC4261183.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ab/5c/srep07413.PMC4261184.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7413 | DOI: 10.1038/srep07413 9",Non-OADS,/arxiv_data1/oa_pdf/ab/5c/srep07413.PMC4261184.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/60/78/ijbsv10p1159.PMC4261200.pdf
This is an open- access article distribu ted under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7e/98/ijbsv10p1171.PMC4261201.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/40/bf/ijbsv10p1181.PMC4261202.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/75/39/ijbsv10p1193.PMC4261203.pdf
"Methods We performed a PubMed search in July 2014 using the phrases ‘‘alien hand syndrome,’’ ‘‘alien hand syndrome pathophysiology,’’Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"In the last 20 years our understanding of AHSsubtypes has evolved to the three, well-defined variants we now accept: the two anterior (frontal and callosal) variants and one posterior.Sarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Table 1.Summary of Reported Cases of Alien Hand Syndrome Reference Case No.Diagnosis Localization of Lesion or Imaging FindingsHand Diagnostic Dyspraxia orIntermanualConflictGrasping Levita- tionGroping Utilization Behavior Goldstein69Infarction L X X Akelaitis701 Callosotomy Body of corpus callosum, genu of corpus callosumLX 2 Callosotomy Complete section of corpus callosumRX Goldberg et al.711 Infarction L medial frontal cortex R X X X 2 Infarction L medial frontal cortex R X X Levine and Rinn23Infarction R temporal/occipital cortex, posterior thalamusLX McNabb, et al.72Infarction L superior and medial frontal cortex and parietalRXX Banks et al.361 Gunshot wound Medial frontal white matter bilaterally, corpus callosum,R basal ganglia, internalcapsule and thalamusLX 2 Ruptured anterior communicatingArtery AneurysmGenu of corpus callosum, bilateral medial frontalcortex, R gyrus rectusLX X X Goldberg and Bloom 731 Infarction Body of corpus callosum, R medial frontal cortex,supplementary motor area,anterior cingulate gyrusLX X X 2 Infarction L medial frontal cortex, supplementary motor area,anterior cingulate gyrusRXX 3 Infarction Corpus callosum, R medial frontal cortex,supplementary motor area,anterior cingulate gyrusLX XAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"391 Idiopathic cortical atrophyL medial frontal cortex atrophyRX 2 Diffuse lymphocyticlymphomaR medial frontal cortex L X 3 Seizures after the removal ofan arteriovenousmalformationL posterior parietal cortex R XSarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"2Infarction Body of corpus callosum, genu of corpus callosum,isthmus of corpus callosum,R supplementary motorarea, anterior cingulategyrus, bilateral medial prefrontal cortexLX X XAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"851 Infarction Post body of corpus callosum, anterior spleniumof corpus callosum, Lcingulate gyrus, temporoparietalLX 2 Infarction Body of corpus callosum, R cingulate gyrus, L anterior cingulate gyrus, bilateral medial frontal cortexLX X 3 Infarction Body of corpus callosum, genu of corpus callosum, L anterior cingulate gyrusLX 4 Infarction Anterior body of corpus callosum, L medial frontal cortex, anterior cingulate gyrusRXX X 5 Infarction Anterior body of corpus callosum, L medial frontal cortexRXX 7 Infarction Anterior body of corpus callosum, R medial frontal cortex, anterior cingulate gyrusLX X X Andre and Domingues 86ReversibleischemiaL internal capsule, R occipital cortex, L cerebellumLXSarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"52Infarction R medial posterior temporal cortex, posterior parietal/ occipital cortexLXAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"31 Corticobasal syndromeR temporal/parietal cortex L X 2 Corticobasal syndromeR temporal/parietal cortex L X 3 Alzheimer’s diseaseL parietal cortex R X 4 Infarction R parietal cortex L XSarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"56Infarction L cortical–subcortical parieto-occipital lobesRX X Giovannetti et al.37Infarction L medial frontal extending into the corpus callosumRX X X XAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"24Infarction R parietal lobe L XSarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"22Infarction Genu, body and splenium of the corpus callosumLX Verleger et al.42Infarction L side of corpus callosum from genu to posterioristhmusLX Huang and Jia 15Cerebral venousmalformationHemorrhage in the genu and body of the corpus callosumLXAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"261 Creutzfeld–Jakob diseaseDiffuse cortical T2 signal on MRIL 2 Creutzfeld–Jakob diseaseNormal L 3 Creutzfeld–Jakob diseaseBilateral striatum, diffuse cortex left hemisphereR 4 Creutzfeld–Jakob diseaseNormal L 5 Creutzfeld–Jakob diseaseUnknown L 6 Creutzfeld–Jakob diseaseR posterior parietal cortical hypoattenuation on CTL 7 Creutzfeld–Jakob diseaseNormal imaging R 8 Creutzfeld–Jakob diseaseCortical and striatal DWI/ FLAIR hyperintensityDiffusely on MRIL 9 Creutzfeld–Jakob diseaseBilateral L .R selective parietal restricted diffusionon MRIR 10 Creutzfeld–Jakob diseaseRestricted diffusion in bilateral striatal nuclei, leftparietal cortex on MRIR 11 Creutzfeld–Jakob diseaseDiffuse restricted diffusion, T2 hyperintensity of Rposterior hemisphericcortex on MRILSarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services12",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"46108casesCorticobasal syndrome 14 cases Cerebrovascular Ischemic strokes, arteriovenous malformationand subdural hematoma 9 cases Creutzfeld–Jakob disease 5 cases Hereditary Diffuse Leukoencephalopathywith SpheroidsAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services13",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"66Hemorrhage L fronto-parietal hemorrhageRX X Abbreviations: CT, Catscan; DWI, Diffusion-weighted Imaging; FLAIR, Fluid-attenuated Inversion Recovery; HIV, Human Imunodeficiency Virus; L, Left; MRI, Magnetic Resonance Imaging; R, Right; X, finding present in that case.Sarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services14",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"39Lesions to the SMA possibly result in the release of the ipsilateral motor cortexfrom this inhibitory control.Table 2.Variants of Alien Hand Syndrome Type Commonly Affected Areas Common Causes Symptoms and Signs Frontal Supplemental motor area Tumors Groping Cingulate gyrus Infarction Grasping Corpus callosum Trauma Utilization behavior Callosal Corpus callosum Callosotomy Intermanual conflict Tumors Infarction Posterior Parieto-occipital cortices Infarction Levitation Thalamus Creutzfeld–Jakob disease Cortical sensory deficits Corticobasal syndrome Abnormal posturing of the limbAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services15",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"The thalamus has wide-ranging, reciprocal connections, and lesions may give rise to sensory and cerebellar ataxia, visuospatial dysfunction, andSarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services16",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"60Alien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services17",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"In two patients with frontal AHS, gradual improve-ment of grasping and groping at 6 months was reported.Unfortunately, the strategies used in therapy, including using bothTable 3.Treatment Modalities Described in Different Alien Hand Syndrome Variants Variant Therapeutic Modality Anterior Sensory tricks Distracting tasks CBT for anxiety control Verbal cues Posterior Botulinum toxin A Clonazepam Visualization strategiesSpatial recognition tasks Abbreviation: CBT, Cognitive Behavioral Therapy.Sarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services18",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Ann Rehabil Med 2012;36:556– 560, doi: http://dx.doi.org/10.5535/arm.2012.36.4.556.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arq Neuropsiquiatr 2001;59:521–525, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1992;55:806–810, doi: http://dx.doi.org/10.1136/jnnp.55.9.806.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 2008;79:246– 252, doi: http://dx.doi.org/10.1136/jnnp.2007.116046.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Ann Rehabil Med 2012;36(4): 556–560, doi: http://dx.doi.10.5535/arm.2012.36.4.556.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Laryngol Otol 2012;126:733–736, doi: http://dx.doi.org/10.1017/S002221511200093X.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Cephalalgia 2007;27:1368–1377, doi: http://dx.doi.org/10.1111/j.1468-2982.2007.01388.x.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arch Neurol 1998; 55:1574–1576, doi: http://dx.doi.org/10.1001/archneur.55.12.1574.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Epilepsy Behav 2001;2:61–64, doi: http://dx.doi.org/10.1006/ebeh.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Pediatr Neurol 2010;42:280–282, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arch Neurol 2004;61:292– 294, doi: http://dx.doi.org/10.1001/archneur.61.2.292.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurology 1992;42:19–24, doi: http://dx.doi.org/10.1212/WNL.42.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurocase 2013;19: 377–381, doi: http://dx.doi.org/10.1080/13554794.2012.690420.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurology 1995;45:802–808, doi: http://dx.doi.org/10.1212/WNL.45.4.802.Alien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services19",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Sci 2012;314:178–180, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurocase 2010;16:488–493, doi: http://dx.doi.org/10.1080/13554794.2010.497154.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Parkinsonism Relat Disord 2011; 17:126–127, doi: http://dx.doi.org/10.1016/j.parkreldis.2010.09.008.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neuroradiology 2002;44:921–923, doi: http://dx.doi.org/ 10.1007/s00234-002-0839-2.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Mov Disord 2005;20:632–633, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"BMC Neurol 2011;11:142, doi: http://dx.doi.org/10.1186/1471-2377-11-142.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurology 1986;36:1094–1097, doi: http://dx.doi.org/10.1212/WNL.36.8.1094.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Stroke Cerebrovasc Dis 2009;18:72–73, doi: http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2008.08.003.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Mov Disord 2006;21:2018–2022, doi: http://dx.doi.org/10.1002/mds.21055.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Parkinsonism Relat Disord 2012; 18:842–846, doi: http://dx.doi.org/10.1016/j.parkreldis.2012.04.009.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurology 2001;57:2143–2144, doi: http://dx.doi.org/10.1212/WNL.57.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1997;63:404–407, doi: http://dx.doi.org/10.1136/jnnp.63.3.404.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Behav Cogn Neurosci Rev 2003;2:261–277, doi: http://dx.doi.org/10.1177/1534582303260119.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"PLoS One 2010;5:e15010, doi: http://dx.doi.org/10.1371/journal.pone.0015010.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Mov Disord 2010;25:1288–1291, doi: http://dx.doi.org/10.1002/mds.23064.33.Kim HY, Kim JY, Kim GU, Han HJ, Shin DI.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Epilepsy Behav 2012;23:71–73, doi: http://dx.doi.org/10.1016/j.yebeh.2011.08.043.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Anarchic hand syndrome: Bimanual coordination and sensitivity to irrelevant information in unimanual reaches.Brain Res Cogn Brain Res 2005;24:634–647, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurol Sci 2003;24:252–257, doi: http://dx.doi.org/10.1007/s10072- 003-0149-4.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arch Neurol 1989;46:456– 459, doi: http://dx.doi.org/10.1001/archneur.1989.00520400116030.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Reduced endogenous control in alien hand syndrome: Evidence from naturalistic action.Neuropsychologia 2005;43:75–88, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Cortex 2013;49:2040–2054, doi: http://dx.doi.org/10.1016/j.cortex.2013.01.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1993;56:788– 792, doi: http://dx.doi.org/10.1136/jnnp.56.7.788.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 2006;77:992–993, doi: http://dx.doi.org/10.1136/jnnp.2005.082529.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Stroke Cerebrovasc Dis 2013;22:e240–244, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Brain Cogn 2011;77:138–150, doi: http://dx.doi.org/10.1016/j.bandc.2011.05.004.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 2000;68: 83–85, doi: http://dx.doi.org/10.1136/jnnp.68.1.83.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Curr Biol 2013;23:R57–58, doi: http://dx.doi.org/10.1016/j.cub.2012.12.003.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Clin Neurol Neurosurg 2009;111:633–635, doi: http://dx.doi.org/10.1016/j.clineuro.2009.05.006.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neuropsychiatry Clin Neurosci 2013;25:E02, doi: http://dx.doi.org/10.1176/appi.neuropsych.12080193.Sarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services20",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurosci Biobehav Rev 2012;36:1107–1118, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 2002;73:447–449, doi: http://dx.doi.org/10.1136/jnnp.73.4.447.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurol Sci 2011;32:483–486, doi: http://dx.doi.org/10.1007/s10072-011-0490-y.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arch Phys Med Rehabil 1999; 80:162–165, doi: http://dx.doi.org/10.1016/S0003-9993(99)90114-4.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Ann Neurol 2007;62:301– 306, doi: http://dx.doi.org/10.1002/ana.21173.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurorehabil Neural Repair 2004;18:176–181, doi: http://dx.doi.org/10.1177/0888439004269031.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurology 1993;43:2710–2712, doi: http://dx.doi.org/10.1212/WNL.43.12.2710.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Mov Disord 2007;22:248–251, doi: http://dx.doi.org/10.1002/mds.21241.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Clin Neurol 2009;5:46–48, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Brain 2014;137:208–220, doi: http://dx.doi.org/10.1093/brain/awt302.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurologist 2010;16:106–108, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurocase 2013;19:36–40, doi: http://dx.doi.org/10.1080/13554794.2011.654213.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arch Phys Med Rehabil 2006;87: 728–732, doi: http://dx.doi.org/10.1016/j.apmr.2006.02.002.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neuropsychol Rehabil 2010;20:406–422, doi: http://dx.doi.org/10.1080/09602010903345298.66.Romano D, Sedda A, Dell’aquila R, et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurocase 2014;20:307–316, doi: http://dx.doi.org/10.1080/13554794.2013.770882.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Sci 2014;338:203–206, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Disabil Rehabil 2002;24:817–818, doi: http://dx.doi.org/10.1080/09638280210142202.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arch Neurol 1981;38:683–686, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1988;51:218–222, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Am J Phys Med Rehabil 1990;69:228–238, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neuropsychologia 1991;29:1113–1127, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1995;59:100–101, doi: http://dx.doi.org/10.1136/jnnp.59.1.100.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1995;59:312–315, doi: http://dx.doi.org/10.1136/jnnp.59.3.312.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1995;58:735–737, doi: http://dx.doi.org/10.1136/jnnp.58.6.735.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1995;59:238–242, doi: http://dx.doi.org/10.1136/jnnp.59.3.238.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"82.Nagumo T, Yamadori A. Callosal disconnection syndrome and knowl- edge of the body: A case of left hand isolation from the body schema withAlien Hand Syndrome Sarva H, Deik A, Severt WL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services21",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1995;59:548–551, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neuropsychologia 1995;33:1703– 1709, doi: http://dx.doi.org/10.1016/0028-3932(95)00044-5.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Eur Neurol 1996;36:39–42, doi: http://dx.doi.org/10.1159/000117198.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Brain 1996;119 (Pt 3):859–873, doi: http://dx.doi.org/ 10.1093/brain/119.3.859.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1996;60:232– 233, doi: http://dx.doi.org/10.1136/jnnp.60.2.232.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Cortex 1997;33:287–299, doi: http://dx.doi.org/10.1016/S0010-9452(08)70005-4.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Arch Phys Med Rehabil 1998;79:113–114, doi: http://dx.doi.org/10.1016/S0003-9993(98)90218-0.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 1998;65:366–369, doi: http://dx.doi.org/10.1136/jnnp.65.3.366.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Cerebrovasc Dis 2000; 10:70–72, doi: http://dx.doi.org/10.1159/000016028.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Am J Phys Med Rehabil 2000;79:395–398, doi: http://dx.doi.org/10.1097/00002060-200007000-00012.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Neurosurg Psychiatry 2000;68:103–104, doi: http://dx.doi.org/10.1136/jnnp.68.1.103.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"A case study.Neurocase 2002;8:480–483, doi: http://dx.doi.org/10.1076/neur.8.5.480.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Surg Neurol 2005;64:538–541, discussion 541, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurology 2006;67:E21, doi: http://dx.doi.org/10.1212/01.wnl.0000249303.88754.48.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurologist 2008;14:316–317, doi: http://dx.doi.org/10.1097/NRL.0b013e318172cf5e.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Rev Bras Psiquiatr 2008;30:290– 291, doi: http://dx.doi.org/10.1590/S1516-44462008000300017.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Clin Neurol Neurosurg 2008;110:190–193, doi: http://dx.doi.org/10.1016/j.clineuro.2007.",OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Mov Disord 2009;24:1557–1559, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Neurocase 2010;16:281–285, doi: http://dx.doi.org/10.1080/13554790903456217.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
BMJ Case Rep 2010; doi: http://dx.doi.org/10.1136/bcr.10.2010.3401.,Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"Behavioral Neurology 2014;2014:873541, doi: http://dx.doi.org/10.1155/2014/873541.",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"J Neurol Sci 2014;341: 153–157, doi: http://dx.doi.org/10.1016/j.jns.2014.04.004.Sarva H, Deik A, Severt WL Alien Hand Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services22",Non-OADS,/arxiv_data1/oa_pdf/c9/42/tre-04-241-6073-2.PMC4261226.pdf
"PDB structure contains Ile at position 180;27to get the correct human or mouse sequence, the Ile was mutated to Leu using the program PyMol (http://www.pymol.org).",Non-OADS,/arxiv_data1/oa_pdf/f7/af/boneres201411.PMC4261231.pdf
( b) Alignment of CLZ sequences derived from the Ensembl database (http://www.ensembl.org).,OADS,/arxiv_data1/oa_pdf/f7/af/boneres201411.PMC4261231.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information for this article can be found on the Bone Research ’s website (http://www.nature.com/boneres).Vitamin D and hnRNPC1/C2 TS Lisse et al 11 /C2232014 Sichuan University Bone Research (2014) 14011",Non-OADS,/arxiv_data1/oa_pdf/f7/af/boneres201411.PMC4261231.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial u se, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"All protein kinases were identiﬁed by a cross search using protein IDs of the human kinome.Analysis of AKT and ERK1/2 in EVs Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"ns /C30non-signiﬁcant.Analysis of AKT and ERK1/2 in EVs Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"ns /C30not signiﬁcant, *p 50.05, **p 50.01, ***p 50.001.Analysis of AKT and ERK1/2 in EVs Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"Unfortunately, no tumour tissuesamples were available for comparative analyses betweenAnalysis of AKT and ERK1/2 in EVs Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"2013;108:924 /C131.Analysis of AKT and ERK1/2 in EVs Citation: Journal of Extracellular Vesicles 2014, 3: 25657 - http://dx.doi.org/10.3402/jev.v3.25657 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/c7/e0/JEV-3-25657.PMC4261239.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial u se, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"UnlessEnrichment of calcifying extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"Mean 9SD.Enrichment of calcifying extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"Mean 9SD.Enrichment of calcifying extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"Functional annotation for proteins enriched in calcifying EV GO term ID GO term Number of genes p GO:0005509 Calcium ion binding 21 4.32 E /C2809 GO:0005198 Structural molecule activity 12 1.80 E /C2804 GO:0004857 Enzyme inhibitor activity 8 2.88 E /C2804 GO:0030246 Carbohydrate binding 7 0.006703GO:0004866 Endopeptidase inhibitor activity 6 6.29 E /C2804 GO:0030414 Peptidase inhibitor activity 6 8.02 E /C2804 GO:0005178 Integrin binding 4 0.002787GO:0004867 Serine-type endopeptidase inhibitor activity 4 0.009633GO:0051082 Unfolded protein binding 4 0.017534GO:0001871 Pattern binding 4 0.037223GO:0030247 Polysaccharide binding 4 0.037223GO:0001948 Glycoprotein binding 3 0.013423GO:0030911 TPR domain binding 2 0.014259 GO:0030235 Nitric-oxide synthase regulator activity 2 0.023654Enrichment of calcifying extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"2012;1:18397, doi: http://dx.doi.org/10.3402/jev.v1i0.18397 8.",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"2013;2:20360, doi: http://dx.doi.org/10.3402/jev.v2i0.",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"A mechanistic analysis of theEnrichment of calcifying extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25129 - http://dx.doi.org/10.3402/jev.v3.25129",OADS,/arxiv_data1/oa_pdf/3f/b9/JEV-3-25129.PMC4261240.pdf
"Tel: +82-54-279-2345, Fax: +82-54-279-  8609; E-mail: ysgho@postech.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.10.164Received 18 July 2014Keywords: Cancer, Component, Diagnosis, Exosome, Function,  Microvesicle, Therapy, Tumor ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Extracellular vesicles as emerging intercellular communicasomes Yae Jin Yoon1,2, Oh Youn Kim1 & Yong Song Gho1,* 1Department of Life Sciences, Pohang University of Science and Technology, 2Division of Integrative Biosciences and Biotechnology,  Pohang University of Science and Technology, Pohang 790-784, Korea All living cells release extracellular vesicles having pleiotropic  functions in intercellular communication.",Non-OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
532 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
533 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
"534 BMB Reports http://bmbreports.orgmiRNAs, and activating receptors of recipient cells (6, 36) (Fig.",OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
535 http://bmbreports.org BMB Reportsof macrophages (69).,OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
536 BMB Reports http://bmbreports.orgACKNOWLEDGEMENTS This work was supported by Mid-Career Researcher Program  through NRF grant funded by the MEST (No.,OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
"537 http://bmbreports.org BMB ReportsS., Krichevsky, A. M. and Breakefield, X. O.",Non-OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
"538 BMB Reports http://bmbreports.orgVidal, M., Laude, H. and Raposo, G. (2004) Cells release  prions in association with exosomes.",OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
539 http://bmbreports.org BMB Reports80.,Non-OADS,/arxiv_data1/oa_pdf/2f/7f/BMB-47-531.PMC4261509.pdf
"Tel: +82-2-6490-2671; Fax: +82-2-6490-  2664; E-mail: ej70@uos.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.10.177Received 7 August 2014Keywords: β-catenin, Crosstalk, Hippo signaling, Wnt signaling,  YAP/TAZ ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Cross-talk between Wnt/ β-catenin and Hippo signaling  pathways: a brief review Minseong Kim & Eek-hoon Jho* Department of Life Science, The University of Seoul, Seoul 130-743, Korea Balanced cell growth is crucial in animal development as well  as tissue homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/a9/1c/BMB-47-540.PMC4261510.pdf
Cross-talk between Wnt/ β-catenin and Hippo signaling pathways: a brief review Minseong Kim and Eek-hoon Jho 541 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/a9/1c/BMB-47-540.PMC4261510.pdf
Cross-talk between Wnt/ β-catenin and Hippo signaling pathways: a brief review Minseong Kim and Eek-hoon Jho 542 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/a9/1c/BMB-47-540.PMC4261510.pdf
"Cross-talk between Wnt/ β-catenin and Hippo signaling pathways: a brief review Minseong Kim and Eek-hoon Jho 543 http://bmbreports.org BMB Reportsquestrating Yorkie to the cytoplasm in a Warts-mediated phos- phorylation-independent manner, to inhibit Yorkie activity in Drosophila  (36, 37); however, the PPxP motifs of Ex and Hippo  necessary for the interaction with Yorkie are not present in mam- malian homologs.",Non-OADS,/arxiv_data1/oa_pdf/a9/1c/BMB-47-540.PMC4261510.pdf
"Cross-talk between Wnt/ β-catenin and Hippo signaling pathways: a brief review Minseong Kim and Eek-hoon Jho 544 BMB Reports http://bmbreports.orgphorylation of β-catenin leads to escape of both β-catenin and  TAZ from the destruction complex, subsequently enhancing ex-pression of the target genes mediated by the β-catenin/Tcf and  TAZ/TEAD complexes.",Non-OADS,/arxiv_data1/oa_pdf/a9/1c/BMB-47-540.PMC4261510.pdf
Cross-talk between Wnt/ β-catenin and Hippo signaling pathways: a brief review Minseong Kim and Eek-hoon Jho 545 http://bmbreports.org BMB Reports2103-2109.,OADS,/arxiv_data1/oa_pdf/a9/1c/BMB-47-540.PMC4261510.pdf
"Tel: +66-2-354-9100; Fax: +66-2-643-5601;  E-mail: saengduen.moo@mahidol.ac.th http://dx.doi.org/10.5483/BMBRep.2014.47.10.192Received 22 August 2013, Revised 16 September 2013,  Accepted 28 October 2013 Keywords: Aedes aegypti , Bacillus thuringiensis , Cry4Ba toxin,  Larvicidal activity, Peritrophic membrane ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/e7/BMB-47-546.PMC4261511.pdf
547 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/ce/e7/BMB-47-546.PMC4261511.pdf
548 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/ce/e7/BMB-47-546.PMC4261511.pdf
549 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/ce/e7/BMB-47-546.PMC4261511.pdf
550 BMB Reports http://bmbreports.orgCry4Ba were selectively produced in order to increase sensi- tivity of toxin detection.,Non-OADS,/arxiv_data1/oa_pdf/ce/e7/BMB-47-546.PMC4261511.pdf
551 http://bmbreports.org BMB Reports4.,Non-OADS,/arxiv_data1/oa_pdf/ce/e7/BMB-47-546.PMC4261511.pdf
"Tel: +86-13-213243710;  Fax: +86-27-85  726337; E-mail: realduxinling@163.com http://dx.doi.org/10.5483/BMBRep.2014.47.10.216Received 4 October 2013, Revised 24 October 2013,  Accepted 26 December 2013 Keywords: β-catenin, M3R, PTP1B, VE-cadherin ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.T ype 3 muscarinic acetylcholine receptor stimulation is a  determinant of endothelial barrier function and adherens junctions integrity: role of protein-tyrosine phosphatase 1B Zhou-Yang Jiao1,2, Jing Wu3, Chao Liu2, Bing Wen2, Wen-Zeng Zhao2 & Xin-Ling Du1,* 1Department of Cardiovascular Surgery, Xiehe Hospital, Huazhong University of Science and Technology, Wuhan 430022, 2Department of  Cardiovascular Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, 3Department of Pediatrics, First Affiliated  Hospital of Zhengzhou University, Zhengzhou 450052, China The main purpose of this study was to investigate whether type  3 muscarinic acetylcholine receptor (M3R) dysfunction induced vascular hyperpermeability.",Non-OADS,/arxiv_data1/oa_pdf/49/8e/BMB-47-552.PMC4261512.pdf
553 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/8e/BMB-47-552.PMC4261512.pdf
554 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/8e/BMB-47-552.PMC4261512.pdf
555 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/8e/BMB-47-552.PMC4261512.pdf
556 BMB Reports http://bmbreports.orginhibition decreased PTP1B activity.,OADS,/arxiv_data1/oa_pdf/49/8e/BMB-47-552.PMC4261512.pdf
"MATERIALS AND METHODS Materials and chemical, Cell culture, Immunoprecipitation and  immunoblotting and PTP1B activity assay are described in the  expanded Material and Methods section in the online data  supplement, available at http://www.bmbreports.org/jbmb_by_ volume.html?vol=47.",OADS,/arxiv_data1/oa_pdf/49/8e/BMB-47-552.PMC4261512.pdf
557 http://bmbreports.org BMB ReportsREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/49/8e/BMB-47-552.PMC4261512.pdf
"Tel: +82-2-2123-2628; Fax: +82-0502-312-  8834; E-mail: yjkim@yonsei.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.10.281Received 16 December 2013, Revised 3 January 2014,  Accepted 5 January 2014 Keywords: Irf7, OASL1, SHAPE, Secondary structure, 1M7 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Secondary structure of the Irf7 5’-UTR, analyzed using SHAPE  (selective 2’-hydroxyl acylation analyzed by primer extension) Yun-Mi Kim1, Won-Young Choi2, Chang-Mok Oh3, Gyoon-Hee Han1 & Young-Joon Kim1,* Departments of 1Integrated OMICs for Biomedical Science, 2Biochemistry, and 3Biotechnology, Yonsei University, Seoul 120-749, Korea OASL1 is a member of the 2’-5’-oligoadenylate synthetase  (OAS) family and promotes viral clearance by activating RNase L. OASL1 interacts with the 5’-untranslated region (UTR) of  interferon regulatory factor 7 (Irf7) and inhibits its translation.",Non-OADS,/arxiv_data1/oa_pdf/5e/46/BMB-47-558.PMC4261513.pdf
559 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/46/BMB-47-558.PMC4261513.pdf
560 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/46/BMB-47-558.PMC4261513.pdf
561 http://bmbreports.org BMB Reportsgions of the Irf7 5’-UTR are probably important elements for  the inhibition of OASL1-mediated Irf7 translation.,Non-OADS,/arxiv_data1/oa_pdf/5e/46/BMB-47-558.PMC4261513.pdf
"562 BMB Reports http://bmbreports.orgple, if Ei+1 , j = Eij, i is unpaired and if Ei, j-1 = Eij, j is  unpaired.",OADS,/arxiv_data1/oa_pdf/5e/46/BMB-47-558.PMC4261513.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.10.252Received 20 November 2013, Revised 11 December 2013,  Accepted 16 January 2014 Keywords: C4orf32, C4orf34, C4orf52, Endoplasmic reticulum,  Type I transmembrane protein ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Characterization of the cellular localization of C4orf34 as a  novel endoplasmic reticulum resident protein Mi-Hee Jun1,#, Young-Wu Jun2,#, Kun-Hyung Kim2, Jin-A Lee1,* & Deok-Jin Jang2,*  1Department of Biotechnology, College of Life Science and Nano Technology, Hannam University, Daejeon 305-811, 2Department of  Ecological Science, College of Ecology and Environmen t, Kyungpook National University, Sangju 742-711, Korea Human genome projects have enabled whole genome  mapping and improved our understanding of the genes in humans.",Non-OADS,/arxiv_data1/oa_pdf/82/2e/BMB-47-563.PMC4261514.pdf
564 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/2e/BMB-47-563.PMC4261514.pdf
565 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/2e/BMB-47-563.PMC4261514.pdf
566 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/2e/BMB-47-563.PMC4261514.pdf
"567 http://bmbreports.org BMB Reportsround PCR); hC4orf34(NGI/PPN,6XLeu), hC4orf34(NGI)-D3-S/  hC4orf34(6XLeu)-A (first-r ound PCR), and hC4orf34(NG I)-D3-S/  hC4orf34(PPN)-EcoRI-A (second-round PCR) (Supplement table  1).",OADS,/arxiv_data1/oa_pdf/82/2e/BMB-47-563.PMC4261514.pdf
568 BMB Reports http://bmbreports.orgmembranes.,OADS,/arxiv_data1/oa_pdf/82/2e/BMB-47-563.PMC4261514.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.10.286Received 17 December 2013, Revised 30 December 2013,  Accepted 20 January 2014 Keywords: Dopaminergic neuron, Heme oxygenase-1, MPTP ,  Parkinson’s disease, Protein transduction domain ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.PEP-1-HO-1 prevents MPTP-i nduced degeneration of  dopaminergic neurons in a Parkinson’s disease mouse model Jong Kyu Youn1,†, Dae Won Kim2,†, Seung Tae Kim1, Sung Yeon Park1, Eun Ji Yeo1, Yeon Joo Choi1, Hae-Ran Lee3,  Duk-Soo Kim4, Sung-Woo Cho5, Kyu Hyung Han1, Jinseu Park1, Won Sik Eum1, Hyun Sook Hwang1,* & Soo Young Choi1,* 1Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 200-702,  2Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Kangnung-Wonju Nat ional  University, Gangneung 210-702, 3Department of Pediatrics, Hallym University Medical Center, Pyungchon 431-796, 4Department of  Anatomy, College of Medicine, Soonchunhyang University, Cheonan 330-090, 5Department of Biochemistry and Molecular Biology, University  of Ulsan College of Medicine, Seoul 138-736, Korea Heme oxygenase-1 (HO-1) degrades heme to carbon dioxide,  biliverdin, and Fe2+, which play important roles in various  biochemical processes.",Non-OADS,/arxiv_data1/oa_pdf/42/86/BMB-47-569.PMC4261515.pdf
570 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/42/86/BMB-47-569.PMC4261515.pdf
571 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/42/86/BMB-47-569.PMC4261515.pdf
"572 BMB Reports http://bmbreports.orgwith HO-1 inductor and substrate hemin exhibited increased  HO-1 expression and characteristics of neuroinflammation such as brain tissue loss, microglial activation, and neuronal  death in the brains (17).",OADS,/arxiv_data1/oa_pdf/42/86/BMB-47-569.PMC4261515.pdf
573 http://bmbreports.org BMB Reports& Quarantine Service of Korea and were approved by the  Hallym Medical Center Institutional Animal Care and Use Committee.,Non-OADS,/arxiv_data1/oa_pdf/42/86/BMB-47-569.PMC4261515.pdf
574 BMB Reports http://bmbreports.org19.,Non-OADS,/arxiv_data1/oa_pdf/42/86/BMB-47-569.PMC4261515.pdf
"Xing Cui, Tel: +81-43-206-3231; Fax: +81-  43-206-4149; E-mail: saisei@nirs.go.jp, Mitsuru Nenoi, Tel: +81- 43-206-3082; Fax: +81-43-255-6497; E-mail: m_nenoi@nirs.go.jp http://dx.doi.org/10.5483/BMBRep.2014.47.10.254Received 22 November 2013, Revised 10 December 2013,  Accepted 26 January 2014 Keywords: Arsenite, Glioma, Heterochromatin formation, Premature  senescence, p53 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Arsenite induces premature senescence via p53/p21 pathway as  a result of DNA damage in human malignant glioblastoma cells Yasuharu Ninomiya1, Xing Cui2,*, Takeshi Yasuda3, Bing Wang1, Dong Yu4, Emiko Sekine-Suzuki5 & Mitsuru Nenoi1,* 1Radiation Risk Reduction Research Program, Research Center for Radiation Protection, National Institute of Radiological Science s, Chiba  263-8555, 2Medical Physics Research Program, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences,  Chiba 263-8555, 3Radiation Emergency Medicine Research Program, Research Center for Radiation Emergency Medicine, National Institute  of Radiological Sciences, Chiba 263-8555, Japan, 4School of Radiological Medicine and Protection, Medical College of Soochow University,  199 Ren Ai Rd, Suzhou Industrial Park, Suzhou 215123, China, 5Research Program for Application of Heavy ions and Medical Science,  Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba 263-8555, Japan In this study, we investigate whether arsenite-induced DNA  damage leads to p53-dependent premature senescence using human glioblastoma cells with p53-wild type (U87MG-neo) and  p53 deficient (U87MG-E6).",Non-OADS,/arxiv_data1/oa_pdf/74/b8/BMB-47-575.PMC4261516.pdf
576 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/74/b8/BMB-47-575.PMC4261516.pdf
577 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/74/b8/BMB-47-575.PMC4261516.pdf
578 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/74/b8/BMB-47-575.PMC4261516.pdf
"MATERIALS AND METHODS Material and Methods are described in the online data supple- ment, available at http://www.bmbreports.org/jbmb_by_vol- ume.html?vol=47.",OADS,/arxiv_data1/oa_pdf/74/b8/BMB-47-575.PMC4261516.pdf
579 http://bmbreports.org BMB ReportsREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/74/b8/BMB-47-575.PMC4261516.pdf
580 BMB Reports http://bmbreports.org29.,Non-OADS,/arxiv_data1/oa_pdf/74/b8/BMB-47-575.PMC4261516.pdf
"Tel: +82-33-2508811; Fax: +82-33-  2427571; E-mail: jhahn@kangwon.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.10.151Received 22 July 2014, Revised 8 August 2014, Accepted 27 August 2014Keywords: EGF , EGFR, Keratinocyte proliferation, Skin regeneration, Tripeptide ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.YAC tripeptide of epidermal growth factor promotes the  proliferation of HaCaT keratinocytes through activation of EGFR Yeon Ho Yoo, Yu Ri Kim, Min Seo Kim, Kyoung-Jin Lee, Kyeong Han Park & Jang-Hee Hahn * Department of Anatomy and Cell Biology, School of Medi cine, Kangwon National University, Chuncheon 200-701, Korea Epidermal growth factor (EGF) is known to play key roles in  skin regeneration and wound-healing.",Non-OADS,/arxiv_data1/oa_pdf/2a/50/BMB-47-581.PMC4261517.pdf
582 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/2a/50/BMB-47-581.PMC4261517.pdf
583 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2a/50/BMB-47-581.PMC4261517.pdf
584 BMB Reports http://bmbreports.orgbeen shown to play a key role in the activation of EGFR (6).,OADS,/arxiv_data1/oa_pdf/2a/50/BMB-47-581.PMC4261517.pdf
"585 http://bmbreports.org BMB Reportsbit-c-jun (Santa Cruz Biotechnology), and mouse-c-fos (Santa  Cruz Biotechnology).",OADS,/arxiv_data1/oa_pdf/2a/50/BMB-47-581.PMC4261517.pdf
586 BMB Reports http://bmbreports.orgman head and neck squamous cell carcinoma lines.,Non-OADS,/arxiv_data1/oa_pdf/2a/50/BMB-47-581.PMC4261517.pdf
"Tel: +82-2-740-8688; Fax: +82-2-741-  3193, E-mail: baekjh@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.10.176Received 25 August 2014, Revised 12 September 2014,  Accepted 12 September 2014 Keywords: Adipocyte, Bone marrow adiposity, Beta-adrenergic  receptor, Osteoblast, Propranolol ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Propranolol attenuates calorie restriction- and high calorie  diet-induced bone marrow adiposity Kyunghwa Baek2, Hyun-Jung Park1, Hyo Rin Hwang1 & Jeong-Hwa Baek1,* 1Department of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul 110-744,  2Department of Pharmacology and Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University,  Gangwon 210-702, Korea We investigated the effects of β-adrenergic activation on bone  marrow adiposity and on adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).",Non-OADS,/arxiv_data1/oa_pdf/1c/ad/BMB-47-587.PMC4261518.pdf
588 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/1c/ad/BMB-47-587.PMC4261518.pdf
589 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/1c/ad/BMB-47-587.PMC4261518.pdf
590 BMB Reports http://bmbreports.orgtrabecular bone mass in high calorie diet-fed obese mice (15).,Non-OADS,/arxiv_data1/oa_pdf/1c/ad/BMB-47-587.PMC4261518.pdf
"591 http://bmbreports.org BMB Reportsphosphate-buffered formaldehyde and routinely processed for  decalcification, paraffin embedding and H&E stain.",Non-OADS,/arxiv_data1/oa_pdf/1c/ad/BMB-47-587.PMC4261518.pdf
592 BMB Reports http://bmbreports.orgtissue during prolonged fasting.,Non-OADS,/arxiv_data1/oa_pdf/1c/ad/BMB-47-587.PMC4261518.pdf
"Tel: +82-43-840-3903; Fax: +82-43-852-  3616; E-mail: bahk12@empal.com http://dx.doi.org/10.5483/BMBRep.2014.47.10.144Received 14 July 2014, Revised 15 July 2014, Accepted 28 July 2014Keywords: CTD phosphatase SCP1, Inducible mammalian ex- pression system, O-GlcNAc, Post-translational modification ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.In vivo  putative O-GlcNAcylation of human SCP1 and evidence  for possible role of its N-terminal disordered structure JaeHyung Koo1 & Young Yil Bahk2,* 1Department of Brain Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Daegu 711-873, 2Department of  Biotechnology, Konkuk University, Chungju 380-701, Korea RNA polymerase II carboxyl-terminal domain (RNAPII CTD)  phosphatases are responsible for the dephosphorylation of the C-terminal domain of the small subunit of RNAPII in  eukaryotes.",Non-OADS,/arxiv_data1/oa_pdf/85/1c/BMB-47-593.PMC4261519.pdf
O-GlcNAcylation of CTD phosphatase SCP1 JaeHyung Koo and Young Yil Bahk 594 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/BMB-47-593.PMC4261519.pdf
"O-GlcNAcylation of CTD phosphatase SCP1 JaeHyung Koo and Young Yil Bahk 595 http://bmbreports.org BMB ReportspTRE-IRES-EGFP vector placing together pEF1α-Tet, several  candidates were primarily chosen based on their antibiotic se-lection (puromycin, 10 μg/ml) and microscopic appearance for  the EGFP monitored into the IRES-driven EGFP expression in  order for the expression to be tracked by fluorescence (Fig.",Non-OADS,/arxiv_data1/oa_pdf/85/1c/BMB-47-593.PMC4261519.pdf
O-GlcNAcylation of CTD phosphatase SCP1 JaeHyung Koo and Young Yil Bahk 596 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/BMB-47-593.PMC4261519.pdf
O-GlcNAcylation of CTD phosphatase SCP1 JaeHyung Koo and Young Yil Bahk 597 http://bmbreports.org BMB Reportsbeads and Western blot analysis.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/BMB-47-593.PMC4261519.pdf
O-GlcNAcylation of CTD phosphatase SCP1 JaeHyung Koo and Young Yil Bahk 598 BMB Reports http://bmbreports.orgACKNOWLEDGEMENTS This study was supported by grants from the National Research  Foundation of Korea: 2010-0024199 for YYB and 2013R1A1  A2009145 for JHK.,OADS,/arxiv_data1/oa_pdf/85/1c/BMB-47-593.PMC4261519.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/BMB-47-593.PMC4261519.pdf
"This core set was  subsequently used as input for a HaMStR ortholog search  (http://sourceforge.net/projects/hamstr ) ( Ebersberger  et al., 2009 ) in 260 eukaryotes, 26 archaea, and 75 cyano - bacteria ( Supplemental Table  1 ).",OADS,/arxiv_data1/oa_pdf/8b/61/ssu095.PMC4261837.pdf
Published online 22 September 2014; http://dx.doi.org/10.1016/j.simyco.2014.09.001 .,OADS,/arxiv_data1/oa_pdf/78/3c/main.PMC4261876.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 78: 343 –371.Studies in Mycology 343,Non-OADS,/arxiv_data1/oa_pdf/78/3c/main.PMC4261876.pdf
"For ITS the RefSeq data set, accessible from the NCBIhomepage ( http://www.ncbi.nlm.nih.gov/refseq/ ), is now available and can be used to query ITS sequences against a veri ﬁed ITS database ( Schoch et al.",OADS,/arxiv_data1/oa_pdf/78/3c/main.PMC4261876.pdf
Theactive version of the list is currently hosted on the ICPA website(http://www.aspergilluspenicillium.org ) where it will be updated as new information comes to light.,Non-OADS,/arxiv_data1/oa_pdf/78/3c/main.PMC4261876.pdf
Database 2014 .http://dx.doi.org/10.1093/database/bau061 .,OADS,/arxiv_data1/oa_pdf/78/3c/main.PMC4261876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Promoter methylation of NIS in B-RafV600E PTC YW Choi et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/39/47/emm201468a.PMC4261912.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/miR-27 results in morphological changes of mitochondria HT a k et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/97/28/emm201473a.PMC4261914.pdf
http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/ed/16/hpu104.PMC4261916.pdf
http://www.heartfoundation.org.au .,Non-OADS,/arxiv_data1/oa_pdf/ed/16/hpu104.PMC4261916.pdf
http://www.nzgg.org.nz .,Non-OADS,/arxiv_data1/oa_pdf/ed/16/hpu104.PMC4261916.pdf
"Data set available on- line [http://www.daac.ornl.gov] from Oak Ridge National Laboratory Distributed Active Archive Center, Oak Ridge, Tennessee, U.S.A. doi:10.3334/ORNLDAAC/797 (2005).",OADS,/arxiv_data1/oa_pdf/52/aa/srep07406.PMC4261933.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/52/aa/srep07406.PMC4261933.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7406 | DOI: 10.1038/srep07406 8",Non-OADS,/arxiv_data1/oa_pdf/52/aa/srep07406.PMC4261933.pdf
Single nucleotide polymorphisms were assigned to genes(Ensembl 54 deﬁnitions) if they were located physically withinthe boundaries of the gene ( ±10 kb) or if they were in high LD [r 2≥0.80 based on HapMap CEU (http://hapmap.ncbi.nlm.nih.gov/)] with another SNP located within the boundaries of the gene(±10 kb).,OADS,/arxiv_data1/oa_pdf/09/9d/gbb0013-0663.PMC4261989.pdf
Thedata reported in this study are tabulated in the Online Sup-porting Information and archived in Dryad at http://dx.doi.,OADS,/arxiv_data1/oa_pdf/61/47/ele0017-0369.PMC4261992.pdf
In-depth analysis for the calculationof the ﬂuorescence intensity in individual cells and a fastcomparison of the ﬂuorescent signal in numerous cells atdifferent time intervals was performed using the Spottyframework (Spotty can be retrieved online at http://bioinformatics.fh-hagenberg.at/projects/microprot/).,OADS,/arxiv_data1/oa_pdf/fb/a4/bph0171-5237.PMC4262000.pdf
Supporting information Additional Supporting Information may be found in the online version of this article at the publisher’s web-site: http://dx.doi.org/10.1111/bph.12845 Figure S1 Inﬂuence of varying starving and buffer condi- tions on GLUT4-GFP signal increase.,Non-OADS,/arxiv_data1/oa_pdf/fb/a4/bph0171-5237.PMC4262000.pdf
MPTS data were obtained from the pub- licly available ‘Visualization and Analysis of Microbial Popu-lations Structure (VAMPS)’ website (http://vamps.mbl.edu/;project AB_SAND_Bv6).,OADS,/arxiv_data1/oa_pdf/d1/6d/emi0016-2672.PMC4262003.pdf
"Toassign possible metabolite identities to the selected masses, themonoisotopic neutral masses of interest were queried againstMassTrix (http://masstrix.org), a free-access software designedto incorporate masses into metabolic pathways using the KyotoEncyclopedia of Genes and Genomes (KEGG; http://www810 K. A. Mattos et al.",OADS,/arxiv_data1/oa_pdf/36/ff/cmi0016-0797.PMC4262048.pdf
"(developed at the National Institutes of Health and available at http://rsb.info.nih.gov/ij/), using the ‘Gel Analysis’ functions.",OADS,/arxiv_data1/oa_pdf/36/ff/cmi0016-0797.PMC4262048.pdf
URL http://www.who.int/lep/en/.,OADS,/arxiv_data1/oa_pdf/36/ff/cmi0016-0797.PMC4262048.pdf
Available from http://www.fws.gov/wetlands.,Non-OADS,/arxiv_data1/oa_pdf/13/31/cobi0028-0959.PMC4262067.pdf
"16S amplicon sequencing and analysis 16s rRNA gene hypervariable region V4-V5 from the bac- terial and archaeal communities was sequenced on an Illu-mina MiSeq sequencer (Illumina Inc. San Diego, CA,USA) at the Josephine Paul Bay Center, Marine BiologicalLaboratory (MBL) in Woods Hole, Massachusetts, USA.Sample preparation, including primers used, PCR condi-tions, and cycling conditions are described at length on the MBL Web site (http://vamps.mbl.edu/resources/primers.",OADS,/arxiv_data1/oa_pdf/a0/61/gbi0012-0511.PMC4262068.pdf
Sequence QC and analyses were performed throughthe Visualization and Analysis of Microbial PopulationStructure (VAMPS) Web site (http://vamps.mbl.edu/index.php) and as described by Huse et al.,OADS,/arxiv_data1/oa_pdf/a0/61/gbi0012-0511.PMC4262068.pdf
All sequences are available via the VAMPSwebpage http://vamps.mbl.edu/ listed as SBJ_BME_ Av4v5 and SBJ_BME_Av4v5.,OADS,/arxiv_data1/oa_pdf/a0/61/gbi0012-0511.PMC4262068.pdf
We conductedthree rounds using a web-based tool (https://www.sur-veymonkey.net/).,OADS,/arxiv_data1/oa_pdf/cc/ee/codi0016-0965.PMC4262073.pdf
"Early detection of anastomotic leakage isclearly a consistent concern among colorectal surgeons, as it was highlighted as an important area of research in 2013 [14] and the development of a signature diagnos-tic test to allow earlier detection of anastomotic leakagewith emerging technologies based on detection of localbiomarkers is now the subject of a NIHR ColorectalTherapies Healthcare Technology Co-operative project(http://colorectal.htc.nihr.ac.uk/ongoing-projects/ear-lier-detection-of-anastomotic-leak/).",Non-OADS,/arxiv_data1/oa_pdf/cc/ee/codi0016-0965.PMC4262073.pdf
Retrieved from http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo53c-eng.htm.,OADS,/arxiv_data1/oa_pdf/a1/16/dev0056-0249.PMC4262075.pdf
"Developed regions were North America, Europe, and Japan (http://unstats.un.org/unsd/methods/m49/ m49regin.htm#least) Experience direct conflict respondents who lived within the range of the species under considerationPublications were initially excluded if respondents’ attitudes were not recorded separately for respondents who lived within the range of the species under consideration and those who did not live within the range of the species under consideration.",Non-OADS,/arxiv_data1/oa_pdf/7e/9d/cobi0028-0924.PMC4262077.pdf
(web document) http://www.fao.org/sard/common/ecg/1357/en/hwc_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/9d/cobi0028-0924.PMC4262077.pdf
Available from http://www.iucnredlist.org/mammals (accessed November 2011).,Non-OADS,/arxiv_data1/oa_pdf/7e/9d/cobi0028-0924.PMC4262077.pdf
Available from http://www.ecologyandsociety.org/ vol16/iss1/art16/.,Non-OADS,/arxiv_data1/oa_pdf/7e/9d/cobi0028-0924.PMC4262077.pdf
Disponível em: http://portal.saude.gov.br/portal/saude/ visualizar_texto.cfm.dtxt =41993 390,Non-OADS,/arxiv_data1/oa_pdf/c0/a4/abc-103-05-0382.PMC4262098.pdf
Available from: http://us.gsk.com/ products/assets/us_votrient.pdf 26.,OADS,/arxiv_data1/oa_pdf/3e/a3/abc-103-05-0403.PMC4262101.pdf
Available  from: http://www.cochrane.org/handbook 18.,OADS,/arxiv_data1/oa_pdf/d5/fe/abc-103-05-0433.PMC4262105.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/7c/ppa-8-1653.PMC4262214.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1653–1664Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1653Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6725 3Treatment adherence and other patient-reported  outcomes as cost determinants in multiple  sclerosis: a review of the literature Luis Lizán1 Marta Comellas1 Silvia Paz1 José Luis Poveda2 Dennis M Meletiche3 Carlos Polanco4 1Outcomes’10, Castellón, Spain;   2Hospital Universitario La Fe, valencia,   Spain; 3eMD Serono inc., Rockland,   MA, USA; 4Merck S.L., Madrid, SpainBackground:  Treatment adherence is one of the key factors for achieving optimal clinical  outcomes.",Non-OADS,/arxiv_data1/oa_pdf/d5/7c/ppa-8-1653.PMC4262214.pdf
"Keywords:  multiple sclerosis, adherence, satisfaction, delivery devices, costs Introduction Multiple sclerosis (MS) is an inflammatory, neurodegenerative disease of the central  nervous system that results in demyelination and transaction of axons in the brain,  spinal cord, and optic nerves.1 The clinical disease course is variable, usually starting  with reversible episodes of neurological disability in the third or fourth decade of life,  then transforming into a disease marked by continuous and irreversible neurological  decline by the sixth or seventh decade.1 This clinical course may be considered the  expression of two phenomena: relapses of acute neurological symptoms, which end  in partial or complete remission; and progression, which refers to the steady and irre - versible worsening of signs and symptoms.2,3Correspondence: Carlos Polanco Corporate Affairs, Merck SL, María de  Molina, 40, 28006 Madrid, Spain Tel +34 917 453 158 Fax +34 917 454 444 email carlos.polanco@merckgroup.co mJournal name: Patient Preference and Adherence Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Lizán et al Running head recto: Patient-reported outcomes and MS cost: a literature review DOI: http://dx.doi.org/10.2147/PPA.S67253",Non-OADS,/arxiv_data1/oa_pdf/d5/7c/ppa-8-1653.PMC4262214.pdf
Available from: http://www.who.int/mental_health/neurology/ Atlas_MS_WEB.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/7c/ppa-8-1653.PMC4262214.pdf
Available  from: http://www.cebm.net/?o =1025.,Non-OADS,/arxiv_data1/oa_pdf/d5/7c/ppa-8-1653.PMC4262214.pdf
Available from: http://scholar.google.,Non-OADS,/arxiv_data1/oa_pdf/d5/7c/ppa-8-1653.PMC4262214.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d5/7c/ppa-8-1653.PMC4262214.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/de/ppa-8-1665.PMC4262215.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1665–1669Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1665OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7413 2The interference in the suicide ideation of patients  with malignant tumors by mental clinical nursing  pathway Zhaofen Xu Baoan chen guohong li Wenjun Dai Department of gynaecology,   Zhongda hospital, southeast  University, nanjing, Jiangsu Province,   People’s republic of chinaBackground:  The purpose of this study was to examine the effect of mental clinical nursing  pathways on suicidal ideation and life quality of patients with malignant tumors.",Non-OADS,/arxiv_data1/oa_pdf/2c/de/ppa-8-1665.PMC4262215.pdf
"Evidence  of other literature has reported that the suicide risk in cancer patients is 1.3–2.8 times  higher than in the normal population,2 and advanced cancer patients might have an  even higher risk of committing suicide.3 In our present study, we implemented a mental  clinical nursing pathway for patients with malignant tumors during hospitalization,  and used the “self-rating idea of suicide scale” (SIOSS) and Karnofsky Performance correspondence: Baoan chen  Department of hematology, Zhongda  hospital, Medical school, southeast  University, nanjing 210009, Jiangsu  Province, People’s republic of china Tel +86 25 8327 2006 Fax +86 25 8327 2011 email cba8888@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Xu et al Running head recto: The interference in the suicide ideation of patients DOI: http://dx.doi.org/10.2147/PPA.S74132",Non-OADS,/arxiv_data1/oa_pdf/2c/de/ppa-8-1665.PMC4262215.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2c/de/ppa-8-1665.PMC4262215.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/79/ott-7-2249.PMC4262216.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 2249–2255OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2249Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6725 1induction of multiple drug resistance in   hMec-1 endothelial cells after long-term   exposure to sunitinib limin huang1,* chaoquan hu2,* Mélanie Di Benedetto3 rémi Varin4 Jielin liu2,3 li Wang3 Jean-Pierre Vannier4 Jian Jin3,5 anne Janin3,6,7 he lu3,6 hong li4 1Department of Oncology, People’s  hospital of guizhou Province,  guiyang, People’s republic of china;  2Department of surgery, affiliated  hospital, guiyang Medical University,  guiyang, People’s republic of china;  3inserM UM r-s 1165, Paris, France;  4Merci (ea 3829), Faculté de  Médecine et de Pharmacie, Université  de rouen, rouen, France; 5school of  Medicine and Pharmaceutics, Jiangnan  University, Wuxi, People’s republic  of china; 6Université Paris Diderot,  laboratoire de Pathologie, Paris,  France; 7aP-hP-hôpital saint-louis,  laboratoire de Pathologie, Paris, France *These authors contributed equally to  this study correspondence: he lu   inserM UMr-s 1165, iUh, hôpital   saint-louis, 1 avenue claude Vellefaux,  F-75010 Paris, France   email he.lu@inserm.f r    hong li   Merci (ea 3829), Faculté de Médecine  et de Pharmacie, Université de rouen,  22 Boulevard gambetta, F-76183 rouen,  France.",Non-OADS,/arxiv_data1/oa_pdf/5b/79/ott-7-2249.PMC4262216.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/79/ott-7-2249.PMC4262216.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/79/ott-7-2249.PMC4262216.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/ppa-8-1671.PMC4262217.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1671–1681Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1671OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7200 4Measuring patients’ satisfaction with their  anti-TnF treatment in severe crohn’s disease:  scoring and psychometric validation of the  satisfaction for PAtients in crohn’s disease  Questionnaire (sPA ce-Q©) hélène gilet1 Benoit Arnould1 Fatoumata Fofana1 Pierre clerson2 Jean-Frédéric colombel10 Olivier D’hondt2 Patrick Faure4 hervé hagège5 Maria n achury3 stéphane nahon6 gilbert T ucat7 luc Vandromme8 ines cazala-T elinge9 emmanuel Thibout9 1heOr and strategic Market Access,   Mapi, lyon, France; 2Orgamétrie,   roubaix, France; 3hôpital claude  huriez, lille, France; 4clinique  saint-Jean du languedoc, T oulouse,   France; 5centre hospitalier  intercommunal, créteil, France;   6centre hospitalier intercommunal,   le raincy Montfermeil, France;   7gastroenterologist, Private  clinical Practice, Paris, France;   8gastroenterologist, Private clinical  Practice, reims, France; 9Abbvie  France, rungis, France; 10icahn school  of Medicine at Mount sinai, new Y ork,   nY, UsABackground:  Severe Crohn’s disease management includes anti-tumor necrosis factor  (anti-TNF) drugs that differ from early-stage treatments regarding efficacy, safety, and  convenience.",Non-OADS,/arxiv_data1/oa_pdf/b1/71/ppa-8-1671.PMC4262217.pdf
"It causes  symptoms such as diarrhea, abdominal pain, fever, loss of appetite, subsequent weight  loss, and, in the most severe cases, complications such as obstructions and abscesses.1  correspondence:  Benoit Arnould 27, rue de la Villette, 69003 lyon, France Tel +33 4 72 13 66 62 Fax +33 4 72 13 51 40 email barnould@mapigroup.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Gilet et al Running head recto: Scoring and psychometric validation of the SPACE-Q DOI: http://dx.doi.org/10.2147/PPA.S72004",Non-OADS,/arxiv_data1/oa_pdf/b1/71/ppa-8-1671.PMC4262217.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b1/71/ppa-8-1671.PMC4262217.pdf
"Available  from: http://www.fda.gov/downloads/Drugs/ GuidanceCompliance   RegulatoryInformation /Guidances/UCM193282.pd f. Accessed October   3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b1/71/ppa-8-1671.PMC4262217.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2449–2460Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2449Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7083 9Current clinical practice: differential management  of uveal melanoma in the era of molecular   tumor analyses Thomas M aaberg Jr1 robert W Cook2 Kristen Oelschlager2 Derek Maetzold2 P Kumar rao3 John O Mason iii4 1Michigan state University Medical  school and retina specialists of  Michigan, grand rapids, M i, 2Castle  Biosciences, Friendswood, TX,   3Washington University school of  Medicine in st louis, st louis, MO,   4retina Consultants of alabama and  University of alabama Birmingham,   Birmingham, al, UsaObjective:  Assess current clinical practices for uveal melanoma (UM) and the impact of  molecular prognostic testing on treatment decisions.",Non-OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
"Keywords:  uveal melanoma, gene expression profiling (GEP), Medicare, molecular diag - nostic test Introduction The most common primary intraocular cancer in the United States is uveal melanoma  (UM), the second most frequent subcategory of melanoma.1 New UM cases occur at Correspondence: Thomas M aaberg Jr Michigan state University Medical school  and retina specialists of Michigan,   2757 leonard st ne, grand rapids,   Mi 49525, Usa Tel +1 616 954 2020 Fax +1 616 949 0408 email thomasaaberg@comcast.netJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Aaberg Jr et al Running head recto: UM clinical use of molecular tumor analyses DOI: http://dx.doi.org/10.2147/OPTH.S70839",Non-OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
Available  from: http://www.nccn.org/default.aspx  8.,Non-OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
Available from: http://www.cancer.gov/ cancertopics/pdq/treatment/intraocularmelanoma/HealthProfessional/ page1 20.,Non-OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
Available from:  http://www.census.gov/newsroom/releases/archives/population/cb13- tps112.html 21.,OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/a5/opth-8-2449.PMC4262218.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/1e/dddt-8-2401.PMC4262375.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2401–2408Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2401Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7141 9cisplatin-induced hyponatremia in malignancy:  comparison between brand-name and generic  formulation nobuaki Ochi1,2 hiromichi Yamane1 Katsuyuki hotta3 hiromi Fujii4 hideko isozaki2,5 Y oshihiro honda1,2 T omoko Yamagishi1 T oshio Kubo6 Mitsune Tanimoto2,3 Katsuyuki Kiura6 nagio Takigawa1 1Department of general internal  Medicine 4, Kawasaki hospital,   Kawasaki Medical school, Okayama,   Japan; 2Department of hematology,   Oncology and respiratory Medicine,   Okayama University graduate  school of Medicine, Dentistry,   and Pharmaceutical sciences,   Okayama, Japan; 3Department  of hematology and Oncology,   Okayama University hospital,   Okayama, Japan; 4Department  of Pharmacy, Kawasaki hospital,   Kawasaki Medical school, Okayama,   Japan; 5Department of  clinical  Pharmaceutics, Okayama University  graduate school of Medicine,   Dentistry, and Pharmaceutical  sciences, Okayama, Japan;   6Department of respiratory Medicine,   Okayama University hospital,   Okayama, JapanIntroduction:  Widespread use of generic drugs is considered to be indispensable if reductions  in total health care costs are to be achieved, but the market share of such drugs remains low.",Non-OADS,/arxiv_data1/oa_pdf/73/1e/dddt-8-2401.PMC4262375.pdf
"CDDP  remains the principal drug of choice for treatment of these malignancies despite the  development of many novel anticancer drugs over the past several decades.2,3 However,  CDDP induces many adverse effects, including nausea, vomiting, appetite loss, renal correspondence: nagio Takigawa Department of general internal  Medicine 4, Kawasaki hospital, Kawasaki  Medical school, 2-1-80 nakasange,  Kita-ku, Okayama, Japan Tel +81 86 225 2111 Fax +81 86 232 8343 email ntakigaw@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Ochi et al Running head recto: Cisplatin-induced hyponatremia DOI: http://dx.doi.org/10.2147/DDDT.S71419",Non-OADS,/arxiv_data1/oa_pdf/73/1e/dddt-8-2401.PMC4262375.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/73/1e/dddt-8-2401.PMC4262375.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/1e/dddt-8-2401.PMC4262375.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/d3/copd-9-1321.PMC4262376.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1321–1329International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1321OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6550 7Prevalence and correlates of suicide ideation   in patients with COPD: a mixed methods study sara Fleehart1,* Vincent s Fan2,3,* huong Q nguyen4 Jungeun lee1 ruth Kohen3 Jerald r herting5 gustavo Matute-Bello2,3 sandra g adams6,7 genevieve Pagalilauan3 soo Borson3 1school of nursing, University of  Washington, seattle, W a, Usa;   2VaPuget sound health Care Center,   seattle, W a, Usa; 3school of Medicine,   University of Washington, seattle, W a,   Usa; 4reseach and evaluation, Kaiser  Permanente southern California,   Pasadena, C a, Usa; 5Department of  sociology, University of Washington,   seattle, W a, Usa; 6school of Medicine,   University of Texas health science  Center; 7south T exas Veterans health  Care system, san antonio, TX, Usa *These authors contributed equally to  this paper Correspondence: soo Borson   school of Medicine, University of  Washington, Box 356560, 1959 ne  Pacific St, Seattle, WA 98195, USA   email soob@uw.ed uPurpose:  The purpose of this study was to examine the prevalence and correlates of suicidal  ideation (SI) in patients with s table  moderate to very severe chronic obstructive pulmonary  disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/3b/d3/copd-9-1321.PMC4262376.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3b/d3/copd-9-1321.PMC4262376.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/d3/copd-9-1321.PMC4262376.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/39/cia-9-2105.PMC4262377.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2105–2112Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2105ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6868 7A single blind randomized control trial   on support groups for Chinese persons   with mild dementia Daniel KW Y oung1 Timothy CY Kwok2 Petrus YN Ng1 1Department of Social Work,   Hong  Kong Baptist University,   Kowloon T ong, Hong Kong;   2Department of Medicine and  Therapeutics, The Chinese University  of Hong Kong, Shatin, Hong KongPurpose:  Persons with mild dementia experience multiple losses and manifest depressive  symptoms.",Non-OADS,/arxiv_data1/oa_pdf/7c/39/cia-9-2105.PMC4262377.pdf
"Keywords:  support group, mild dementia, Chinese, depression Introduction In Hong Kong, ~8.9% persons aged 70 years or older suffer from dementia.1 There were  ~70,000 persons with dementia in Hong Kong in 2006, and the number is expected to  escalate to 330,000 by the year 2050.2 Among persons with dementia in Hong Kong,  about 85% suffer from mild dementia.1 At present, the pharmacological treatments for  mild dementia are found to have small benefits on cognitive decline.3 Mild dementia  has an adverse impact on the lives of sufferers, including progressive loss of memory,  increasingly impaired cognitive impairments, and an increasing inability to conduct  daily living activities.4  Depression is common in dementia, and the prevalence of depression in persons  with dementia is higher than in those persons without dementia.5 One research study  has reported that up to one-half of persons with mild dementia manifested depressive  symptoms.6 Depression has negative impacts for persons with mild dementia and their  caregivers, including negative impacts on quality of life,7 functional impairment,8  increased risk of early institutionalization,9 and an increased stress level of caregivers.10 Correspondence: Daniel KW Young  AAB1015, Department of Social Work,  Hong Kong Baptist University, Kowloon  Tong, Hong Kong Tel +852 341 177 72  Fax +852 341 171 45 Email danielyoung@hkbu.edu.h k Journal name: Clinical Interventions in Aging Article Designation: ORIGINAL RESEARCH Y ear: 2014 Volume: 9 Running head verso: Y oung et al Running head recto: Support groups for mild dementia DOI: http://dx.doi.org/10.2147/CIA.S68687",Non-OADS,/arxiv_data1/oa_pdf/7c/39/cia-9-2105.PMC4262377.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7c/39/cia-9-2105.PMC4262377.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7c/39/cia-9-2105.PMC4262377.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/06/ijwh-6-999.PMC4262378.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 999–1010International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  999RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5036 5Long-term efficacy and safety of human  papillomavirus vaccination Rosa De vincenzo1 Carmine Conte1 Caterina Ricci1 Giovanni Scambia1 Giovanni Capelli2 1Division of Gynecologic Oncology,   Department of Obstetrics and  Gynecology, Catholic University of  the Sacred Heart, Rome, 2Department  of Human Sciences, Society and  Health, University of Cassino and  Southern Lazio, Cassino, Italy Correspondence: Rosa De vincenzo   Division of Gynecologic Oncology,  Department of Obstetrics and  Gynecology, Catholic University   of the Sacred Heart, 8 Largo A Gemelli,   Rome 00168, Italy   email rosa.devincenzo@rm.unicatt.i tAbstract:  In this paper, we review the published evidence about the long-term efficacy of  the available human papillomavirus (HPV) vaccines and their safety profile.",Non-OADS,/arxiv_data1/oa_pdf/04/06/ijwh-6-999.PMC4262378.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/04/06/ijwh-6-999.PMC4262378.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/06/ijwh-6-999.PMC4262378.pdf
2014. http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Assessment_Report_-_Variation/human/000703/ WC500170695.pdf .,Non-OADS,/arxiv_data1/oa_pdf/04/06/ijwh-6-999.PMC4262378.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/69/dddt-8-2409.PMC4262379.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 2409–2421Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2409Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S5972 2Functional characterization of a competitive   peptide antagonist of p65 in human macrophage-   like cells suggests therapeutic potential   for chronic inflammation Mythily srinivasan1 corinne Blackburn1 Debomoy K lahiri2,3 1Department of Oral Pathology,   Medicine and radiology, indiana  University school of Dentistry,   2institute of Psychiatry research,   Department of Psychiatry,   3Department of Medical and  Molecular genetics, school of  Medicine, indiana University-Purdue  University, indianapolis, in, Usa correspondence: Mythily srinivasan   Oral Pathology, radiology and Medicine,   indiana University school of Dentistry,   1121 West Michigan st, indianapolis,   in 46202, Usa   Tel +1 317 278 9686  Fax +1 317 278 3018  email mysriniv@iupui.ed u    Debomoy K lahiri   Department of Psychiatry,   indiana University school of Medicine,   institute of Psychiatric research,   791 Union Drive, indianapolis,   in 46202, Usa   Tel +1 317 274 2706  Fax +1 317 274 1365  email dlahiri@iupui.ed uAbstract:  Glucocorticoid-induced leucine zipper (GILZ) is a glucocorticoid responsive protein  that links the nuclear factor-kappa B (NF κB) and the glucocorticoid signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/45/69/dddt-8-2409.PMC4262379.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/45/69/dddt-8-2409.PMC4262379.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/69/dddt-8-2409.PMC4262379.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/c1/deu268.PMC4262466.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/90/ddu415.PMC4262490.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"Proportion of rotavirus diarrhea in children aged 55 PlaceDiarrhea casesRotavirus casesProportion rotavirus (%) Zliten city 281 167 59 Khoms city 264 144 55Hospitals 410 (75%) 239 (77%) 58Outpatient clinic 135 (25%) 72 (23%) 53Total number 545 311 57Male 315 179 57Female 230 132 570/C1B1 years old 336 175 52 1/C1B2 years old 142 91 64 2/C1B3 years old 46 33 72 3/C1B4 years old 10 6 60 4/C155 years old 11 6 55Cost-effectiveness analysis of rotavirus vaccination Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"Input variables for estimating the cost-effectiveness of rotavirus vaccination with baseline, minimum (Min), and maximum (Max) values Variables Baseline Min Max Source Annual birth cohort 160,000 (28) Vaccination coverage rate 98% 78% 100% (26) Inflation rate 4.7% 3.8% 5.6% (24)Cost per consultation GP (US$) 15 Local expert opinionCost per consultation pediatrician (US$) 29 Local expert opinionProportion going to the GP 70% (7)Cost for medical visit (US$) 15*0.7 /C2729*0.3/C3019.2 15.4 23.0 Calculated Cost of prescribed drugs (US$) 108.61 This studyCost for hospital day care (US$) 332.69 This study Cost for lab test (US$) 33.94 This study Cost hospitalization (US$) 108.61 /C27332.69/C2733.94/C30475.24 380 570 Calculated Cost labor woman per day (US$) 34 27.2 40.8 This studyProportion working mothers 35% 28% 42% (29)Days lost mild 3 2.4 3.6 (7)Days lost moderate 1 0.8 1.2 (7)Days lost severe 3 2.4 3.6 (7)Cost indirect loss mild/event (US$) 34*3*0.35 /C3036 Calculated Cost indirect loss moderate/event (US$) 34*1*0.35 /C3012 Calculated Cost indirect loss severe/event (US$) 34*3*0.35 /C3036 Calculated Cost for transportation severe (US$) 74 59.2 88.8 This studyCost for household (US$) 70.99 56.8 85.2 This studyCost vaccine per course (US$) 27 21.60 32.40 This studyDisutility mild /C280.00016 /C280.00013 /C280.00020 (25) Disutility moderate /C280.00068 /C280.00055 /C280.00082 (25) Disutility severe /C280.00575 /C280.00460 /C280.00690 (25) Life expectancy 75 60 90 (27) Proportion mild 40% 32% 48% (23)Proportion moderate 15.1% 12.1% 18.1% Local expert opinionProportion severe 2.44% 2% 2.9% Local expert opinionProportion deaths 0.0055% 0.0044% 0.0066% (7)Vaccine efficacy against mild 75% 60% 90% (30)Vaccine efficacy against moderate 85% 68% 100% (30)Vaccine efficacy against severe 90% 72% 100% (30) Vaccine efficacy against death 100% 80% 100% (30)Cost-effectiveness analysis of rotavirus vaccination Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"6 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"Sensitivity analysis (tornado diagram) on the cost difference per child in the birth cohort (Vaccination /C1No Vaccination) analyzed from a societal perspective (example: the lower the proportion of mild disease, blue color, the lower the cost savings onthe X-axis).Cost-effectiveness analysis of rotavirus vaccination Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
Available from: http://www.immunizationinfo.,Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
Available from: http://data.worldbank.org/c ountry/libya [cited 13 May 2014].,OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
Available from: http://apps.who.int/immunization_monitoring/glob alsummary/countries?country criteria[country][] /C30LBY&commit /C30OK [cited 26 March 2014].,OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
Available from: http://www.who.int/ countries/lby/en/ [cited 9 November 2014].,OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
Available from: http://www.ons.gov.uk/ons/dcp171776_328352.pdf [cited 13 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
Available from: http://www.who.int/choice/costs/ CER_thresholds/en/ [cited 22 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"8 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
"2011; 29: 7463/C173.Cost-effectiveness analysis of rotavirus vaccination Citation: Libyan J Med 2014, 9: 26236 - http://dx.doi.org/10.3402/ljm.v9.26236 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/LJM-9-26236.PMC4262756.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS We thank the College of American Pathologists for its support of the staff effort to conduct this study and support of the author  participation through face-to-face meetings and telecommunica- tions.,Non-OADS,/arxiv_data1/oa_pdf/14/c7/gim201460a.PMC4262758.pdf
The recorded  webinar is available at http://www.cap.org.,OADS,/arxiv_data1/oa_pdf/14/c7/gim201460a.PMC4262758.pdf
Issued 30 September 2013. http://www.cms.gov/Medicare/Medicare-Fee-for- Service-Payment/ClinicalLabFeeSched/Gapfill-Pricing-Inquiries.html.,Non-OADS,/arxiv_data1/oa_pdf/14/c7/gim201460a.PMC4262758.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/  Genetics in Medicine  |   Volume 16  |  Number 12  |  December 2014",Non-OADS,/arxiv_data1/oa_pdf/14/c7/gim201460a.PMC4262758.pdf
"The key ele- ment of this project, which is now integrated into the Newborn  Screening Translation Research Network (https://www.nbstrn.",Non-OADS,/arxiv_data1/oa_pdf/ed/6f/gim201462a.PMC4262759.pdf
"Details of the design, content, and clinical utilization of the one-condition tools and  dual-scatter plots have been reported previously.3 A recorded educational presentation is also available at http://www.mayomedicallaboratories.com/articles/ hot-topic/2013/06-15-r4s-pt-3/index.html.",Non-OADS,/arxiv_data1/oa_pdf/ed/6f/gim201462a.PMC4262759.pdf
Analyte results are paired with  the corresponding logical observation identifiers names and code (LOINC; http://www.loinc.org/).,OADS,/arxiv_data1/oa_pdf/ed/6f/gim201462a.PMC4262759.pdf
Access to R4S can be requested through NBSTRN (http://www.nbstrn.org/) or from the R4S login page (http://www.clir-r4s.org/).,OADS,/arxiv_data1/oa_pdf/ed/6f/gim201462a.PMC4262759.pdf
http://www.ncbi.nlm.nih.gov/books/NBK55832/.,Non-OADS,/arxiv_data1/oa_pdf/ed/6f/gim201462a.PMC4262759.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ GEnEticS in MEdicinE  |   Volume 16  |  Number 12  |  December 2014",Non-OADS,/arxiv_data1/oa_pdf/ed/6f/gim201462a.PMC4262759.pdf
"7–13 However, although  the human genome contains more than 30 imprinting domains (http://www.geneimprint.com), a limited number of imprinted  DMRs have been analyzed so far, with the exception of a  report by Court et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/fe/gim201446a.PMC4262761.pdf
"resuL ts Validation of methylation analyses, MALdi-toF Ms, and  bisulfite pyrosequencing First, we selected 37 regions reported previously as imprinted  DMRs in the human genome16,20,23 (refer to http://www.geneim- print.com/).",OADS,/arxiv_data1/oa_pdf/fe/fe/gim201446a.PMC4262761.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked in the online version of the paper  at http://www.nature.com/gim.,Non-OADS,/arxiv_data1/oa_pdf/fe/fe/gim201446a.PMC4262761.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/  Volume 16  |  Number 12  |  December 2014  |  Genetics in Medicine",Non-OADS,/arxiv_data1/oa_pdf/fe/fe/gim201446a.PMC4262761.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/MicroRNAs and p63 E Candi et al 21 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/3d/47/cdd2014113a.PMC4262770.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/News and Commentary 5 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/4f/a4/cdd201439a.PMC4262784.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/(Lymph)angiogenic in ﬂuences on hematopoietic cells in AML JY Lee and H-J Kim 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/a6/aa/emm201472a.PMC4262793.pdf
"Available at: http://www.britthoracic.org.uk/Portals/0/Guidelines/AsthmaGuidelines/sign101%20Jan%202012.pdf [3] Martel MJ, Rey E, Beauchesne MF, et al.",Non-OADS,/arxiv_data1/oa_pdf/33/0d/TONURSJ-8-56.PMC4262795.pdf
"Available at: http://www.ualberta.ca/~iiqm/backissues/pdf/caellieta l.pdf [16] Whittaker A, Williamson GR.",Non-OADS,/arxiv_data1/oa_pdf/33/0d/TONURSJ-8-56.PMC4262795.pdf
"Available at: http://journals.sfu.ca/hneh/index.php/hneh/article/vie w/236/134 [25] Neergaard MA, Olesen F, Andersen RA, Sondergaard J. Qualitat-ive description – the poor cousin of health research?",Non-OADS,/arxiv_data1/oa_pdf/33/0d/TONURSJ-8-56.PMC4262795.pdf
"Available at: http://arrow.monash.edu.au/vital/access/manager/Rep ository/monash:120591   Received: May 30, 2014 Revised: July 23, 2014 Accepted: August 9, 2014  © Chamberlain et al.",Non-OADS,/arxiv_data1/oa_pdf/33/0d/TONURSJ-8-56.PMC4262795.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/0d/TONURSJ-8-56.PMC4262795.pdf
conducted the numerical simulations and wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c3/80/srep07421.PMC4262817.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7421 | DOI: 10.1038/srep07421 6",Non-OADS,/arxiv_data1/oa_pdf/c3/80/srep07421.PMC4262817.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/34/87/srep07420.PMC4262821.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7420 | DOI: 10.1038/srep07420 5",Non-OADS,/arxiv_data1/oa_pdf/34/87/srep07420.PMC4262821.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7437 | DOI: 10.1038/srep07437 5,Non-OADS,/arxiv_data1/oa_pdf/29/a0/srep07437.PMC4262822.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7437 | DOI: 10.1038/srep07437 6",Non-OADS,/arxiv_data1/oa_pdf/29/a0/srep07437.PMC4262822.pdf
(2012) Available at: http://www.who.int/malaria/publications/world_malaria_report_2012/en/ (Accessed: 1 stOctober 2014).,Non-OADS,/arxiv_data1/oa_pdf/fe/53/srep07435.PMC4262823.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fe/53/srep07435.PMC4262823.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Chiesa, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/3b/srep07423.PMC4262827.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7423 | DOI: 10.1038/srep07423 8",Non-OADS,/arxiv_data1/oa_pdf/0e/3b/srep07423.PMC4262827.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare competing financial interests: patent application that is related to the research in this paper.,Non-OADS,/arxiv_data1/oa_pdf/00/79/srep07439.PMC4262828.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7439 | DOI: 10.1038/srep07439 6",Non-OADS,/arxiv_data1/oa_pdf/00/79/srep07439.PMC4262828.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/14/srep07430.PMC4262830.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7430 | DOI: 10.1038/srep07430 11",Non-OADS,/arxiv_data1/oa_pdf/4e/14/srep07430.PMC4262830.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/af/76/NMJ-55-465.PMC4262841.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/bc/88/NMJ-55-480.PMC4262844.pdf
Obtainable at http://www.un.org/en/ecosoc/newfunct/pdf/doha_programme_2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/9e/NMJ-55-499.PMC4262848.pdf
FMOH; 2004.Obtainable at http://www.internationalhealthpartnership.net/fileadmin/uploads/ihp/Documents/Country_Pages.,OADS,/arxiv_data1/oa_pdf/2a/9e/NMJ-55-499.PMC4262848.pdf
Available from: http://www.who.int/nmh/events/2013/revised_draft_ncd_action_plan.pdf [Last assessed on 2013 Aug 10].,Non-OADS,/arxiv_data1/oa_pdf/2a/9e/NMJ-55-499.PMC4262848.pdf
Available from: http://www.who.int/macrohealth [Last cited on 2011 Feb 05].,OADS,/arxiv_data1/oa_pdf/9e/ba/NMJ-55-512.PMC4262851.pdf
Available from: http://www.nhis.gov.ng.,Non-OADS,/arxiv_data1/oa_pdf/9e/ba/NMJ-55-512.PMC4262851.pdf
Available from: http://www.history.qmul.ac.uk/research/modbiomed/Publications/wit_vols/44832.pdf [Last accessed on 2014 Jul 6].,Non-OADS,/arxiv_data1/oa_pdf/5c/cd/NMJ-55-519.PMC4262853.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/5c/cd/NMJ-55-519.PMC4262853.pdf
Available  from: http://www.who.int/mediacentre/events/2006/g8summit/ health_workers/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/4a/10/JRPP-3-109.PMC4262855.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/6f/3d/JRPP-3-112.PMC4262856.pdf
Available from: http://www.coe.int/v  t/e/social_cohesion/socsp/Medication%20Safety%20Report.,Non-OADS,/arxiv_data1/oa_pdf/b9/c4/JRPP-3-117.PMC4262857.pdf
Available from: http://medsask.usask.,Non-OADS,/arxiv_data1/oa_pdf/b9/c4/JRPP-3-117.PMC4262857.pdf
Available from: http://www.Uptodate.,Non-OADS,/arxiv_data1/oa_pdf/74/e1/JRPP-3-142.PMC4262861.pdf
Available from:  http://www.Uptodate.com/home/index.html.,Non-OADS,/arxiv_data1/oa_pdf/74/e1/JRPP-3-142.PMC4262861.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs275/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/33/83/JRPP-3-145.PMC4262862.pdf
Available from:  http://www.endocrine-abstracts.org/ea/0029/ea0029p15.htm.,Non-OADS,/arxiv_data1/oa_pdf/bb/90/WJNM-13-201.PMC4262881.pdf
"Recommendations from the Centers for Disease Control and Prevention, theNational Institutes of Health, and the HIV Medicine Association of the InfectiousDiseases Society of America, 2013 URL: http://www.guideline.gov/content.aspx?id545359 (accessed: 09.09.2014) 24.",Non-OADS,/arxiv_data1/oa_pdf/f9/14/srep07438.PMC4262884.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f9/14/srep07438.PMC4262884.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/64/91/srep07425.PMC4262885.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7425 | DOI: 10.1038/srep07425 9",Non-OADS,/arxiv_data1/oa_pdf/64/91/srep07425.PMC4262885.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/81/srep07432.PMC4262886.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/90/srep07424.PMC4262888.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7424 | DOI: 10.1038/srep07424 8",Non-OADS,/arxiv_data1/oa_pdf/99/90/srep07424.PMC4262888.pdf
The full review is available to view at http://www.phr.nihr.ac.uk/funded_projects/obesity.asp.,Non-OADS,/arxiv_data1/oa_pdf/1f/ba/ijo201475a.PMC4262962.pdf
Further information available at: http://www.phr.nihr.ac.uk/funded_projects/obesity.asp.,Non-OADS,/arxiv_data1/oa_pdf/1f/ba/ijo201475a.PMC4262962.pdf
Available at: http://www.phr.nihr.ac.uk/funded_projects/obesity.asp.,Non-OADS,/arxiv_data1/oa_pdf/1f/ba/ijo201475a.PMC4262962.pdf
Available from http://www.ephpp.ca/tools.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/ba/ijo201475a.PMC4262962.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Reducing inequalities in adult obesity FC Hillier-Brown et al 1490 International Journal of Obesity (2014) 1483 –1490 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/1f/ba/ijo201475a.PMC4262962.pdf
"The latter databases were downloaded from the web pages of the respective sequencing projects at the Broad Institute of Harvard and MIT (http:// www.broad.mit.edu) and the DOE joint Genome Institute (http://www.jgi.doe.gov) using the PHYTOZOME and MYCOCOSM portals34,35.",OADS,/arxiv_data1/oa_pdf/e5/26/srep07436.PMC4262963.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/26/srep07436.PMC4262963.pdf
"Journal of  Preventive Medicine  & Public Health 289 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:289-297   •  http://dx.doi.org/10.3961/jpmph.14.020 Incidence of and Factors for Self-reported Fragility   Fractures Among Middle-aged and Elderly Women in   Rural Korea: An 11-Year Follow-up Study Soon-Ki Ahn1, Sin Kam2, Byung-Yeol Chun2 1Health Consultation Center for Daejeon Regional Headquarters, National Health Insurance Service, Daejeon; 2Department of Preventive Medicine,  Kyungpook National University School of Medicine, Daegu, Korea Original Article Objectives: This community-based cohort study was performed to investigate the incidence of and factors related to self-reported  fragility fractures among middle-aged and elderly women living in rural Korea.",Non-OADS,/arxiv_data1/oa_pdf/68/8d/jpmph-47-6-289.PMC4263002.pdf
"Key words:  Fracture, Fragility, Incidence, Osteoporosis Received:  May 15, 2014 Accepted:  September 15, 2014 Corresponding author:  Sin Kam, MD, PhD 680 Gukchaebosang-ro, Jung-gu, Daegu 700-842, Korea Tel: +82-53-420-4865, Fax: +82-53-425-2447 E-mail : kamshin@knu.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION A fragility fracture is defined as a fracture occurring after a  fall, such as from a standing height.",Non-OADS,/arxiv_data1/oa_pdf/68/8d/jpmph-47-6-289.PMC4263002.pdf
Avail - able from: http://www.wpro.who.int/nutrition/documents/ docs/Redefiningobesity.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/8d/jpmph-47-6-289.PMC4263002.pdf
"Kre ´n, E. & Marx, D. Web Gallery of Art, image collection, virtual museum, searchable database of European fine arts (1000-1900) http://www.wga.hu/ (1996)Date of access 09/05/2009 16.",Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Google Inc. Google Cultural Institute http://www.google.com/culturalinstitute/ project/art-project (2011) Date of Access 14/02/2011 25.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Jacques Bodin gallery http://www.jacquesbodin.com/ Date of Access 07/04/2010.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Roberto Bernardi http://www.robertobernardi.com/ Date of Access 07/04/2010.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Raphaella Spence http://www.raphaellaspence.com/ Date of Access 07/04/2010.28.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Hubert de Lartigue Accueil http://www.hubertdelartigue.com/ Date of Access 07/ 04/2010.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Gus Heinze on artnet http://www.artnet.com/artist/26318/gus-heinze.html Date of Access 07/04/2010.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Bernardo Torrens http://www.bernardotorrens.com/ Date of Access 07/04/2010.31.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
The Hyperrealism Paintings by Denis Peterson http://www.denispeterson.com/ Date of Access 07/04/2010.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
http://instagram.com/natgeo (1999) Date of access 20/08/2014 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7370 | DOI: 10.1038/srep07370 6,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
http://www.naver.com/ (1999) Date of access 20/07/2009 34.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
Allauthors discussed the results and commented on the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/srep07370.PMC4263068.pdf
"Author contributions All authors have agreed on the ﬁnal version and meet atleast one of the following criteria [recommended by the IC- MJE (http://www.icmje.org/ethical_1author.html)]: substantial contributions to conception and design,acquisition of data, or analysis and interpretation ofdata; drafting the article or revising it critically for importantintellectual content.",Non-OADS,/arxiv_data1/oa_pdf/21/2a/jan0070-2257.PMC4263097.pdf
Retrieved from http://www.ha.,Non-OADS,/arxiv_data1/oa_pdf/21/2a/jan0070-2257.PMC4263097.pdf
Retrieved from http://www.sf-36.org/tools/sf36.,Non-OADS,/arxiv_data1/oa_pdf/21/2a/jan0070-2257.PMC4263097.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/21/2a/jan0070-2257.PMC4263097.pdf
Retrieved from http://www.york.ac.uk/inst/crd/index_guidance.htm on January 2012.,Non-OADS,/arxiv_data1/oa_pdf/29/9d/jan0070-2222.PMC4263098.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/29/9d/jan0070-2222.PMC4263098.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/65/99/jan0070-2673.PMC4263100.pdf
"To estimate the probability of false positive clusters, weused the 3dClustSim tool in AFNI (http://afni.nimh.nih.gov/afni/).",OADS,/arxiv_data1/oa_pdf/2f/52/ncomms6547.PMC4263140.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/52/ncomms6547.PMC4263140.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Maass, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/2f/52/ncomms6547.PMC4263140.pdf
Available at: http://www.degruyter.com/view/j/ijnes.,Non-OADS,/arxiv_data1/oa_pdf/94/5d/jocn0023-2958.PMC4263152.pdf
http://www.nln.org/faculty programs/pdf/think_tank.pdf (accessed 1 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/94/5d/jocn0023-2958.PMC4263152.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jcnur.,Non-OADS,/arxiv_data1/oa_pdf/94/5d/jocn0023-2958.PMC4263152.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/2b/45/jcph0054-0468.PMC4263153.pdf
http://www.cpdd.vcu.edu/Pages/M eetings/CPDD12AbstractBook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2b/45/jcph0054-0468.PMC4263153.pdf
http://www.cpdd.vcu.edu/ Pages/Meetings/CPDD12AbstractBook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2b/45/jcph0054-0468.PMC4263153.pdf
http://www.abstracts2view.com/ iasp/view.php?nu ¼110444&type ¼abstract&terms ¼coplan.,OADS,/arxiv_data1/oa_pdf/2b/45/jcph0054-0468.PMC4263153.pdf
http://www.abstracts2view.com/iasp/view.php?,Non-OADS,/arxiv_data1/oa_pdf/2b/45/jcph0054-0468.PMC4263153.pdf
http://www.painweek.org/ media/media ﬁle_attachments/02/572 ‐painweek2012abstracts.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2b/45/jcph0054-0468.PMC4263153.pdf
Food and Drug Administration website http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/UCM071612.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/ed/jcph0054-0394.PMC4263154.pdf
Food and Drug Administration website http://www.fda.gov/down-loads/Drugs/Guidances/ucm070107.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/ed/jcph0054-0394.PMC4263154.pdf
The authors thank Martek Biosciences Inc. nowDSM Nutritional Lipids (http://www.lifesdha.com/) for fundingthis study.,Non-OADS,/arxiv_data1/oa_pdf/b5/ad/jsr0023-0364.PMC4263155.pdf
Available at: http://www.who.int/dg/speeches/2010/medical_ed_20101214/ en/ (accessed 22 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/7c/0f/jocn0023-2790.PMC4263156.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jcnur.,Non-OADS,/arxiv_data1/oa_pdf/7c/0f/jocn0023-2790.PMC4263156.pdf
Available at: http://manhattanresearch.com/Products-and-Services/Physician/Physician-Research-Modules.,Non-OADS,/arxiv_data1/oa_pdf/87/fa/jhm0009-0573.PMC4263157.pdf
Available at: http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/.,OADS,/arxiv_data1/oa_pdf/87/fa/jhm0009-0573.PMC4263157.pdf
Available at: http://www.hhs.gov/ocr/pri-vacy/hipaa/understanding/srsummary.html.,Non-OADS,/arxiv_data1/oa_pdf/87/fa/jhm0009-0573.PMC4263157.pdf
Available at: http://facts.stanford.edu/about/hospital.,Non-OADS,/arxiv_data1/oa_pdf/87/fa/jhm0009-0573.PMC4263157.pdf
Available at: http://www.wikinvest.com/ stock/USA_Mobility_(USMO).,Non-OADS,/arxiv_data1/oa_pdf/87/fa/jhm0009-0573.PMC4263157.pdf
"ml.org )brand: Although this snippet appears to contain private PII, the text actually is a configuration file for the Philips VCR3 infraredremote control system and is part of the Linux Infrared Remote Control package available for download at http://lirc.sourceforge.",Non-OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
This feature was found with a web search and attributed to thegSOAP 2.6.0 User Guide ; we downloaded a copy from http://alien.cern.ch/cache/gsoap-2.6/soapcpp2 /soapdoc2.pdf .,OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
"In: Black hat, 2008; http://sebug.net/paper/Meeting-Documents/BlackHat-USA2008/BH_US_08_Suiche_Windows_hibernation.pdf (accessed December 3,2011).",Non-OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
"Grenier C. Photorec, 2011; http://www.cgsecurity.org/wiki/PhotoRec (accessed December 3, 2011).",Non-OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
"Oracle outside in technology, 2013; http://www.oracle.com/us/ technologies/embedded/025613.htm (accessed February 23, 2013).",OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
"Technical report, PKWare, Inc., September 28 2007; http://www.pkware.com/docu-ments/casestudies/APPNOTE.TXT.",Non-OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
"Forensic toolkit (FTK), 2011; http://accessdata.com/prod- ucts/computer-forensics/ftk (accessed December 3, 2011).",OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
"RFC 4648 (Proposed Standard), October 2006; http://www.ietf.org/rfc/rfc4648.txt.",Non-OADS,/arxiv_data1/oa_pdf/f5/38/jfo0059-1386.PMC4263158.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jcnur.,Non-OADS,/arxiv_data1/oa_pdf/7a/4b/jocn0023-2367.PMC4263159.pdf
"http://www.ema.europa.eu/docs/en_GB/document_li- brary/Summary_of_opinion_ ‐_Initial_authorisation/human/ 002097/WC500106531.pdf Accessed May 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/0e/5d/jcph0054-0053.PMC4263161.pdf
"Gene content and prediction .Repeats were annotated using RepeatModeler (http://www.repeatmasker.org) and RepeatMasker (http://www.repeatmasker.org), combined with the repeat database, RepBase50.",OADS,/arxiv_data1/oa_pdf/29/ed/ncomms6227.PMC4263168.pdf
Calibration time was obtained from the TimeTree database (http://www.timetree.org/).,OADS,/arxiv_data1/oa_pdf/29/ed/ncomms6227.PMC4263168.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/ed/ncomms6227.PMC4263168.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Wu, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/29/ed/ncomms6227.PMC4263168.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6227 ARTICLE NATURE COMMUNICATIONS | 5:5227 | DOI: 10.1038/ncomms6227 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/29/ed/ncomms6227.PMC4263168.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/2b/ndt-10-2299.PMC4263193.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2299–2306Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2299OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7530 4cerebrolysin effects on neurological outcomes  and cerebral blood flow in acute ischemic stroke Mohammad reza amiri- Nikpour1 surena Nazarbaghi1 Babak Ahmadi-Salmasi1 Tayebeh Mokari2 Urya Tahamtan2 Y ousef rezaei3 1Department of Neurology,   imam Khomeini hospital, 2school  of Medicine, 3seyyed-al- shohada  heart center, Urmia University  of Medical sciences, Urmia, iranBackground:  Cerebrolysin, a brain-derived neuropeptide, has been shown to improve the  neurological outcomes of stroke, but no study has demonstrated its effect on cerebral blood  flow.",Non-OADS,/arxiv_data1/oa_pdf/d3/2b/ndt-10-2299.PMC4263193.pdf
"The acute secondary  preventions include antiplatelet agents, antihypertensives, statins, anticoagulants, and  carotid endarterectomy; and the long-term secondary preventions are composed of  antithrombotic agents, lipid modification, antihypertensive drugs, and multi-risk factor  modification.4,5 The acute primary treatment is crucial to decrease the burden of stroke  lesion, and therefore, some studies have focused on administering new therapies at  presentation for improving the clinical outcomes of stroke.6 Cerebrolysin is one of correspondence: Yousef rezaei seyyed-al-shohada heart  center, 17 shahrivar Boulevard,  Urmia 5718749441, iran Tel +98 912 623 1864 Fax +98 441 237 5907 email yousefrezaei1986@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Amiri-Nikpour et al Running head recto: Ischemic stroke and cerebrolysin efficacy DOI: http://dx.doi.org/10.2147/NDT.S75304",Non-OADS,/arxiv_data1/oa_pdf/d3/2b/ndt-10-2299.PMC4263193.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d3/2b/ndt-10-2299.PMC4263193.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/2b/ndt-10-2299.PMC4263193.pdf
URL http://emedicine.medscape.com/article/ 842367-treatment#a1135 (last accessed: 8 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/jdv0028-1707.PMC4263247.pdf
"The scaffolds for the A. hypochondriacus genome and transcriptome are available at GenBank under theBioProject IDs of PRJNA214803 and PRJNA214804, respectively, and also at http://resource.ibab.ac.in/ Plant_Genomics for download.",OADS,/arxiv_data1/oa_pdf/6d/a2/dsu021.PMC4263292.pdf
The raw reads were trimmed by fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/).,OADS,/arxiv_data1/oa_pdf/32/a9/dsu026.PMC4263297.pdf
Average nucleotide identity (ANI) was calculated using ANI calculator (http://enve-omics.ce.gatech.edu/ani/).,OADS,/arxiv_data1/oa_pdf/32/a9/dsu026.PMC4263297.pdf
Available at: http://www.hjarnkoll.se/Global/Rapport%20befolkningsunders%C3%B6kning%20Hj%C3%A4rnkoll%202011%20slutversion%20(2).pdf (accessed 28June 2013).,Non-OADS,/arxiv_data1/oa_pdf/99/13/jpm0021-0782.PMC4263306.pdf
Availableat: http://www.riksdagen.se/sv/Dokument -Lagar/Lagar/Svenskforfattningssamling/Halso–och-sjukvardslag-1982_sfs-1982-763/(accessed 28 June 2013).,OADS,/arxiv_data1/oa_pdf/99/13/jpm0021-0782.PMC4263306.pdf
Available at: http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/Svenskforfattningssamling/Socialtjanstlag-2001453_sfs-2001-453/ (accessed 28 June2013).,Non-OADS,/arxiv_data1/oa_pdf/99/13/jpm0021-0782.PMC4263306.pdf
Available at:http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/Svenskforfattningssamling/Lag-2003460-om-etikprovning_sfs-2003-460 (accessed 28June 2013).,Non-OADS,/arxiv_data1/oa_pdf/99/13/jpm0021-0782.PMC4263306.pdf
"Available from URL:http://www.who.int/mediacentre/factsheets/fs164/en/index.html 2 Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB; American Association for Study of Liver Diseases.",Non-OADS,/arxiv_data1/oa_pdf/12/5c/jgh0029-1996.PMC4263356.pdf
"Durham University, 2011. https://www.hcpc - uk.org/assets/documents/1000361BProfessionalismandconscientiousnessinhealthcareprofessionals-progressreportS2.pdf   (accessed in 2014)  12.",Non-OADS,/arxiv_data1/oa_pdf/69/9b/jmehm-7-17.PMC4263380.pdf
http://www.rismoon.com/moeenworddetail-9320-fa.html  .,Non-OADS,/arxiv_data1/oa_pdf/16/80/jmehm-7-7.PMC4263381.pdf
http://www.rismoon.com/moeenworddetail-9046-fa.html  (accessed in 2012)  [In Persian]  11.,Non-OADS,/arxiv_data1/oa_pdf/16/80/jmehm-7-7.PMC4263381.pdf
http://oxforddictionaries.com/definition/conflict?q=conflict  .,Non-OADS,/arxiv_data1/oa_pdf/16/80/jmehm-7-7.PMC4263381.pdf
http://www.answers.com/topic/conflict-of - interest#Ways_to_mitigate_conflicts_of_interests .,Non-OADS,/arxiv_data1/oa_pdf/16/80/jmehm-7-7.PMC4263381.pdf
http://www.herdsa.org.au/wp-content/uploads/conference/2003/PDF/HERDSA16.pdf  (accessed in 2013)  7.,Non-OADS,/arxiv_data1/oa_pdf/5c/5c/jmehm-7-12.PMC4263383.pdf
"183-224. http://www.oecd.org/dataoecd/8/26/34846890.pdf  (accessed in 2013)  60. ter Bogt T, Raaijmakers Q, van Wel F. Socialization and development of the work ethic among adolescents and young  adults.",Non-OADS,/arxiv_data1/oa_pdf/5c/5c/jmehm-7-12.PMC4263383.pdf
"History of Work Ethic, The Work Ethic Site, 1996. http://rhill.coe.uga.edu/workethic/hist.htm  (accessed in  2013)  63.",Non-OADS,/arxiv_data1/oa_pdf/5c/5c/jmehm-7-12.PMC4263383.pdf
"Anonymous.NEOMED Expectations of student conduct and professional commitment, 2012- 13.http://www.neomed.edu/students/studentaffairs/Student%20Handbook%20and%20Policies/student-honor - code/expectations-of-student-conduct-and-professional-commitment-2012-13.pdf (accessed in 2013).",Non-OADS,/arxiv_data1/oa_pdf/c5/ee/jmehm-7-8.PMC4263384.pdf
http://cshe.berkeley.edu/sites/default/files/shared/publications/docs/ROPS.GEISER._SAT_6.13.07.pdf  (accessed in  2013).,OADS,/arxiv_data1/oa_pdf/c5/ee/jmehm-7-8.PMC4263384.pdf
http://news.mak.ac.ug/documents/Makfiles/theses/Kyoshaba%20Martha.pdf  (accessed in 2013).,Non-OADS,/arxiv_data1/oa_pdf/c5/ee/jmehm-7-8.PMC4263384.pdf
http://www.victoria.ac.nz/documents/policy/student-policy/student-workload - policy.pdf (accessed in 2013).,Non-OADS,/arxiv_data1/oa_pdf/c5/ee/jmehm-7-8.PMC4263384.pdf
Undergraduate Medical Education Executive  Committee; 2013. http://wbacademy.utoronto.ca/wp-content/uploads/Standards-for-call-duty-and-student-workload-in - clerkship_revised-2013-01-15.pdf (accessed in2013).,Non-OADS,/arxiv_data1/oa_pdf/c5/ee/jmehm-7-8.PMC4263384.pdf
http://avivy.com/quran/almizan/fehrest.aspx  (accessed in 2013) [in Persian]  29.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/jmehm-7-2.PMC4263386.pdf
http://www.islam - usa.com/index.php?view=article&catid=57%3Amedical-ethics-an-isla.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/jmehm-7-2.PMC4263386.pdf
http://siasat.behdasht.gov.ir/index.aspx?siteid=291&pageid=34985   (accessed in 2013) [in Persian]  41.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/jmehm-7-2.PMC4263386.pdf
http://en.wikipedia.org/wiki/Usuli  (accessed in 2014),Non-OADS,/arxiv_data1/oa_pdf/4d/7d/jmehm-7-2.PMC4263386.pdf
http://www.britannica.com/EBchecked/topic/45755/Avicenna   (accessed in  2010)  19.,Non-OADS,/arxiv_data1/oa_pdf/93/17/jmehm-7-16.PMC4263387.pdf
http://bma.org.uk/practical-support-at-work/ethics/confidentiality-and-health-records  (accessed in 2013)  3.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.oaic.gov.au/privacy/privacy-resources/privacy-fact-sheets/other/privacy-fact-sheet-2-national-privacy - principles (accessed in 2013).,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
"[Masouliat Haye Herfei, Ma'a roufiat Haye Kazeb Va Aba'ade Hoghooghie A'an ]  http://hoghoogh.com.online.fr/maseoliat-e-herfeei.htm  (accessed in 2013)[in Persian]  13.",Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
"[Ghanoon Mojazat eslami 1375,Ketabe Panjom, Fasle bistom] Article 448.  http://www.dadkhahi.net/law/Ghavanin/Ghavanin_Jazaee/gh_mojazat_eslami2.htm  (accessed in 2012) [in Persian]  14.",Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
https://depts.washington.edu/bioethx/topics/physpt.html#ques11  (accessed in 2012)  15.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
"[Ghanoon sabte ahval e Iran 1355], Article 19 http://www.sabteahval.ir/pishkhan/default-5144.aspx   (accessed in 2012) [In Persian]  16.",Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
"Public Health (Infection Disease) Regulations 1988.SI 1988/1546.r.12,  http://legislation.data.gov.uk/uksi/1988/1546/made/data.htm?wrap=true  (accessed in 2013)   17.",Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://ocfp.on.ca/docs/collaborative-mental-health-care-network/cpso-policy-statement-on-mandatory - reporting.pdf?sfvrsn=2 Cited Jan/Feb 2006 (accessed in 2012)  19.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://rc.majlis.ir/fa/law/show/96265  (accessed in 2012)  [in Persian]    25.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
National Diabetes Fact Sheet United States 2005.  http://ndep.nih.gov/media/2005_National_Diabetes_Fact_Sheet.pdf?redirect=true  (accessed in 2012).,OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
"Motor Vehicle Act 1959, Section 148.  http://www.legislation.sa.gov.au/lz/c/a/motor%20vehicles%20act%201959.aspx  (accessed in 2013)  31.",Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://rc.majlis.ir/fa/law/show/90952  (accessed in 2012) [in Persian]  32.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.state.nj.us/health/cd/documents/reportable_disease_magnet.pdf  (accessed in 2012),Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.endcorporalpunishment.org/pages/progress/reports/finland.html  (accessed in 2013)  35.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://m.whitehouse.gov/sites/default/files/docs/vawa_factsheet.pdf  (accessed in 2013)  36.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
Maryland Mandatory Reporting Requirements  http://www.msba.org/sec_comm/sections/health/docs/req_chart .,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.who.int/topics/child_abuse/en/  (accessed in 2013)  43.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.aifs.gov.au/nch/resources/links/links.html  (accessed in 2013)  44.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
https://www.childwelfare.gov/pubs/reslist/rl_dsp.cfm?rs_id=5&rate_chno=11-11172  (accessed in 2012)  45.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
46. http://ican4kids.org/documents/CANProtocol/MandatedReporting   (accessed in 2012)  47.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.aifs.gov.au/cfca/pubs/factsheets/a141787/  (accessed in 2013)   48.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.cpso.on.ca/uploadedFiles/policies/policies/policyitems/medical_records.pdf   (accessed in 2012)  50.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.yasa.co  (accessed in 2012) [in Persian].,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.eapu.com.au/uploads/research_resources/Mandatory_Reporting_Position_Statement_MAR_2006-EAPU.pdf   (accessed in 2012).,OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.ncea.aoa.gov/NCEAroot/Main_Site/Find_Help/State_Resources.aspx .,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.rcdso.org/Assets/DOCUMENTS/Professional_Conduct/RCDSO_Mandatory_Reporting_Sexual_Abuse.pdf   (accessed in 2012)  56.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.cappaa.com/about-cappaa .,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
Section 14.  http://www.legislation.sa.gov.au/LZ/C/A/BOXING%20AND%20MARTIAL%20ARTS%20ACT%202000/CURRENT/ 2000.36.UN.PDF (accessed in 2012)   59.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.who.int/patientsafety/worldalliance/en/  (accessed in 2012)  66.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://patientsikkerhed.dk/media/566771/act_on_patient_safety.pdf   (accessed in 2012)  68.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
"Department of health & human  services, 2000.   http://archive.ahrq.gov/news/medscap1.htm  (accessed in 2013)  69.",OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
Anonymous.109th US Congress: Patient Safety and Quality Improvement Act of 2005.  https://www.govtrack.us/congress/bills/109/s544/text .,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.zums.ac.ir/find.php?item=45.1131.586.fa  (accessed in 2012) [in Persian]  71.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://www.hc-sc.gc.ca/ahc - asc/media/advisories-avis/reaction-eng.php#Vaccines (accessed in 2013)  72.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
http://fdo.behdasht.gov.ir/index.aspx?fkeyid=&siteid=114&pageid=32102&siteid=114  (accessed in 2012) [in Persian]  73.,Non-OADS,/arxiv_data1/oa_pdf/36/2d/jmehm-7-13.PMC4263389.pdf
"Albanian Penal Code, October 2004, Section 81. http://ligjet.info/kodipenal  [in Albanian].",Non-OADS,/arxiv_data1/oa_pdf/47/6b/jmehm-7-4.PMC4263390.pdf
http://docs.askives.com/what-is-units-of-distress-scale.html   (accessed in 2014)   11.,Non-OADS,/arxiv_data1/oa_pdf/c0/f4/jmehm-7-3.PMC4263391.pdf
http://www.aacn.org/WD/practice/Docs/moral_distress.pdf   (accessed in 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/f4/jmehm-7-3.PMC4263391.pdf
"The impact of unit difference gender and years of stress among staff nurses in  Jordan, 2004.   http://faculty.ksu.edu.sa/omar%20omari/research%20paper/the%20impact%20of%20unit%20differences.pdf  (accessed  in 2013).",Non-OADS,/arxiv_data1/oa_pdf/c0/f4/jmehm-7-3.PMC4263391.pdf
http://edis.ifas.ufl.edu/fy393  (accessed in 2011).,Non-OADS,/arxiv_data1/oa_pdf/57/6e/jmehm-7-14.PMC4263394.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/7a/ijn-9-5653.PMC4263440.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5653–5665International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5653OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6851 1Nanoparticle delivery of an aKT/PDK1  inhibitor improves the therapeutic effect  in pancreatic cancer armando lucero-acuña1 Justin J Jeffery2 edward r abril3,4 raymond B Nagle3,4 roberto guzman1 Mark D Pagel2,3,5,6 emmanuelle J Meuillet3,7,8 1Department of chemical and  environmental engineering, University  of arizona, 2Department of Biomedical  engineering, University of arizona,   3University of arizona cancer  center, 4Department of Pathology,   University of arizona, 5Department  of chemistry and Biochemistry,   University of arizona, 6Department of  Medical Imaging, University of arizona,   7Department of Molecular and  cell Biology, University of arizona,   8Department of Nutritional sciences,   University of arizona, T ucson, aZ, UsaAbstract:  The K- ras mutation in pancreatic cancer can inhibit drug delivery and increase drug  resistance.",Non-OADS,/arxiv_data1/oa_pdf/38/7a/ijn-9-5653.PMC4263440.pdf
"We have previously shown that PH-427 is highly  efficient in treating a BxPC3 xenograft model that has wild-type K- ras, but is poorly correspondence: emmanuelle J Meuillet Department of Nutritional sciences,  University of arizona, PO Box 210038,  Tucson, aZ 85721-0038, Usa  Tel +1 520 626 5794 Fax +1 520 621 9446 email emeuillet@azcc.arizona.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Lucero-Acuña et al Running head recto: PH-427-PNP improves pancreatic cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S68511",Non-OADS,/arxiv_data1/oa_pdf/38/7a/ijn-9-5653.PMC4263440.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/38/7a/ijn-9-5653.PMC4263440.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/7a/ijn-9-5653.PMC4263440.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/b3/ijn-9-5639.PMC4263441.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5639–5651International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5639OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7395 0Ultrasound-targeted stromal cell-derived  factor-1-loaded microbubble destruction  promotes mesenchymal stem cell homing  to kidneys in diabetic nephropathy rats shengzheng Wu1 lu li1 gong Wang1 Weiwei shen2 Yali Xu1 Zheng liu1 Zhongxiong Zhuo1 hongmei Xia1 Yunhua gao1 Kaibin Tan1 1Department of Ultrasound,   2Department of Orthopedics,   Xinqiao hospital, Third Military  Medical University, chongqing,   People’s republic of chinaAbstract:  Mesenchymal stem cell (MSC) therapy has been considered a promising strategy  to cure diabetic nephropathy (DN).",Non-OADS,/arxiv_data1/oa_pdf/84/b3/ijn-9-5639.PMC4263441.pdf
"DN is the most  detrimental complication and greatly increases the occurrence of social and economic  burdens because it progresses to end-stage chronic kidney disease, which results  in the requirement of hemodialysis or even kidney transplantation.2 Mesenchymal  stem cell (MSC) transplantation has been considered a promising strategy to manage  patients with DN due to the renoprotective potential of MSCs and the safety of this correspondence: Yunhua gao;   Kaibin Tan Department of Ultrasound, Xinqiao  hospital, Third Military Medical  University, 183 Xinqiao street, chongqing  400037, People’s republic of china Tel +86 23 6875 5631 Fax +86 23 6875 5631 email gyh755631@163.co m;   tkbhjcc@aliyun.com Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Wu et al Running head recto: SDF-1-loaded MB promotes MSC homing DOI: http://dx.doi.org/10.2147/IJN.S73950",Non-OADS,/arxiv_data1/oa_pdf/84/b3/ijn-9-5639.PMC4263441.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/84/b3/ijn-9-5639.PMC4263441.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/b3/ijn-9-5639.PMC4263441.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b6/c6/3999.PMC4263444.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/35/f1/4010.PMC4263445.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/78/1e/4024.PMC4263446.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/81/86/4034.PMC4263447.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/46/fd/4049.PMC4263448.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b2/20/4063.PMC4263449.pdf
Two months after publica - tion it is available to the public under an Attribution–Noncommercial–Share Alike  3.0 Unported Creative Commons License (http://creativecommons.org/licenses/ by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7d/6c/4072.PMC4263450.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4f/07/4083.PMC4263451.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a4/2f/4096.PMC4263452.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/86/fb/4106.PMC4263453.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/62/b3/4115.PMC4263454.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc- sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ea/f4/4130.PMC4263455.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/45/89/4150.PMC4263456.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/4166.PMC4263457.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/li - censes/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/49/71/4174.PMC4263458.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/65/a7/4187.PMC4263459.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/57/ca/4195.PMC4263460.pdf
He required four courses of intravenous antibiotics for pulmonary exacerbations over the course of his ﬁrst yearThis case report is an illustration of an invited review available in Respirology :http://dx.doi.org/10.1111/resp.12382.,Non-OADS,/arxiv_data1/oa_pdf/60/44/rcr20002-0129.PMC4263492.pdf
She had been switched to second-line ART twoyears previously for virological and immunological failure This case report is an illustration of an invited review available in Respirology :http://dx.doi.org/10.1111/resp.12385.,Non-OADS,/arxiv_data1/oa_pdf/6e/cb/rcr20002-0135.PMC4263494.pdf
"World Health Organisation, Geneva, Switzerland.Available at: http://www.who.int/tb/publications/global_report/en/ (accessed 9 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/6e/cb/rcr20002-0135.PMC4263494.pdf
MeanThis case report is an illustration of an invited review available in Respirology :http://dx.doi.org/10.1111/resp.12388.,Non-OADS,/arxiv_data1/oa_pdf/d1/1e/rcr20002-0141.PMC4263496.pdf
"ACKNOWLEDGMENTS This work was supported by a Wellcome Trust (http://www.wellcome.ac.uk) grant 82586 (CEP), an MRC (http://www.mrc.ac.uk) grant G0901844 (CEP), and a BSF (http://www.britishskinfoundation.org.uk) grant 929 s (CEP).",Non-OADS,/arxiv_data1/oa_pdf/16/04/jid2014312a.PMC4263603.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/f8/27/nna-45-14.PMC4263611.pdf
"21To address this gap, leaders at a tertiary healthca re organization implemented a point-of-care research trai ning program, led by the or- ganization’s nursing research facilitator, targeting nurses and other clinicians to reduc e EBP barriers and to pro- mote engagement in research (Job Description for Nurs-ing Research Facilitator, see Document, SupplementalDigital Content 1, http://links.lww.com/JONA/A369).The program provided mentor ing and funding for teams of novice researchers to conduct small-scale studies intheir practice settings.",Non-OADS,/arxiv_data1/oa_pdf/f8/27/nna-45-14.PMC4263611.pdf
"A brief demographic form (see Table, Supplemental Digital Content 3, http://links.lww.com/JONA/A371),including age, gender, profe ssion, position, level of edu- cation, years in practice, and practice area, was com-pleted by participants at the time of enrollment.",Non-OADS,/arxiv_data1/oa_pdf/f8/27/nna-45-14.PMC4263611.pdf
"Results Quantitative Findings There were 136 participants in the study (response rate of 88.9%) (see Table, Supplemental Digital Content 3,http://links.lww.com/JONA/A371), mostly women (87%),between 25 and 44 years of age (80%), and workingin acute care (85%).",Non-OADS,/arxiv_data1/oa_pdf/f8/27/nna-45-14.PMC4263611.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial u se, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922",OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"The dashed line shows a ﬁt of a normal distribution with a mean size of 127 nm and standard deviation of 19 nm.Size and concentration determination with TPRS Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922",OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"The combination of parameters selected for further optimization is indicated with a bold circle.Size and concentration determination with TPRS Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922",OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"Average minimum/median detected diameter and % CV for 2 methods to conﬁgure TRPS measurements Method Fixed stretch Fixed blockade height Inter-pore Particle rate (min) 67 136 Minimum diameter (nm) (% CV) 96 (3.6) 121 (4.3)Median diameter (nm) (% CV) 130 (2.8) 160 (4.7) Intra-pore Particle rate 115 199 Minimum diameter (nm) (% CV) 118 (15.5) 123 (4.5)Median diameter (nm) (% CV) 156 (15.6) 166 (4.7)Size and concentration determination with TPRS Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"J Extracell Vesicles.2014;3:23430, doi: http://dx.doi.org/10.3402/jev.v3.23430Frank A. W. Coumans et al.",OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 25922 - http://dx.doi.org/10.3402/jev.v3.25922",OADS,/arxiv_data1/oa_pdf/40/eb/JEV-3-25922.PMC4263901.pdf
"http://dx.doi.org/10.1016/j.stemcr.2014.11.005 (Stem Cell Reports 3, 516–529, September 9, 2014) In the Supplemental Experimental Procedures of this article as originally published, the concentration of monothiogly-cerol was stated at 39 l/mL instead of the correct concentration of 0.45 mM.",Non-OADS,/arxiv_data1/oa_pdf/64/e0/main.PMC4263977.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6b/88/jcav05p0797.PMC4263990.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c3/62/jcav05p0804.PMC4263991.pdf
"Target gene prediction of the  candidat e  miRNAs   In order to understand how these five miRNAs  function in RB tumor development and progression,  predicted target genes of those five miRNAs were  obtained via three computational algorithms, mi-Randa (http://www.microrna.org/), TargetScan (http://ww w.targetscan.org/), and DianaMicroT  (http://diana.cslab.ece.ntua.gr/microT/).",OADS,/arxiv_data1/oa_pdf/c3/62/jcav05p0804.PMC4263991.pdf
"Stem Cell Reports Meeting Report International Coordination of Large-Scale Human Induced Pluripotent Stem Cell Initiatives: Wellcome T rust and ISSCR Workshops White Paper Filipa A.C. Soares,1Michael Sheldon,2Mahendra Rao,3Christine Mummery,4and Ludovic Vallier1,5,* 1Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine and Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK 2Department of Genetics and The Human Genetics Institute of New Jersey, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8009, USA 3New York Stem Cell Foundation, New York, NY 10023, USA 4Department of Anatomy and Embryology, Leiden University Medical Centre, Leiden 2300 RC, The Netherlands 5Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK *Correspondence: lv225@cam.ac.uk http://dx.doi.org/10.1016/j.stemcr.2014.11.006 There is growing recognition of the potential value of human induced pluripotent stem cells (hiPSC) for understanding disease and iden- tifying drugs targets.",Non-OADS,/arxiv_data1/oa_pdf/03/37/main.PMC4263998.pdf
"The development of robust protocols for reprogrammingblood cell is potentially game changing, making it possibleto develop hiPSC initiatives that leverage very large exist-ing collections, such as that of the NIMH Repository andGenomics Resource (NRGR, https://www.nimhgenetics.",OADS,/arxiv_data1/oa_pdf/03/37/main.PMC4263998.pdf
"Historically, reposi-tories such as RUCDR ( http://www.rucdr.org ) have per- formed all of these functions for many large-scale human genetics initiatives involving the use of nucleic acids, cell lines, and other biomaterials collected and processedfrom study participants.",Non-OADS,/arxiv_data1/oa_pdf/03/37/main.PMC4263998.pdf
"The hESReg database, originally estab-lished to provide information on all hESC lines used in EU projects, is now being expanded to include hiPSC lines ( http://www.hescreg.eu ).",OADS,/arxiv_data1/oa_pdf/03/37/main.PMC4263998.pdf
"A number of other effortsare underway, including eagle-i ( https://www.eagle-i.net ), the Neuroscience Information Framework ( http://www.",Non-OADS,/arxiv_data1/oa_pdf/03/37/main.PMC4263998.pdf
"neuinfo.org ), and the International Stem Cell Registry (http://www.umassmed.edu/iscr ).",Non-OADS,/arxiv_data1/oa_pdf/03/37/main.PMC4263998.pdf
"The key objectives of this coordination would be (1) to deﬁne technical standards for derivation and charac-terization of hiPSC lines, (2) create a panel of fully validatedstandard hiPSC lines originating from different centers, (3)standardize training between the different centers, (4)coordinate ethics/IP among the different initiatives, and(5) centralize resources and information on hiPSC lines derived by each initiative.SUPPLEMENTAL INFORMATION Supplemental Information includes two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/03/37/main.PMC4263998.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.09.016 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4263999.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, four tables, and three movies and can befound with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c8/4d/main.PMC4263999.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9e/4e/srep07450.PMC4264001.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7450 | DOI: 10.1038/srep07450 5",Non-OADS,/arxiv_data1/oa_pdf/9e/4e/srep07450.PMC4264001.pdf
All the analyses were done by survival package in R 2.15.1 (http://www.r-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/10/d4/srep07455.PMC4264002.pdf
Linear electrostatic charge was estimatedusing default options in the protcalc webserver (http://protcalc.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/10/d4/srep07455.PMC4264002.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/10/d4/srep07455.PMC4264002.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7455 | DOI: 10.1038/srep07455 11",Non-OADS,/arxiv_data1/oa_pdf/10/d4/srep07455.PMC4264002.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/srep07449.PMC4264003.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Nunes, T.M.",Non-OADS,/arxiv_data1/oa_pdf/9e/36/srep07449.PMC4264003.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7449 | DOI: 10.1038/srep07449 7",Non-OADS,/arxiv_data1/oa_pdf/9e/36/srep07449.PMC4264003.pdf
The predicted ORFs were scanned to identify protein domains using HMMPfam (http://hmmer.janelia.org/).,OADS,/arxiv_data1/oa_pdf/14/08/srep07457.PMC4264004.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/08/srep07457.PMC4264004.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c6/1b/srep07463.PMC4264005.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7446 | DOI: 10.1038/srep07446 5",Non-OADS,/arxiv_data1/oa_pdf/a2/a1/srep07446.PMC4264008.pdf
NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (2014) Available at: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp#breast.,Non-OADS,/arxiv_data1/oa_pdf/4a/e1/srep07466.PMC4264011.pdf
Early and locally advanced breast cancer: Diagnosis and treatment (2009) Available at: http://publications.nice.org.uk/early-and-locally-advanced-breast- cancer-cg80/guidance#follow-up.,Non-OADS,/arxiv_data1/oa_pdf/4a/e1/srep07466.PMC4264011.pdf
30.Taiwan Cancer Registry (2009) Available at: http://tcr.cph.ntu.edu.tw/main.,Non-OADS,/arxiv_data1/oa_pdf/4a/e1/srep07466.PMC4264011.pdf
Taiwan Cancer Registry Annual Report 2010 (2013) Available at: http://www.hpa.gov.tw/BHPNet/Portal/File/StatisticsFile/201305061037065219/99%E5%B9%B4%E7%99%8C%E7%97%87%E7%99%BB% E8%A8%98%E5%A0%B1%E5%91%8A.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/e1/srep07466.PMC4264011.pdf
(2013) Available at: http://seer.cancer.gov/statfacts/html/breast.,Non-OADS,/arxiv_data1/oa_pdf/4a/e1/srep07466.PMC4264011.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4a/e1/srep07466.PMC4264011.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/62/srep07451.PMC4264012.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7451 | DOI: 10.1038/srep07451 9",Non-OADS,/arxiv_data1/oa_pdf/be/62/srep07451.PMC4264012.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2d/15/srep07465.PMC4264014.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7458 | DOI: 10.1038/srep07458 8",Non-OADS,/arxiv_data1/oa_pdf/7c/62/srep07458.PMC4264015.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2c/4c/srep07452.PMC4264016.pdf
"Study of Single DW Generation Using Micromagnetic Simula- tion.To further understand and extrapolate our experimental studies, micromagnetic simulations were performed using Landau- Lifshitz-Gilbert (LLG) simulator (M. R. Scheinfein, LLG Micromag- netics Simulator, http://llgmicro.home.mindspring.com/).",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/srep07459.PMC4264026.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7459 | DOI: 10.1038/srep07459 5",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/srep07459.PMC4264026.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/db/srep07454.PMC4264028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7454 | DOI: 10.1038/srep07454 5",Non-OADS,/arxiv_data1/oa_pdf/57/db/srep07454.PMC4264028.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1b/13/srep07462.PMC4264030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7462 | DOI: 10.1038/srep07462 8",Non-OADS,/arxiv_data1/oa_pdf/1b/13/srep07462.PMC4264030.pdf
"Stem Cell Reports Article AmiR-590/Acvr2a/Rad51b Axis Regulates DNA Damage Repair during mESC Proliferation Qidong Liu,1Guiying Wang,1Yafang Chen,1Guoping Li,1Dandan Yang,1and Jiuhong Kang1,* 1Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signaling and Diseas e Research, School of Life Science and Technology, Tongji University, 1239 Siping Road, Shanghai 200092, People’s Republic of China*Correspondence: jhkang@tongji.edu.cn http://dx.doi.org/10.1016/j.stemcr.2014.10.006 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b0/2c/main.PMC4264031.pdf
All other methods can be found in the Supplemental Information .SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and ﬁve ﬁgures and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2014.10.006 .,Non-OADS,/arxiv_data1/oa_pdf/b0/2c/main.PMC4264031.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
"Received August 14, 2014 /C15Revision received August 28, 2014 /C15Accepted September 4, 2014 /C15Available online 16 September 2014 http://dx.doi.org/10.1016/j.molmet.2014.09.004 Minireview MOLECULAR METABOLISM 3 (2014) 813 e822/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/main.PMC4264037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
"Abbreviations: apoB100, apolipoproteinB100; FFA, free fatty acid; GLP-1, glucagon-like peptide-1; GLP-1R, GLP-1 receptor; ICV, intracerebroventricular; ip, i ntraperitoneal; RER, respiratory exchange ratio; T2D, type 2 diabetes; VLDL, very low density lipoprotein Received August 25, 2014 /C15Revision received September 7, 2014 /C15Accepted September 11, 2014 /C15Available online 28 September 2014 http://dx.doi.org/10.1016/j.molmet.2014.09.005 Original article MOLECULAR METABOLISM 3 (2014) 823 e833/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/db/main.PMC4264039.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.10.002 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/a4/main.PMC4264040.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and one table andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2014.10.002 .,Non-OADS,/arxiv_data1/oa_pdf/04/a4/main.PMC4264040.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
"Received August 13, 2014 /C15Revision received September 3, 2014 /C15Accepted September 4, 2014 /C15Available online 16 September 2014 http://dx.doi.org/10.1016/j.molmet.2014.09.003 Original article 834MOLECULAR METABOLISM 3 (2014) 834 e847/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/be/main.PMC4264041.pdf
"Stem Cell Reports Article p19INK4dControls Hematopoietic Stem Cells in a Cell-Autonomous Manner during Genotoxic Stress and through the Microenvironment during Aging Morgane Hilpert,1,2,3,4Ce´line Legrand,1,2,3Dominique Bluteau,1,2,3,5Natalie Balayn,1,2,3Aline Betems,1,2,3 Olivier Bluteau,1,2,3Jean-Luc Villeval,1,2,3Fawzia Louache,1,2,3Patrick Gonin,2,3Najet Debili,1,2,3 Isabelle Plo,1,2,3William Vainchenker,1,2,3Laure Gilles,1,2,3,6and Hana Raslova1,2,3,6,* 1Institut National de la Sante ´et de la Recherche Me ´dicale, U1009, Equipe labellise ´e Ligue Nationale contre le Cancer, 114 rue Edouard Vaillant, 94805 Villejuif, France 2University Paris Sud, 114, rue Edouard Vaillant, 94805 Villejuif, France 3Gustave Roussy, IFR54, 114, rue Edouard Vaillant, 94805 Villejuif, France 4University Paris Diderot, 5 rue Thomas-Mann, 75205 Paris, France 5Ecole Pratique des Hautes Etudes, 4-14 rue Ferrus, 75014 Paris, France 6Co-senior author *Correspondence: hraslova@igr.fr http://dx.doi.org/10.1016/j.stemcr.2014.10.005 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/52/01/main.PMC4264042.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and one table and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2014.",OADS,/arxiv_data1/oa_pdf/52/01/main.PMC4264042.pdf
"Nanduri,1Mirjam Baanstra,1,2Hette Faber,1,2Cecilia Rocchi,1,2Erik Zwart,3Gerald de Haan,3 Ronald van Os,3and Robert P. Coppes1,2,* 1Department of Cell Biology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713AV Groningen, the Netherlands 2Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands 3Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Aging (ERIBA), University Medical Center Groningen, University of Groningen, Building 3226, Antonius Deusinglaan 1, 9713AV Groningen, the Netherlands *Correspondence: r.p.coppes@umcg.nl http://dx.doi.org/10.1016/j.stemcr.2014.09.015 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC4264052.pdf
Gene Ontology analysis was performed using Amigo labs(http://amigo1.geneontology.org/cgi-bin/amigo/term_enrichment ).,OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC4264052.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and four tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.09.",OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC4264052.pdf
"Clearly, further work will be neededDOI of original article: http://dx.doi.org/10.1016/j.molmet.2014.06.003 .",Non-OADS,/arxiv_data1/oa_pdf/5b/41/main.PMC4264055.pdf
http://dx.doi.org/10.1016/j.molmet.2014.09.009 MOLECULAR METABOLISM 3 (2014) 855 e856/C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/5b/41/main.PMC4264055.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/41/main.PMC4264055.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/41/main.PMC4264055.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.10.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/68/main.PMC4264057.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, one table, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.",Non-OADS,/arxiv_data1/oa_pdf/ee/68/main.PMC4264057.pdf
"Nu ´n˜ez-Gil,7In˜igo Valiente,2Amparo Ruı ´z-Sauri,8 Pilar Sepu ´lveda,5Malte Tiburcy,4Wolfram-H. Zimmermann,4and Antonio Bernad1,2,* 1Immunology and Oncology Department, National Center for Biotechnology, CSIC, 28049 Madrid, Spain 2Department of Cardiovascular Development and Repair, Fundacio ´n Centro Nacional de Investigaciones Cardiovasculares Carlos III, 28029 Madrid, Spain 3Cardiovascular Area, CIMUS, University of Santiago de Compostela-Instituto de Investigacio ´n Sanitaria, 15706 Santiago de Compostela, Spain 4Institute of Pharmacology, Heart Research Center Go ¨ttingen, University Medical Center, Georg-August University Go ¨ttingen and DZHK (German Center for Cardiovascular Research), 37075 Go ¨ttingen, Germany 5Instituto de Investigacio ´n Sanitaria INCLIVA, 46010 Valencia, Spain 6Unidad de Cardioregeneracio ´n, Hospital La Fe, 46009 Valencia, Spain 7Servicio de Cardiologı ´a, Hospital Clı ´nico San Carlos, 28040 Madrid, Spain 8Departamento de Patologı ´a, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain 9Co-ﬁrst author *Correspondence: abernad@cnb.csic.es http://dx.doi.org/10.1016/j.stemcr.2014.10.010 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a6/26/main.PMC4264058.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, and four tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.",OADS,/arxiv_data1/oa_pdf/a6/26/main.PMC4264058.pdf
"Published online July 30, 2013. http://dx.doi.org/10.1002/term.",OADS,/arxiv_data1/oa_pdf/a6/26/main.PMC4264058.pdf
"Stem Cell Reports Report A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Speciﬁcation Syandan Chakraborty,1,5HaYeun Ji,1,5Ami M. Kabadi,1Charles A. Gersbach,1,2,3Nicolas Christoforou,1,4 and Kam W. Leong1,5,* 1Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA 2Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA 3Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC 27708, USA 4Department of Biomedical Engineering, Khalifa University, Abu Dhabi 127788, UAE 5Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA *Correspondence: kam.leong@duke.edu http://dx.doi.org/10.1016/j.stemcr.2014.09.013 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/56/82/main.PMC4264059.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one movie and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2014.09.",Non-OADS,/arxiv_data1/oa_pdf/56/82/main.PMC4264059.pdf
"Published online August 13, 2014. http://dx.doi.org/10.1093/nar/gku749.",Non-OADS,/arxiv_data1/oa_pdf/56/82/main.PMC4264059.pdf
"Stem Cell Reports Resource Characterization of Cre Recombinase Activity for In Vivo T argeting of Adipocyte Precursor Cells Katherine C. Krueger,1Maria Jose ´Costa,1Hongqing Du,1and Brian J. Feldman1,2,3,* 1Department of Pediatrics/Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA 2Cardiovascular Institute, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA 3Program in Regenerative Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA *Correspondence: feldman@stanford.edu http://dx.doi.org/10.1016/j.stemcr.2014.10.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0e/37/main.PMC4264060.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.10.009 .,Non-OADS,/arxiv_data1/oa_pdf/0e/37/main.PMC4264060.pdf
"Stem Cell Reports Resource Fast and Efﬁcient Neural Conversion of Human Hematopoietic Cells Julio Castan ˜o,1,9Pablo Menendez,1,2,9Cristina Bruzos-Cidon,3,9Marco Straccia,4,5Amaia Sousa,6 Lorea Zabaleta,7Nerea Vazquez,6Amaia Zubiarrain,6,7Kai-Christian Sonntag,8Luisa Ugedo,3 Xonia Carvajal-Vergara,7,10Josep Maria Canals,4,5Maria Torrecilla,3Rosario Sanchez-Pernaute,6,* and Alessandra Giorgetti1,* 1Josep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Barcelona 08036, Spain 2Institucio ´Catalana de Recerca i Estudis Avanc ¸ats (ICREA), Barcelona 08010, Spain 3Department of Pharmacology, Faculty of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa 48940, Spain 4Department of Cell Biology, Immunology and Neurosciences, Faculty of Medicine, Institut d’Investigacions Biome `diques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona 08036, Spain 5Centro de Investigaciones Biome ´dicas en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona 08036, Spain 6Laboratory of Stem Cells and Neural Repair, Inbiomed, San Sebastian 20009, Spain 7Cell Reprogramming and Differentiation Platform, Inbiomed, San Sebastian 20009, Spain 8Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA 9Co-ﬁrst author 10Present address: Department of Cell Therapy, Centro de Investigacio ´nM e´dica Aplicada (CIMA), Pamplona 31008, Spain *Correspondence: rpernaute@inbiomed.org (R.S.-P.), agiorgetti@carrerasresearch.org (A.G.) http://dx.doi.org/10.1016/j.stemcr.2014.10.008 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/28/ce/main.PMC4264063.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/28/ce/main.PMC4264063.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.10.003 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/f2/main.PMC4264065.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three ﬁgures, one table, and three movies and canbe found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2014.10.003 .",Non-OADS,/arxiv_data1/oa_pdf/99/f2/main.PMC4264065.pdf
"Stem Cell Reports Report Low/Negative Expression of PDGFR- aIdentiﬁes the Candidate Primary Mesenchymal Stromal Cells in Adult Human Bone Marrow Hongzhe Li,1Roshanak Ghazanfari,1Dimitra Zacharaki,1Nicholas Ditzel,2Joan Isern,3Marja Ekblom,1,6 Simo´nM e´ndez-Ferrer,3Moustapha Kassem,2,4,5and Stefan Scheding1,6,* 1Lund Stem Cell Center, Lund University, 22184 Lund, Sweden 2Department of Endocrinology, University of Southern Denmark, Molecular Endocrinology Laboratory (KMEB), Odense 5000, Denmark 3Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain 4Stem Cell Unit, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia 5Danish Stem Cell Center (DanStem), Panum Institute, University of Copenhagen, Copenhagen 2200, Denmark 6Department of Hematology, Ska ˚ne University Hospital Lund, 22184 Lund, Sweden *Correspondence: stefan.scheding@med.lu.se http://dx.doi.org/10.1016/j.stemcr.2014.09.018 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8e/61/main.PMC4264066.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and three tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2014.09.",OADS,/arxiv_data1/oa_pdf/8e/61/main.PMC4264066.pdf
"Stem Cell Reports Report Direct Lineage Conversion of Adult Mouse Liver Cells and B Lymphocytes to Neural Stem Cells John P. Cassady,1,2Ana C. D’Alessio,1Sovan Sarkar,1Vardhan S. Dani,3Zi Peng Fan,1,4Kibibi Ganz,1 Reinhard Roessler,1Mriganka Sur,3Richard A. Young,1,2and Rudolf Jaenisch1,2,* 1The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA 2Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 3Department of Brain and Cognitive Sciences, Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 4Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02139, USA *Correspondence: jaenisch@wi.mit.edu http://dx.doi.org/10.1016/j.stemcr.2014.10.001 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/6a/a5/main.PMC4264067.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and four ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2014.10.001 .,Non-OADS,/arxiv_data1/oa_pdf/6a/a5/main.PMC4264067.pdf
"Stem Cell Reports Article 3D Reconstitution of the Patterned Neural T ube from Embryonic Stem Cells Andrea Meinhardt,1Dominic Eberle,1Akira Tazaki,1Adrian Ranga,4Marco Niesche,2 Michaela Wilsch-Bra ¨uninger,3Agnieszka Stec,1Gabriele Schackert,2Matthias Lutolf,4and Elly M. Tanaka1,3,* 1DFG-Research Center for Regenerative Therapies, Technische Universita ¨t Dresden, 01307 Dresden, Germany 2Neurosurgery Department, Faculty of Medicine, Technische Universita ¨t Dresden, 01307 Dresden, Germany 3Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany 4Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, Ecole Polytechnique Fe ´de´rale de Lausanne, 1015 Lausanne, Switzerland *Correspondence: elly.tanaka@crt-dresden.de http://dx.doi.org/10.1016/j.stemcr.2014.09.020 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/13/17/main.PMC4264068.pdf
"SUPPLEMENTAL INFORMATION Supplemental InformationincludesSupplementalExperimentalPro- cedures, seven ﬁgures, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.09.020 .",Non-OADS,/arxiv_data1/oa_pdf/13/17/main.PMC4264068.pdf
With this in mind the Royal Marsden Hospital designed and  launched the 6 versus 12 study (http://www.clinical trials.,Non-OADS,/arxiv_data1/oa_pdf/b0/44/IJMPO-35-235.PMC4264265.pdf
Available	from:	 http://www.pbcrindia.org.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/IJMPO-35-239.PMC4264267.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/IJMPO-35-239.PMC4264267.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc)  and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/97/ad/IJMPO-35-244.PMC4264268.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/97/ad/IJMPO-35-244.PMC4264268.pdf
Available  from: http://www.globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/64/9f/IJMPO-35-253.PMC4264270.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/64/9f/IJMPO-35-253.PMC4264270.pdf
Available  from: http://www.globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/ee/4a/IJMPO-35-288.PMC4264276.pdf
Available from: http://www.pbcrindia.org.,Non-OADS,/arxiv_data1/oa_pdf/ee/4a/IJMPO-35-288.PMC4264276.pdf
Available from:  http://www.pbcrindia.org.,Non-OADS,/arxiv_data1/oa_pdf/ee/4a/IJMPO-35-288.PMC4264276.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ba/04/JMH-5-186.PMC4264282.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.,Non-OADS,/arxiv_data1/oa_pdf/5d/a4/JMH-5-198.PMC4264285.pdf
Available from: http://socialjustice.nic.in/oldageact.,Non-OADS,/arxiv_data1/oa_pdf/19/f2/JMH-5-205.PMC4264287.pdf
Available from:  http://pib.nic.in/newsite/erelease.aspx?relid=77868 [Last  accessed on Sept 30 2013].,OADS,/arxiv_data1/oa_pdf/19/f2/JMH-5-205.PMC4264287.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/19/f2/JMH-5-205.PMC4264287.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/19/f2/JMH-5-205.PMC4264287.pdf
Available from: http://archive.indianexpress.com/news/delhi-gangrape-bite-marks-nailed-december-16-convicts/1233309/ [Last accessed 2014 Jun 12].,Non-OADS,/arxiv_data1/oa_pdf/83/35/NAJMS-6-553.PMC4264289.pdf
Available from: http://timesofindia.indiatimes.com/city/mumbai/Bite-mark-on-Powai-rape-survivor-is-that-ofaccused/articleshow/29918926.cms [Last accessed 2014 Jun 12].,Non-OADS,/arxiv_data1/oa_pdf/83/35/NAJMS-6-553.PMC4264289.pdf
Available from: http://www.thehindu.com/todays-paper/tpnational/tp-tamilnadu/women-lawyers-vital-for-transformationof-future-society/article4517849.ece [Last accessed 2014 Jun 27].,Non-OADS,/arxiv_data1/oa_pdf/83/35/NAJMS-6-553.PMC4264289.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2379LETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/32/ea/bjc2014114a.PMC4264418.pdf
"All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: K-LG Spindler; E-mail: k.g.spindler@rm.dk 4Current address: Department of Oncology, Aarhus University Hospital, Aarhus, Denmark Published online 11 March 2014 &2014 Cancer Research UK.",Non-OADS,/arxiv_data1/oa_pdf/32/ea/bjc2014114a.PMC4264418.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2380 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/32/ea/bjc2014114a.PMC4264418.pdf
"All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: K-LG Spindler; E-mail: k.g.spindler@rm.dk 4Current address: Department of Oncology, Aarhus University Hospital, Aarhus, Denmark Published online 11 March 2014 &2014 Cancer Research UK.",Non-OADS,/arxiv_data1/oa_pdf/44/b2/bjc2014115a.PMC4264419.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2380 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/44/b2/bjc2014115a.PMC4264419.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr SC-H Kao; E-mail: steven.kao@lh.org.au Published online 8 April 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/ec/94/bjc2014185a.PMC4264420.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2376 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/ec/94/bjc2014185a.PMC4264420.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2377,Non-OADS,/arxiv_data1/oa_pdf/8d/41/bjc2014187a.PMC4264421.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2375,Non-OADS,/arxiv_data1/oa_pdf/ff/4e/bjc2014216a.PMC4264422.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr SC-H Kao; E-mail: steven.kao@lh.org.au Published online 8 April 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/ff/4e/bjc2014216a.PMC4264422.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2376 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/ff/4e/bjc2014216a.PMC4264422.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2377,Non-OADS,/arxiv_data1/oa_pdf/3a/88/bjc2014248a.PMC4264423.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2378 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/3a/88/bjc2014248a.PMC4264423.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2378 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/c3/30/bjc2014249a.PMC4264424.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2379LETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/c3/30/bjc2014249a.PMC4264424.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2370 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/83/d4/bjc2014284a.PMC4264425.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Professor J-H Nam; E-mail: jhnam@amc.seoul.kr Published online 14 August 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/83/d4/bjc2014284a.PMC4264425.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2371,Non-OADS,/arxiv_data1/oa_pdf/83/d4/bjc2014284a.PMC4264425.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2372 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/38/4b/bjc2014285a.PMC4264426.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2373LETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/38/4b/bjc2014285a.PMC4264426.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2372 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/7f/8f/bjc2014296a.PMC4264427.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Professor J-H Nam; E-mail: jhnam@amc.seoul.kr Published online 14 August 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/9c/83/bjc2014330a.PMC4264428.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2371,Non-OADS,/arxiv_data1/oa_pdf/9c/83/bjc2014330a.PMC4264428.pdf
"All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/LETTERS TO THE EDITOR British Journal of Cancer (2014) 111, 2369 | doi:10.1038/bjc.2014.390 www.bjcancer.com 2369",Non-OADS,/arxiv_data1/oa_pdf/e2/45/bjc2014389a.PMC4264430.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2370 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/e2/45/bjc2014389a.PMC4264430.pdf
"All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/LETTERS TO THE EDITOR British Journal of Cancer (2014) 111, 2369 | doi:10.1038/bjc.2014.390 www.bjcancer.com 2369",Non-OADS,/arxiv_data1/oa_pdf/57/02/bjc2014390a.PMC4264431.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2373LETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/4a/0a/bjc2014464a.PMC4264433.pdf
Available from http://www.ons.gov.uk/ons/rel/vsob1/ cancer-statistics-registrations–england–series-mb1-/index.html (accessed 20 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/4a/0a/bjc2014464a.PMC4264433.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr A Castanon; E-mail: a.castanon@qmul.ac.uk Published online 28 August 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/4a/0a/bjc2014464a.PMC4264433.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2374 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/4a/0a/bjc2014464a.PMC4264433.pdf
Available from http://www.ons.gov.uk/ons/rel/vsob1/ cancer-statistics-registrations–england–series-mb1-/index.html (accessed 20 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/b3/34/bjc2014465a.PMC4264434.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr A Castanon; E-mail: a.castanon@qmul.ac.uk Published online 28 August 2014 &2014 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/b3/34/bjc2014465a.PMC4264434.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ 2374 www.bjcancer.comLETTERS TO THE EDITORLETTERS TO THE EDITORLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/b3/34/bjc2014465a.PMC4264434.pdf
Department of Health (2012) https://www.gov.uk/government/publications/ improving-older-peoples-access-to-cancer-treatment-services.,Non-OADS,/arxiv_data1/oa_pdf/ce/27/bjc2014496a.PMC4264435.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Low-grade toxicity in older cancer patients undergoing chemotherapy 2228 www.bjcancer.com | DOI:10.1038/bjc.2014.496,Non-OADS,/arxiv_data1/oa_pdf/ce/27/bjc2014496a.PMC4264435.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Non-endoscopic screening for ESCC in Northern Iran BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.506 2241,Non-OADS,/arxiv_data1/oa_pdf/53/12/bjc2014506a.PMC4264437.pdf
Males with breast cancers were obtained from the kConFab repository (http://www.kconfab.org) and included cases from Australia and New Zealand diagnosed between 1980 and 2009.,Non-OADS,/arxiv_data1/oa_pdf/4e/c7/bjc2014511a.PMC4264438.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Somatic mutations in familial male breast cancer 2360 www.bjcancer.com | DOI:10.1038/bjc.2014.511,Non-OADS,/arxiv_data1/oa_pdf/4e/c7/bjc2014511a.PMC4264438.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Supplementation and liver cancer and liver disease BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.514 2223,Non-OADS,/arxiv_data1/oa_pdf/bc/4a/bjc2014514a.PMC4264440.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Gossypol/temozolamide combined therapy in glioblastoma 2286 www.bjcancer.com | DOI:10.1038/bjc.2014.529,Non-OADS,/arxiv_data1/oa_pdf/19/2a/bjc2014529a.PMC4264441.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Ex vivo tumour dormancy 2350 www.bjcancer.com | DOI:10.1038/bjc.2014.533,Non-OADS,/arxiv_data1/oa_pdf/fd/83/bjc2014533a.PMC4264444.pdf
"This contains 46 228 probes comprising 7815 probe sets and covers 71 organisms including 1100 human miRNAs derived from the Sanger miRBase and miRNA database v11 (15 April 2008, http://microrna.sanger.ac.uk).",OADS,/arxiv_data1/oa_pdf/cb/d5/bjc2014535a.PMC4264445.pdf
The RMA normalisation was performed using the ‘Affy’ package of the Bioconductor suite (http://www.bioconductor.org/) for R statistical language (http://cran.r-project.org/).,OADS,/arxiv_data1/oa_pdf/cb/d5/bjc2014535a.PMC4264445.pdf
The DIANA-miRPath v2.0 can be accessed at the following address: http://www.microrna.gr/miRPathv2.,OADS,/arxiv_data1/oa_pdf/cb/d5/bjc2014535a.PMC4264445.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MiR-152 and miR-497 in familial breast cancer 2368 www.bjcancer.com | DOI:10.1038/bjc.2014.535,Non-OADS,/arxiv_data1/oa_pdf/cb/d5/bjc2014535a.PMC4264445.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Neoadjuvant sunitinib and radiotherapy in STS BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.537 2261,Non-OADS,/arxiv_data1/oa_pdf/86/1b/bjc2014537a.PMC4264446.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Significance of nucleostemin in oral cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.539 2315,Non-OADS,/arxiv_data1/oa_pdf/02/00/bjc2014539a.PMC4264447.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)AnxA2 antibody inhibits EGFR function BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.542 2341,Non-OADS,/arxiv_data1/oa_pdf/c9/70/bjc2014542a.PMC4264449.pdf
Stage at diagnosis was determined using the cancer registry and/or FIGO stage informa- tion from each site (SEER guidelines: http://seer.cancer.gov/) and categorised as FIGO stage I/II (localised and regional) and FIGO stage III/IV (distant).,Non-OADS,/arxiv_data1/oa_pdf/4a/92/bjc2014567a.PMC4264456.pdf
"We gratefully acknowledge the contributions of the AOCS Group (http://www.aocstudy.org) (AOC); Mie Konno, Michelle Darago, Faye Chambers, the Tom Baker Cancer Centre Translational Laboratories (AOV); Karin Goodman, Ashley Pitzer, Mayo Clinic Medical Genome Facility (MAY, MAC); Kristy Angell, SEARCH team, the Human Research Tissue Bank at Addenbrooke’s Hospital that is supported by the NIHR Cambridge Biomedical Research Centre (SEA); Ian Jacobs, Eva Wozniak, Andy Ryan, Jeremy Ford, Nayala Balogun (UKO); and the Cheryl Brown Ovarian Cancer Outcomes Unit (VAN).",Non-OADS,/arxiv_data1/oa_pdf/4a/92/bjc2014567a.PMC4264456.pdf
"To disclose the biological events accompanying the alterations of cell invasion caused by NUAK1, online miRNA target prediction databases (miRNA.org (http://www.microrna.org/microrna/search Genes.do) and Targetscan (http://www.targetscan.org/)) were usedMiR-204 inhibits human NSCLC metastasis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.580 2321",Non-OADS,/arxiv_data1/oa_pdf/69/e5/bjc2014580a.PMC4264457.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)MiR-204 inhibits human NSCLC metastasis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.580 2327,Non-OADS,/arxiv_data1/oa_pdf/69/e5/bjc2014580a.PMC4264457.pdf
All rights reserved 0007 – 0920/14 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 2375,Non-OADS,/arxiv_data1/oa_pdf/b0/ab/bjc20148a.PMC4264463.pdf
"Vienna, Foundation for  Statistical Computing, 2011. http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/dee-0004-0431.PMC4264487.pdf
"http://www.infinitivision.com/product -labeling.asp   (accessed June 1, 2012 ).",Non-OADS,/arxiv_data1/oa_pdf/0f/bd/cop-0005-0373.PMC4264489.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
"Abbreviations: DI, disposition index; FSIVGTT, frequently sampled intravenous glucose tolerance test; GIR, glucose infusion rate; GSIS, glucose-stimulated ins ulin secretion; IDE, insulin degrading enzyme; IVGTT, intravenous glucose tolerance test; MI, insulin sensitivity index; NNT, nicotinamide nucleotide transhydr ogenase; OGTT, oral glucose tolerance test Received September 5, 2014 /C15Revision received September 16, 2014 /C15Accepted September 18, 2014 /C15Available online 28 September 2014 http://dx.doi.org/10.1016/j.molmet.2014.09.006 Brief communication 848MOLECULAR METABOLISM 3 (2014) 848 e854/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
"DNA extraction and genotyping The presence of the NNT mutation was veri ﬁed by PCR performed on DNA extracted from the liver using the protocol and primers described on the Jackson Laboratory website: http://jaxmice.jax.org/protocolsdb/f?p ¼116: 2:0::NO:2:P2_MASTER_PROTOCOL_ID,P2_JRS_CODE:7470,012371 .",OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/main.PMC4264561.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.10.004 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/7c/main.PMC4264562.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and ﬁve tables and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2014.10.004 .",OADS,/arxiv_data1/oa_pdf/65/7c/main.PMC4264562.pdf
"Published online July 26, 2014.http://dx.doi.org/10.1007/7651_2014_90.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/main.PMC4264562.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/ca/ciu744.PMC4264582.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/67/ciu767.PMC4264583.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/38/jiu393.PMC4264589.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/17/jiu396.PMC4264590.pdf
http://www.who.int/csr/ don/2014_05_23_mers/en/ .,OADS,/arxiv_data1/oa_pdf/ec/17/jiu396.PMC4264590.pdf
http://www.who.int/csr/disease/coronavirus_infections/ InterimGuidance_ClinicalManagement_NovelCoronavirus_11Feb13u.,Non-OADS,/arxiv_data1/oa_pdf/ec/17/jiu396.PMC4264590.pdf
http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_ C/1317139281416 .,Non-OADS,/arxiv_data1/oa_pdf/ec/17/jiu396.PMC4264590.pdf
http://www.crd.york.ac.uk/PROSPERO/ display_record.asp?ID=CRD42013005091 .,Non-OADS,/arxiv_data1/oa_pdf/ec/17/jiu396.PMC4264590.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2123–2132Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2123OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6414 0The healthy Aging Brain Care (hABC) Monitor:  validation of  the Patient self-report Version of  the clinical tool designed to measure and monitor  cognitive, functional, and psychological health Patrick O Monahan1 Catherine A Alder2–4 Babar A Khan1–3 Timothy stump1 Malaz A Boustani1–4 1Indiana University school  of Medicine, Indianapolis, In , UsA;   2Indiana University Center for  Aging research, Indianapolis, In ,   UsA; 3regenstrief Institute Inc.,   Indianapolis, In , UsA; 4eskenazi  health, Indianapolis, In , UsABackground:  Primary care providers need an inexpensive, simple, user-friendly, easily  standardized, sensitive to change, and widely available multidomain instrument to measure the  cognitive, functional, and psychological symptoms of patients suffering from multiple chronic  conditions.",Non-OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
"Keywords:  symptoms, monitor, validation, cognitive, psychological, functional Introduction Older adults attending primary care clinics have multiple chronic conditions that result  in a spectrum of cognitive, functional, and psychological symptoms.1–3 These  symptoms Correspondence: Malaz A Boustani regenstrief Institute Inc., 410 West  10th street, suite 2000, Indianapolis,  In 46202-3012, UsA Tel +1 317 423 5633 Fax +1 317 423 5695 email mboustan@iupui.ed u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Monahan et al Running head recto: The Healthy Aging Brain Care Monitor DOI: http://dx.doi.org/10.2147/CIA.S64140",Non-OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
A public website also hosts  our instrument ( http://www.agingbraincare.org/tools/habc- monitor/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
The HABC Monitor and scoring rules are available  at http://www.agingbraincare.org/tools/habc-monitor/ .,Non-OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
"Evaluating Cutoff Criteria of Model Fit Indices for Latent  V ariable Models with Binary and Continuous Outcomes  [dissertation],  University of California, Los Angeles; 2002: Available from:  http://www.statmodel.com/download/Yudissertation.pdf.",OADS,/arxiv_data1/oa_pdf/51/fe/cia-9-2123.PMC4264599.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cia-9-2113.PMC4264601.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2113–2122Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2113OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7273 1Perceived barriers and facilitators to increasing  physical activity among people with musculoskeletal  disorders: a qualitative investigation to inform  intervention development steven M McPhail1,2 Mandy schippers1,2 Alison l Marshall1 Monique Waite1,2 Pim Kuipers2,3 1Institute of health and Biomedical  Innovation and school of Public  health and social Work, Queensland  University of T echnology, 2Centre  for Functioning and health research,   Metro south health, 3griffith health  Institute and school of human  services and social Work, griffith  University, Brisbane, QlD, AustraliaPurpose:  Musculoskeletal conditions can impair people’s ability to undertake physical activity  as they age.",Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cia-9-2113.PMC4264601.pdf
"Keywords:  exercise, pain, comorbidity, lifestyle, sedentary, behavior Introduction Physical inactivity has been identified by the World Health Organization as the fourth  leading risk factor for mortality globally.1 In addition to mortality, insufficient physi - cal activity has substantial negative personal, economic, and social impacts.2,3 There  is an increasing burden of musculoskeletal disorders among increasingly sedentary  and aging populations.4–9 In contrast, benefits of physical activity include improved Correspondence: steven M McPhail Centre for Functioning and health  research, PO Box 6053, Buranda,  Brisbane, QlD 4102, Australia Tel +61 7 3406 2266 Fax +61 7 3406 2267 email steven.mcphail@qut.edu.a u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: McPhail et al Running head recto: Increasing physical activity among people with musculoskeletal disorders DOI: http://dx.doi.org/10.2147/CIA.S72731",Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cia-9-2113.PMC4264601.pdf
Available from: http://www.medibank.com.au/Client/Documents/Pdfs/ pyhsical_inactivity.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cia-9-2113.PMC4264601.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cia-9-2113.PMC4264601.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d2/e9/cia-9-2113.PMC4264601.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/f3/cia-9-2133.PMC4264602.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2133–2141Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2133OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7338 8Predictors of improved functional outcome  in elderly inpatients after rehabilitation:  a retrospective study Koji naruishi1,2 Akiko Kunita3 Katsuyuki Kubo1,2 T oshihiko nagata4 shogo Takashiba2,5 seiji Adachi1 1Division of local Care Center,   T ottori Municipal hospital, T ottori,   Japan; 2Department of Periodontics  and endodontics, Okayama University  hospital, Okayama, Japan; 3Division  of rehabilitation, Tottori Municipal  hospital, T ottori, Japan; 4Department  of Periodontology and endodontology,   Institute of health Biosciences,   Tokushima University graduate  school, T okushima, Japan; 5Department  of Pathophysiology-Periodontal  science, Okayama University  graduate school of Medicine,   Dentistry and Pharmaceutical  sciences, Okayama, JapanPurpose:  The number of elderly inpatients has been steadily increasing worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ba/f3/cia-9-2133.PMC4264602.pdf
"An increase of the elderly population  may weaken the country’s economic strength, and it may also force changes in the  framework of social welfare, such as medical expenses.1,2Correspondence: Koji naruishi Department of Periodontics, Tokushima  University hospital, 2-50-1 Kuramoto,  Tokushima 770-8503, Japan Tel +81 88 631 3111 Fax +81 88 633 7009 email naruishi@tokushima-u.ac.j p Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Naruishi et al Running head recto: Predictors of improved function in elderly DOI: http://dx.doi.org/10.2147/CIA.S73388",Non-OADS,/arxiv_data1/oa_pdf/ba/f3/cia-9-2133.PMC4264602.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ba/f3/cia-9-2133.PMC4264602.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ba/f3/cia-9-2133.PMC4264602.pdf
Available at http://www.endoﬂifecare-intelligence.org.uk/resources/ publications/deaths_in_older_adults Last accessed 6 January 2014.,Non-OADS,/arxiv_data1/oa_pdf/e6/0f/dme0031-0606.PMC4264938.pdf
"The Clinical Practice Research Datalink - CPRD 2012, 30 August 2012; Available from: http://www.cprd.com/intro.asp Last accessed 6 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/e6/0f/dme0031-0606.PMC4264938.pdf
Available from http://www.ipcc.ch/report/ar5/wg1 (accessed October 2013).,OADS,/arxiv_data1/oa_pdf/cf/aa/cobi0028-1206.PMC4264944.pdf
Available from http://www.oceansatlas.org/ (accessed June 2012).,Non-OADS,/arxiv_data1/oa_pdf/cf/aa/cobi0028-1206.PMC4264944.pdf
"Images wereacquired and processed using ImageCell (Mauna KeaTechnologies), Adobe Photoshop (USA), or ImageJsoftware (downloadable from http://imagej.nih.gov/ij/),running on Apple Mac G5 or Powerbook computers.",OADS,/arxiv_data1/oa_pdf/76/6b/acn30001-0867.PMC4265058.pdf
Available at: http://www.ncdc.,Non-OADS,/arxiv_data1/oa_pdf/51/a1/acn30001-0921.PMC4265063.pdf
Volumetry was performed using the Advanced Normal- ization Tools (ANTs) software package (http://www.picsl.upenn.edu/ANTS) followed by manual correction usingITK-Snap software tools.,OADS,/arxiv_data1/oa_pdf/50/b6/acn30001-0933.PMC4265065.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005660).,Non-OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
2012. http://publications.nice.org.uk/the-guidelines-manual-pmg6 (accessed 29 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
"London: National Institute for Health and Clinical Excellence, 2012. http://www.nice.org.uk 30.",Non-OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
"Canberra:NHMRC, 2003:95. http://www.nhmrc.gov.au/publications/synopses/cp65syn.htm (accessed 20 Jan 2013).",OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
"Geneva, Switzerland: WHO Press, 2012. http://www.who.int 33.",Non-OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
http://www.sign.ac.uk/guidelines/fulltext/50/ index.html (accessed 29 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
http://mdm.ca/cpgsnew/cpgs/gccpg-e.htm(accessed 29 Oct 2013).,OADS,/arxiv_data1/oa_pdf/38/ba/bmjopen-2014-005660.PMC4265087.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005813).,Non-OADS,/arxiv_data1/oa_pdf/0a/d7/bmjopen-2014-005813.PMC4265088.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005927).,Non-OADS,/arxiv_data1/oa_pdf/7a/35/bmjopen-2014-005927.PMC4265094.pdf
"Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure .pdf and declare: all authors had financial support from Tekes (The Finnish Funding Agency for Innovation) for the submitted work; EH, JP and IK report research grant fromFirstbeat Technologies Ltd, during the conduct of the study, and they also report other research grant from Firstbeat Technologies Ltd, outside the submitted work; and IK is a co-founder in PulseOn Ltd, which is a company developing optical heart rate monitoring technology, http://www.pulseon.com Ethical approval This study was approved by the Ethics Committee of Tampere University Hospital (Reference No R13160).",Non-OADS,/arxiv_data1/oa_pdf/7a/35/bmjopen-2014-005927.PMC4265094.pdf
"Jyväskylä, Finland: University of Jyväskylä; 2003. https://jyx.jyu.fi/dspace/bitstream/handle/123456789/13267/951391707X.pdf?sequence=1 27.",Non-OADS,/arxiv_data1/oa_pdf/7a/35/bmjopen-2014-005927.PMC4265094.pdf
2 Dec 2008. http://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=7460901B2&KC=B2&FT=D&ND=4&date=20081202&DB=EPODOC&locale=fi_FI 28.,Non-OADS,/arxiv_data1/oa_pdf/7a/35/bmjopen-2014-005927.PMC4265094.pdf
"United States patent US 7,330,752 B2.12 Feb 2008. http://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20080212&DB=EPODOC&locale=fi_FI&CC=US&NR=7330752B2&KC=B2&ND=4 29.",OADS,/arxiv_data1/oa_pdf/7a/35/bmjopen-2014-005927.PMC4265094.pdf
"Published Feb 2005, updated March 2012. http://www.firstbeat.com/userData/firstbeat/download/ white_paper_vo2_estimation.pdf 12 Mutikainen S, et al.BMJ Open 2014; 4:e005927.",OADS,/arxiv_data1/oa_pdf/7a/35/bmjopen-2014-005927.PMC4265094.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006174).,Non-OADS,/arxiv_data1/oa_pdf/62/6d/bmjopen-2014-006174.PMC4265095.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/62/6d/bmjopen-2014-006174.PMC4265095.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006350).,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
http://www.who.int/mediacentre/news/ statements/2009/h1n1_pandemic_phase6_20090611/en/index.html (accessed 20 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
http://mohfw-h1n1.nic.in/August2010.html(accessed 20 Feb 2014).7.,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
"The Indian Express, 4 August 2009. http://indianexpress.com/article/news-archive/web/first-india-h1n1-death-is-girl-in-pune/ 8.",Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
http://www.censusindia.gov.in/pca/default.aspx (accessed 10 Feb 2014).,OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
http://mohfw-h1n1.nic.in/documents/PDF/ayush.pdf (accessed 20 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
http://mohfw-h1n1.nic.in/documents/PDF/Strategic%20Approach.pdf (accessed 22 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
http://mohfw-h1n1.nic.in/documents/PDF/Annexure%20XXIII.pdf(accessed 22 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
"The Hindu, 30 July 2010. http://www.thehindu.com/news/national/second-wave-of-swine-flu-hits-pune/article542400.ece 47.",Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/ (accessed 20 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
29 December 2013. http://timesofindia.indiatimes.com/city/pune/More-deaths-cases-of-swine-flu-in-2013-virus-still-prevalent/articleshow/28067230.cms 49.,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
20 August 2014. http://timesofindia.indiatimes.com/city/pune/Four-swine-flu-patients-critical/articleshow/40437983.cms 50.,Non-OADS,/arxiv_data1/oa_pdf/53/20/bmjopen-2014-006350.PMC4265096.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006587).,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
Further information on thislarger study is available here: http://5cpa.com.au/programs/research-and- development.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
2014. http://5cpa.com.au/programs/research-and-development/current-projects/consumer-needs/ 6.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
2005. http://www.guild.org.au/services-programs/research-and-development/archive —third- agreement/2005-501 7.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
2014. http://www.dispensinghealth.org/wp-content/uploads/2014/01/DH-Launch-FINA1.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
2014. http://www.pharmacists.ca/index.cfm/news-events/events/pharmacist-awareness-month-pam/ (accessed 15 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
Forefront 2014;4. http://guild.org.au/news-events/forefront/volume-4-number-39/campaign-update 10.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
2011. http://www.pharmacyresearchuk.org/waterway/wp-content/uploads/2012/11/Patient_centred_professionalism_in_newly_registered_pharmacists.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
2011. http://www.safetyandquality.gov.au/wp-content/uploads/2012/03/PCC_Paper_August.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
2014. http://www.guild.org.au/docs/default-source/public-documents/issues-and-resources/pharmacy-services-expectations-survey-report-april-20141ed28133c06d6d6b9691ff000026bd16.pdf?sfvrsn=0 48.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/bmjopen-2014-006587.PMC4265097.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006460).,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
"London: Overseas DevelopmentInstitute, 2006. http://www.odihpn.org/documents/networkpaper055.",Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
2000. http://www.odi.org.uk/resources/details.asp?id=252&title=politics-principles-humanitarian-action-practice(accessed 31 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
http://www.redcross.,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
"Geneva, 2004. http://www.spherehandbook.org (accessed 28 Dec 2013).",Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
"Geneva: IFRC, 1994. http://www.ifrc.org/Global/Publications/disasters/WDR/43800-WDR2003_En.pdf (accessed 13 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
http://www.hapinternational.org/pool/files/2010-hap-standard-in-accountability.pdf (accessed 31Mar 2014).,OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
2006. http://www.odi.,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
http://www.msf-crash.org/livres/en/humanitarian-negotiations-revealed (accessed 23 Mar2014).,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
http://www.dndi.org (accessed 23 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
Humanitarian Exchange Magazine 2010;48. http://www.odihpn.org/humanitarian- exchange-magazine/issue-48/mobile-field-hospitals-in-the-haiti-earthquake-response-a-red-cross-model (accessed 23 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
Humanitarian Exchange Magazine 2010;46. http://www.odihpn.org/humanitarian-exchange-magazine/issue-46/preparing-humanitarian-workers-for-disaster-response-a-red-cross/red-crescent-field-training-model (accessed 23 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/15/87/bmjopen-2014-006460.PMC4265098.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006199).,Non-OADS,/arxiv_data1/oa_pdf/a0/ad/bmjopen-2014-006199.PMC4265099.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjdrc-2014- 000040).,Non-OADS,/arxiv_data1/oa_pdf/ed/f8/bmjdrc-2014-000040.PMC4265121.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/f8/bmjdrc-2014-000040.PMC4265121.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006544).,Non-OADS,/arxiv_data1/oa_pdf/ba/f9/bmjopen-2014-006544.PMC4265124.pdf
https://sites.google.com/a/york.ac.uk/issg-search-filters-resource/filters-to-identify-qualitative-research 25.,Non-OADS,/arxiv_data1/oa_pdf/ba/f9/bmjopen-2014-006544.PMC4265124.pdf
"To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjresp-2014- 000056) LS, YH and YZ contributed equally.",Non-OADS,/arxiv_data1/oa_pdf/d9/31/bmjresp-2014-000056.PMC4265126.pdf
"First, we obtained information about the predicted potential biomarkers that corresponded to the exactmolecular mass data (m/z) from signi ﬁcant peaks pro- vided from high-resolution LTQ Orbitrap mass spec- trometry by searching the Metlin database (http://metlin.scripps.edu) and HMDB database (http://www.",OADS,/arxiv_data1/oa_pdf/d9/31/bmjresp-2014-000056.PMC4265126.pdf
http://www.cdc.gov/nchs/data/series/ sr_01/sr01_032.pdf (accessed 15 Oct 2014).,OADS,/arxiv_data1/oa_pdf/8c/cd/bmjopen-2014-006491.PMC4265136.pdf
doi:10.1136/ bmjopen-2014-006327 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006327).,Non-OADS,/arxiv_data1/oa_pdf/8a/59/bmjopen-2014-006327.PMC4265137.pdf
1998 [cited 28 Nov 2013] 61. http://althingi.is/lagas/nuna/1998061.html 29.,Non-OADS,/arxiv_data1/oa_pdf/8a/59/bmjopen-2014-006327.PMC4265137.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/8f/syu048.PMC4265139.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/0b/syu053.PMC4265140.pdf
"2012 ) generated lots of survey, metagenome, and whole-genome sequencing data and these data are available ona dedicated website ( http://www.hmpdacc.org/).",OADS,/arxiv_data1/oa_pdf/3b/0b/syu053.PMC4265140.pdf
[14:11 8/12/2014 Sysbio-syu053.tex] Page: e29 e26–e412014 MATSEN—PHYLOGENETICS AND THE HUMAN MICROBIOME e29 sampled from the environment and grown in culture (http://www.fda.gov/Food/FoodScienceResearch/WholeGenomeSequencingProgramWGS/).,Non-OADS,/arxiv_data1/oa_pdf/3b/0b/syu053.PMC4265140.pdf
The uBiome ( http://ubiome.com/) and American Gut (http://americangut.org/) projectspromise to bring gut microbiome sequencing to theaverage citizen for a low price.,Non-OADS,/arxiv_data1/oa_pdf/3b/0b/syu053.PMC4265140.pdf
http://arxiv.org/abs/1404.1029.,Non-OADS,/arxiv_data1/oa_pdf/3b/0b/syu053.PMC4265140.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"A short account of the provisional taxonomy is given inSupplementary Appendix 1 (see online Appendix 1,http://dx.doi.org/10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"We sampled 42species (Supplementary Table S1, http://dx.doi.org/10.5061/dryad.jc754) that represent all 16 tentativesections of Viola (Table 1).",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"Further details about primer sequences, PCR protocols,and alignment procedures are given in SupplementaryAppendix 2 see online Appendix 2, http://dx.doi.org/ 10.5061/dryad.jc754.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"Data for a total of 55 species were included (Supplementary Table S3, http://dx.doi.org/ 10.5061/dryad.jc754), obtained mainly from the studiesofYoo and Jang (2010 ),Liang and Xing (2010 ), and Burgess et al.",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"Parsimony evaluation of ﬁve HOLM phylogenetic networks (A-E; Supplementary Table S4, http://dx.doi.org/10.5061/dryad.jc754) for Viola Section Erpetion Section T ridens (1) Inferred (2) Sum (3) Undetected (3) Undetected ghost poly- Inferred Actual poly- Inferred Actual poly- Parsimony Scenario Lineages lineages ploidizations ploidy ploidy ploidizations ploidy ploidy ploidizations score A1 0 6 6 x 10x 28 x 12x 21 0 B2 0 9 8 x 10x 11 2 x 12x 01 0 C 2 1: Erpetion1 9 10 x 10x 01 2 x 12x 01 0 D 2 1: Chilenium3 9 8 x 10x 11 2 x 12x 01 1 E 2 2: Chilenium3, Erpetion1 7 10 x 10x 01 2 x 12x 09 Notes: The corresponding multilabeled trees are shown in Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"The networks corresponding to scenario E is shown in Figure 4; networks for scenarios A–D are shown in SupplementaryTable S4, http://dx.doi.org/10.5061/dryad.jc754.",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S1–S4, http://dx.doi.org/10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S2,http://dx.doi.org/10.5061/dryad.jc754) compared with NRPD2a (Supplementary Fig.",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S3, http://dx.doi.org/ 10.5061/dryad.jc754) and SDH (Supplementary Fig.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S4, http://dx.doi.org/10.5061/dryad.jc754), indicatingeither deep coalescence (Fig.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S2–S4,http://dx.doi.org/10.5061/dryad.jc754), but containednumerous well-supported lineages.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S1–S4, http://dx.doi.org/10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S5–S8, http://dx.doi.org/ 10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S2–S4, http://dx.doi.org/10.5061/dryad.jc754).The topologies were similar to those obtained withMrBayes (Supplementary Figs.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S1–S4, http://dx.doi.org/10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S9, http://dx.doi.org/10.5061/dryad.jc754), tmrca of Viola , produced phylogenies that differed considerably from the fossil-constrained ones (Supplementary Figs.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S5–S8, http://dx.doi.org/10.5061/dryad.jc754) and the unconstrainedMrBayes phylogenies (Supplementary Figs.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S1–S4,http://dx.doi.org/10.5061/dryad.jc754): (i) The ageof the polytomious CHAM and MELVIO clades werevariably 5–10 Ma younger.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S1–S4, http://dx.doi.org/10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S1–S4,http://dx.doi.org/10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S2–S4,http://dx.doi.org/10.5061/dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"2A–E) are listed in Table 2, and were calculated based on the following criteria, (i) fewest gene lossevents, (ii) fewest polyploidizations as identiﬁed usingthe HOLM algorithm, and (iii) minimum deviationfrom expected ploidy levels in the affected polyploids.The corresponding HOLM networks (A–E) are shownin Supplementary Table S4, http://dx.doi.org/10.5061/ dryad.jc754.",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S10;P1 and P2, http://dx.doi.org/10.5061/dryad.jc754).",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S3,http://dx.doi.org/10.5061/dryad.jc754), as it was onestep more parsimonious to interpret it as a paralogthan as a homoeolog (i.e., paralogization versuspolyploidization +extinction in the second parental clade); frameshift mutations and premature stop codonssuggested this was a pseudogene.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"The multigene coalescent model returned species node ages on average 0.48 Ma(SD 0.26, min 0.15, max 1.26) younger than theyoungest corresponding allele split in the threegene trees (Supplementary Table S5, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S11 and Supplementary Table S6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S2–S4, http://dx.doi.org/ 10.5061/dryad.jc754) and the failure to detectall homoeologs for all lineages (Fig.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S9, http://dx.doi.org/10.5061/ dryad.jc754).",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S1–S10, http://dx.doi.org/ 10.5061/dryad.jc754) which implies that the numberof polyploidizations in this lineage could rangefrom one (invoking parsimony) to seven (asreconstructed by the Holm algorithm; Huber et al.",OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S10,http://dx.doi.org/10.5061/dryad.jc754), i.e., onetetraploidization putatively shared by sects.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
"S UPPLEMENTARY MATERIAL Supplementary material, including data ﬁles and online-only appendices, can be found in the Dryad datarepository at http://dx.doi.org/10.5061/dryad.jc754.",Non-OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
Alignment ﬁles and tree ﬁles can in addition be found inthe Treebase data repository at http://purl.org/phylo/treebase/phylows/study/TB2:S15248.,OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
Available from: http://beast.bio.ed.ac.uk/Tracer.,OADS,/arxiv_data1/oa_pdf/06/32/syu071.PMC4265142.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005360).,Non-OADS,/arxiv_data1/oa_pdf/ba/b6/bmjopen-2014-005360.PMC4265146.pdf
Pediatr Pharmacother July 2003;9:7. http://www.medscape.com/viewarticle/ 460500 32.,Non-OADS,/arxiv_data1/oa_pdf/ba/b6/bmjopen-2014-005360.PMC4265146.pdf
"New York, 2001. http://www.un.org/esa/population/publications/ worldageing19502050/ 3.",Non-OADS,/arxiv_data1/oa_pdf/37/d0/openhrt-2014-000177.PMC4265147.pdf
http://www.abs.gov.au/ausstats/abs@.nsf/Products/3235.0~2009~Main+Features~Western+Australia 19.,Non-OADS,/arxiv_data1/oa_pdf/37/d0/openhrt-2014-000177.PMC4265147.pdf
"Australian Bureau of Statistics 3101.0 —Australian Demographic Statistics, June 1990 PDF http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%201990 20.",Non-OADS,/arxiv_data1/oa_pdf/37/d0/openhrt-2014-000177.PMC4265147.pdf
3302.0 http://www.abs.gov.au/ausstats/abs@.nsf/Products/3302.0~2010~Chapter~Main+Features?OpenDocument 23.,Non-OADS,/arxiv_data1/oa_pdf/37/d0/openhrt-2014-000177.PMC4265147.pdf
"United Nations, New York 2009. http://www.un.org/esa/population/publications/WPA2009/WPA2009_ WorkingPaper.pdf 33.",Non-OADS,/arxiv_data1/oa_pdf/37/d0/openhrt-2014-000177.PMC4265147.pdf
"Funding This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (http://www.ctmm.nl), projectPREDICCt (grant 01C-104) and supported by the Netherlands Heart Foundation, Dutch Diabetes Research Foundation, and Dutch Kidney Foundation.",Non-OADS,/arxiv_data1/oa_pdf/a8/fa/bmjdrc-2014-000034.PMC4265148.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006552).,Non-OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
"Geneva: WHO Press, 2008. http://www.who.int/tobacco/mpower/en/ (accessed Aug 2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
"Geneva: World Health Organization, 2003. http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
"Atlanta, GA: American Cancer Society, Inc, 2012. http://www.TobaccoAtlas.org(accessed Aug 2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
http://www.cmtabacos.es/wwwcmt/paginas/EN/ mercadoEstadisticas.tmpl (accessed Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
http://www.cmtabacos.es/wwwcmt/ verEstadistica.php?a=2008&f=2008_comun-u (accessed Aug 2014).,OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
http://www.cmtabacos.es/wwwcmt/ verEstadistica.php?a=2009&f=2009_comun-u (accessed Aug 2014).,OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
http://www.ine.es/en/inebmenu/mnu_cifraspob_en.htm (accessed Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/ba/64/bmjopen-2014-006552.PMC4265149.pdf
National Center for Chronic Disease Prevention and Health Promotion Division for Heart Disease and Stroke Prevention Factsheet; http://www.cdc.gov/salt/pdfs/Sodium_Fact_Sheet.pdf(accessed 28 Sep 2013).,OADS,/arxiv_data1/oa_pdf/fc/ba/bmjopen-2014-006671.PMC4265150.pdf
"GSK Clinical Study Register, Available at : http://www.gsk-clinicalstudyregister.",Non-OADS,/arxiv_data1/oa_pdf/1c/3a/pds0023-0321.PMC4265189.pdf
These data are produced every 4 h and are acces-sible at the web page http://www.nrlmry.navy.mil/aerosol/#aerosolobservations.,OADS,/arxiv_data1/oa_pdf/46/55/pce0037-1810.PMC4265192.pdf
The weekly number of clinical inﬂuenza cases reported by sentinels.Available at: http://www.iph.pref.osaka.jp/infection/2-old.,Non-OADS,/arxiv_data1/oa_pdf/94/7a/liv0034-0700.PMC4265193.pdf
2012. http://www.meddramsso.com/ (accessed 21 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/pds0023-0456.PMC4265196.pdf
1998. http://www.cioms.ch/publications/g4-bene ﬁt- risk.pdf (accessed 21 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/pds0023-0456.PMC4265196.pdf
December 2012. http://www.mhra.gov.uk/PrintPreview/DefaultSplashPP/CON023340?ResultCount=10&DynamicListQuery=&DynamicListSortBy=xCreationDate&DynamicLis-tSortOrder=Desc&DynamicListTitle=&PageNumber=1&Title=Human%20papillomavirus%20(HPV)%20vaccine (accessed 17 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/pds0023-0456.PMC4265196.pdf
2010. http://www.eurosurveillance.org/viewarticle.aspx?ArticleId=19730(accessed 7 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/pds0023-0456.PMC4265196.pdf
2012. http://yellowcard.mhra.gov.uk/(accessed 17 January 2012).,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/pds0023-0456.PMC4265196.pdf
http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Product-speci ﬁcinformationandadvice/Prod- uct-speci ﬁcinformationandadvice-G-L/HumanpapillomavirusHPVvaccine/in- dex.htm (accessed 17 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/pds0023-0456.PMC4265196.pdf
"http://www.who.int/water_sanitation_health/dwq/iwachap13.pdf (accessed September 6, 2013).",Non-OADS,/arxiv_data1/oa_pdf/37/88/gwat0052-0126.PMC4265197.pdf
"7.1. http://pubs.water.usgs.gov/twri9A7/ (accessed April 2, 2012).",OADS,/arxiv_data1/oa_pdf/37/88/gwat0052-0126.PMC4265197.pdf
"http://www.R-project.org/ (accessed September 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/37/88/gwat0052-0126.PMC4265197.pdf
"http://dhhs.ne.gov/publichealth/Documents/TheGroutStudy.pdf (accessed August 28, 2013).",OADS,/arxiv_data1/oa_pdf/37/88/gwat0052-0126.PMC4265197.pdf
EPA-821-R-09- 016. http://water.epa.gov/scitech/methods/cwa/bioindicato rs/upload/method_1600.pdf (accessed December 2009).,OADS,/arxiv_data1/oa_pdf/37/88/gwat0052-0126.PMC4265197.pdf
"Progress on sani- tation and drinking water, Update 2013. http://www.who.int/water_sanitation_health/publications/2013/jmp_report/en/index.html (accessed on September 6, 2013).World Health Organization (WHO).",Non-OADS,/arxiv_data1/oa_pdf/37/88/gwat0052-0126.PMC4265197.pdf
"Diarrheal disease, Factsheet 330, April 2013. http://www.who.int/mediacentre/factsheets/fs330/en/index.html (accessed onSeptember 6, 2013).",Non-OADS,/arxiv_data1/oa_pdf/37/88/gwat0052-0126.PMC4265197.pdf
"3) 1 –481, http://onlinelibrary.wiley.com/doi/10.1002/pds.3324/pdf.",Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
"15 In the context of a wider study to assess the implica- tions of the Internet in relation to medication access andsafety information for pregna ncy (http://euromedicat.eu/) and in the light of the ongoing need to review the effec- tiveness of the PPP for isotretinoin, this paper reports astudy to determine how readily consumers can purchase isotretinoin online and the associated safety procedures and information.",Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationa ndadvice/Product-speci ﬁcinformationandadvice/ Product-speci ﬁcinformationandadvice-G-L/Isotretinoinforsevereacne/index.htm [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://www.gao.gov/new.items/d04820.pdf [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://statcounter.com/ [9 September 2013].17.,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://blog.hubspot.com/blog/tabid/6307/bid/14416/100-Awesome-Marketing- Stats-Charts-Graphs-Data.aspx [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://vipps.nabp.net/ [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://www.hon.ch/ [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32001L0083:EN:NOT [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://www.pharmacopoeia.co.uk/ [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://drugs.about.com/od/costofdrugs/a/trust_online_rx.htm [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://ec.europa.eu/health/ ﬁles/eudralex/vol-1/dir_2011_62/ dir_2011_62_en.pdf [9 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
Available at: http://www.cdc.gov/ncbddd/preconception/documents/at-a-glance-4-11-06.pdf [9 September 2013].b.,Non-OADS,/arxiv_data1/oa_pdf/67/88/pds0023-0411.PMC4265198.pdf
"4,and the website (http://ips.iis.sinica.edu.tw/coral/)aimed to accommodate the needs of a greater cadre ofresearchers by considering a range of statistical strin- gency for each biological comparison of interest.",Non-OADS,/arxiv_data1/oa_pdf/d2/e3/mec0023-5816.PMC4265203.pdf
"Coral- trans-dbase (http://ips.iis.sinica.edu.tw/coral/), whichwas constructed in SQL ITE(ver.",OADS,/arxiv_data1/oa_pdf/d2/e3/mec0023-5816.PMC4265203.pdf
"Data accessibility The unassembled sequences reported herein have beendeposited in the Sequence Read Archive (SRA;http://www.ncbi.nlm.nih.gov/sra/SRX378204), whichis cross-referenced with the Transcriptome Shotgun Assembly database (www.ncbi.nlm.nih.gov/genbank/ tsa; BioProject PRJNA227785).",OADS,/arxiv_data1/oa_pdf/d2/e3/mec0023-5816.PMC4265203.pdf
"Also, an interactive web-site (http://ips.iis.sinica.edu.tw/coral) that is describedin the manuscript has been designed to serve as a perpet-ual depository for the sequence data set.",Non-OADS,/arxiv_data1/oa_pdf/d2/e3/mec0023-5816.PMC4265203.pdf
The webtool is freely available and can be accessed at http://cida.usgs.gov/gamactt/.,OADS,/arxiv_data1/oa_pdf/39/8d/gwat0052-0008.PMC4265208.pdf
"We provide MIAME-compliant description of themicroarray study, available in the arrayexpress database(http://www.ebi.ac.uk/arrayexpress), with accession num-ber E-MTAB-2170.",OADS,/arxiv_data1/oa_pdf/a7/27/mrd0081-0619.PMC4265210.pdf
"This study was funded by the EU-project LIFECYCLE(FP7222719, http://www.lifecycle.gu.se/, 19.12.2013).",Non-OADS,/arxiv_data1/oa_pdf/a7/27/mrd0081-0619.PMC4265210.pdf
Geneva: WHO; 2011. http://www.who.int/nmh/publications/ncd_ report_full_en.pdf .,OADS,/arxiv_data1/oa_pdf/25/0d/40119_2014_Article_31.PMC4265229.pdf
http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/d0/cb/ijcp0068-0609.PMC4265239.pdf
http://ec.europa.eu/enterprise/newsroom/cf/itemdetail.cfm?&item_id=897.,Non-OADS,/arxiv_data1/oa_pdf/d0/cb/ijcp0068-0609.PMC4265239.pdf
Tremor Other Hyperkinet Mov (N Y) http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/b2/10/ijcp0068-1514.PMC4265240.pdf
"This open-source program is freely downloaded from http://www.r-project.org and comes with the ‘rpart’ command package, enabling the generation of classiﬁcation and regression trees.",OADS,/arxiv_data1/oa_pdf/ca/6d/jan0070-1276.PMC4265242.pdf
"Author contributions All authors have agreed on the ﬁnal version and meet atleast one of the following criteria [recommended by the ICMJE (http://www.icmje.org/ethical_1author.html)]: substantial contributions to conception and design,acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for importantintellectual content.",Non-OADS,/arxiv_data1/oa_pdf/ca/6d/jan0070-1276.PMC4265242.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/ca/6d/jan0070-1276.PMC4265242.pdf
Available at: http://www.ema.europa.eu/docs/e n_GB/document_library/Scienti ﬁc_guideline/ 2009/09/WC500003658.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/25/hup0029-0470.PMC4265248.pdf
Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073122.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/25/hup0029-0470.PMC4265248.pdf
"Available on- line at: http://psycnet.apa.org/?&fa=main.doiLanding&doi=10.1037/1522-3736.5.1.523a Koesters M, Guaiana G, Cipriani A, Becker T, Barbui C. 2013.",OADS,/arxiv_data1/oa_pdf/d3/25/hup0029-0470.PMC4265248.pdf
Available at: http://guidance.nice.org.uk/CG90.,Non-OADS,/arxiv_data1/oa_pdf/d3/25/hup0029-0470.PMC4265248.pdf
Available at: http://www.ema.europa.e u/docs/en_GB/document_library/ EPAR_-_Product_Information/hum an/000915/WC500046227.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/25/hup0029-0470.PMC4265248.pdf
Avail- able at: http://eurlex.europa.eu/Lex-UriServ.do?uri=OJ: L:2001:121:0034:0044:en:PDF.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/nmo0026-1792.PMC4265251.pdf
Avail-able at: http://ich.org/.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/nmo0026-1792.PMC4265251.pdf
Available at: http://www.wma.net/en/30publications/10policies/b3/17c.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/nmo0026-1792.PMC4265251.pdf
Improved discovery success is being sought via col- laborative efforts such as the New Drugs For Bad Bugs (ND4BB) project sponsored in Europe un- der the aegis of the Innovative Medicines Initiative project (http://www.imi.europa.eu/).,Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
"The IDSA has even made this part of their call to arms, calling for 10 new agents by 2020 in their “10 ×20” campaign (http://www.idsociety.org/10x20/).",Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
"Key questions to be resolved include deﬁnitions of appropriate antibiotic stewardship (we lack a common language for these ideas and we also lack ready measures of progress toward the ill-deﬁned goal of better stewardship), best approaches to implementing stewardship on a broad scale (e.g., what lessons have been learned from the implemen- tation in 2010 of such a program in California for general acute care hospitals (http://www.cdph.ca.",Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
be approached via a multistakeholder consortium within the ND4BB project (http://www.imi.europa.,Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
http://www.cdc.gov/drug resistance/threat-report-2013/.,OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
http://www.ecdc.europa.eu/en/publicati ons/_layouts/forms/Publication _DispForm.aspx?ID =199& List=4f55ad51-4aed-4d32-b960-af70113dbb90.,Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/Guida nces/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/Guida nces/ucm064980.htm.,Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
http://www.fda.gov/ regulatoryinformation/guidances/ucm125126.htm.,Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
http://www.ohe.org/publications/article/new-drugs-to- tackle-antimicrobial-resistance-analysis-of-eu-policy- options-21.cfm.,Non-OADS,/arxiv_data1/oa_pdf/c0/9c/nyas1323-0011.PMC4265259.pdf
"http://www.karstwaters.org/kwitour/whatiskarst.htm (accessed June, 2012).",Non-OADS,/arxiv_data1/oa_pdf/40/31/gwat0052-0063.PMC4265260.pdf
"2010. http://2010.census.gov/ (accessed January, 2012).",OADS,/arxiv_data1/oa_pdf/40/31/gwat0052-0063.PMC4265260.pdf
"http://water.epa.gov/drink/contaminants/index.cfm(accessed October, 2013).",OADS,/arxiv_data1/oa_pdf/40/31/gwat0052-0063.PMC4265260.pdf
Seven papers on public-supply-well vulnerability to contamination at different spatial and temporal scales from a 10-year U.S. Geological Survey study of the transport of anthropogenic and natural contaminants to supply wells (http://oh.water.usgs.gov/tanc/NAWQATANC.htm) are included in this issue of Groundwater .,Non-OADS,/arxiv_data1/oa_pdf/ac/90/gwat0052-0003.PMC4265273.pdf
Kinase- speciﬁc assay conditions and data analyses are described ontheir Web site http://www.lifetechnologies.com/us/en/home/products-and-services/services/c ustom-services/screening-and- proﬁling-services/selectscreen-proﬁling-service/selectscreen-kinase- proﬁling-service.html.,OADS,/arxiv_data1/oa_pdf/41/e0/jvp0037-0317.PMC4265276.pdf
Available from URL: http://www.nhi.gov.tw 5.,Non-OADS,/arxiv_data1/oa_pdf/d6/f5/nep0019-0699.PMC4265277.pdf
"For thisanalysis, we used the public DAVID Bioinformatics database; http://david.abcc.ncifcrf.gov/ [40].",OADS,/arxiv_data1/oa_pdf/7c/19/ics0036-0253.PMC4265278.pdf
Published 2011. http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/ (Accessed 21 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/cd/56/pds0023-0240.PMC4265280.pdf
"July 2010. http://www.has-sante.fr/portail/upload/docs/application/ pdf/2010-07/synthese_ef ﬁcacite_et_ef ﬁcience_des_hypolipemiants_- _une_analyse_centree_sur_les_statines.pdf (accessed 28 January 2013) 55. de Lorgeril M, Salen P, Abramson J, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/56/pds0023-0240.PMC4265280.pdf
"These parameters were determined using SPM and a script(CorrClusTh.m, http://www2.warwick.ac.uk/fac/sci/statistics/staff/academic-res earch/nichols/scripts/spm), which uses estimated smoothn ess (estimated Full Width at Half Maximum: 3.56 33.6533.46 voxels) and Random Field Theory to ﬁnd these corrected thresholds.",OADS,/arxiv_data1/oa_pdf/8c/08/HBM-35-5578.PMC4265283.pdf
17. http://www.accessdata.fda.gov/cdrh_docs/pdf12/k122248.pdf accessed 5/1/14.,Non-OADS,/arxiv_data1/oa_pdf/83/42/lsm0046-0601.PMC4265291.pdf
"Most of the tri- tium data are in the USGS National Water Information System database (http://waterdata.usgs.gov/ut/nwis/qw/).Additional data are contained in the papers by Manning (2002), Thiros (2003), and from USGS sites reported by University of Utah and Lamont-Doherty Earth Observa-tory.",OADS,/arxiv_data1/oa_pdf/c5/e2/gwat0052-0053.PMC4265292.pdf
"Continued Health State Costs Mean Standard Error PSA Distribution Source HCC 38,871 9410.46 LT 69,174 7054.86Post-LT 4,356 861.57 Treatment Costs Treatment Cost Source Genotype 1: treatment na €ıve Peg-IFN- a-2a and RBV/TVR 32,809 British National Formulary 64 http://www.bnf.org/bnf/index.htm Genotype 1: treatment na €ıve Peg-IFN- a-2b and RBV/BOC 33,270 Genotype 1: patients with cirrhosis Peg-IFN- a-2b and RBV/BOC 41,670 Genotypes 2 and 3 Peg-IFN- a-2a and RBV 4,446 Genotypes 2 and 3 Peg-IFN- a-2b and RBV 5,435 Genotype 4 Peg-IFN- a-2a and RBV 10,411 Genotype 4 Peg-IFN- a-2b and RBV 10,870 Utilities Mean Standard Error PSA Distribution Source Without treatment with antiviral agents Mild ﬁbrosis 0.77 0.035 Beta Wright et al.27 Moderate ﬁbrosis 0.66 0.018Compensated cirrhosis 0.55 0.032 Decompensated cirrhosis 0.49 0.056 Longworth et al.",Non-OADS,/arxiv_data1/oa_pdf/05/85/hep0060-0832.PMC4265295.pdf
"Then, the bar code sequences were removed by a customized perl script, and the resulting sequences were alignedto the reference sequences of the relevant rice genes using Bowtie 2.0 (a software tool which aligns NGS data with reference sequences, http://bowtie-bio.sourceforge.net/bowtie2/index.shtml).The data ﬁles were converted into ‘bam’ format to allow sortingand pile-up analyses using the software package SAMtools (http:// samtools.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/b5/34/pbi0012-0709.PMC4265296.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/73/68/mec0022-5848.PMC4265302.pdf
Guidelines for this purpose have been released by the American Food and Drug Administration (http://www.fda .gov/downloads/Drugs/Guidances/ucm070107.pdf).,Non-OADS,/arxiv_data1/oa_pdf/ae/4b/pmic0014-0441.PMC4265304.pdf
"These criteria are approaching the threshold set by the Food and Drug Ad- ministration for small molecules, where the CV at LLOQ should not exceed 20% (http://www.fda.gov/downloads/ Drugs/Guidances/ucm070107.pdf).",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/pmic0014-0441.PMC4265304.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/dd/ehu305.PMC4265383.pdf
http://dx.doi.org/10.1016/j.jare.2012.01.001,OADS,/arxiv_data1/oa_pdf/83/1b/main.PMC4265671.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/2693.PMC4265673.pdf
Corresponding authors: jchen8@mdanderson.org; zgong@mdanderson.org Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.252478.114.,OADS,/arxiv_data1/oa_pdf/d8/b1/2693.PMC4265673.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3f/94/2699.PMC4265674.pdf
Corresponding author: ja.mitchell@utoronto.ca Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.248526.114.,Non-OADS,/arxiv_data1/oa_pdf/3f/94/2699.PMC4265674.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a6/2a/2712.PMC4265675.pdf
ac.uk Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.247528.114.,Non-OADS,/arxiv_data1/oa_pdf/a6/2a/2712.PMC4265675.pdf
"They each divide five more times (DIV5–9) asa monolayer on the follicle surface before a majorregulatory event, the mitotic/endocycle (M–E) transi- tion, terminates proliferation and initiates differentia- /C2112014 Lee and Spradling This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/0b/13/2739.PMC4265677.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.Corresponding author: spradling@ciwemb.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.252692.114.",Non-OADS,/arxiv_data1/oa_pdf/0b/13/2739.PMC4265677.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/17/c0/2750.PMC4265678.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Corresponding authors: jlw@stowers.org, sma@stowers.org Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.249730.114.",Non-OADS,/arxiv_data1/oa_pdf/17/c0/2750.PMC4265678.pdf
RNA-seq data are available in the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-2521.,OADS,/arxiv_data1/oa_pdf/17/c0/2750.PMC4265678.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b2/a6/2764.PMC4265679.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.Corresponding authors: omelchet@mskcc.org, halla@mskcc.org Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.251371.114.",Non-OADS,/arxiv_data1/oa_pdf/b2/a6/2764.PMC4265679.pdf
Genomic information on mouseArhgef7 was obtained from the NCBI (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/b2/a6/2764.PMC4265679.pdf
gov) and Ensemble (ENSMUSG00000031511; http://www.useast.,OADS,/arxiv_data1/oa_pdf/b2/a6/2764.PMC4265679.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 773 Korean J Urol 2014;55:773-774http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.773&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.773 Editorial Report of the Korean Journal of Urology   Editorial Board Meeting 2014 FIG.",Non-OADS,/arxiv_data1/oa_pdf/bf/8f/kju-55-773.PMC4265709.pdf
There were also many changes to the KJU website  (http://www.kjurology.org).,Non-OADS,/arxiv_data1/oa_pdf/bf/8f/kju-55-773.PMC4265709.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 775 Korean J Urol 2014;55:775-779http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.775&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.775 Review Article Medical and Dietary Therapy for Kidney Stone Prevention Zeynep Gul, Manoj Monga1 Case Western Reserve University Sc hool of Medicine, Cleveland, OH, 1The Cleveland Clinic, Glickman Ur ological and Kidney Institute,  Cleveland, OH, USA The prevalence of kidney stone disease is in creasing, and newer research is finding that  stones are associated with several serious morbidities.",Non-OADS,/arxiv_data1/oa_pdf/f7/4a/kju-55-775.PMC4265710.pdf
"Keywords:  Diet therapy; Drug therapy; Ki dney calculi; Nephrolithiasis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 July, 2014 accepted 11 August, 2014 Corresponding Author: Manoj Monga Stevan B. Streem Center for Endourology & Stone Disease,  Glickman Urological & Kidney  Institute, The Cleveland Clinic Foundation, 9500 Euclid  Avenue/Q10-1, Cleveland, OH  44195, USATEL: +1-216-445-8678 FAX: +1-216-636-0770 E-mail: mongam@ccf.org TABLE  1.",Non-OADS,/arxiv_data1/oa_pdf/f7/4a/kju-55-775.PMC4265710.pdf
Available from:  https://www.auanet.org/univers ity/abstract_detail.cfm?id =2147&meetingID=11WAS.,Non-OADS,/arxiv_data1/oa_pdf/f7/4a/kju-55-775.PMC4265710.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 780 Korean J Urol 2014;55:780-788http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.780&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.780 Review Article Current Status of Cryotherapy for Prostate and Kidney Cancer Seok Cho, Seok Ho Kang Department of Urology, Korea Univ ersity Anam Hospital, Seoul, Korea In terms of treating diseas es, minimally invasive treatment has become a key element  in reducing perioperative co mplications.",Non-OADS,/arxiv_data1/oa_pdf/a1/26/kju-55-780.PMC4265711.pdf
"Keywords:  Cryotherapy; Kidney; Neoplasm; Prostate This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 21 May, 2014 accepted 2 October, 2014 Corresponding Author: Seok Ho KangDepartment of Urology, Korea  University Anam Hospital, 73  Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea TEL: +82-2-920-5367 FAX: +82-2-928-7864E-mail: mdksh@korea.ac.kr INTRODUCTION Low temperature as a treatment method has been used in  medicine for a long time for it s anesthetic effect.",Non-OADS,/arxiv_data1/oa_pdf/a1/26/kju-55-780.PMC4265711.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 789 Korean J Urol 2014;55:789-796http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.789&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.789 Review Article Overview of Pediatric Testicular Tumors in Korea Jae Min Chung, Sang Don Lee Department of Urology, Pusan National University School of Medicine, Yangsan, Korea Prepubertal testicular tumors are rare compared with post pubertal testicular tumors.",Non-OADS,/arxiv_data1/oa_pdf/b8/6f/kju-55-789.PMC4265712.pdf
"Keywords:  Child; Pediatrics; Testicular germ  cell tumor; Testicular neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 3 July, 2014 accepted 28 October, 2014 Corresponding Author: Sang Don Lee Department of Urology, Pusan National University Yangsan  Hospital, 20 Geumo-ro,  Mulgeum-eup, Yangsan 626-770, Korea TEL: +82-55-360-2671 FAX: +82-55-360-2164E-mail: lsd@pusan.ac.kr INTRODUCTION Testicular tumors are rare in children compared with those  occurring postpubertally or with other genitourinary tu- mors in childhood such as Wi lms’ tumor.",Non-OADS,/arxiv_data1/oa_pdf/b8/6f/kju-55-789.PMC4265712.pdf
Available from: http://www.pediatricurologybook.com/tumors.html.,Non-OADS,/arxiv_data1/oa_pdf/b8/6f/kju-55-789.PMC4265712.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 797 Korean J Urol 2014;55:797-801http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.797&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.797 Original Article - Urological Oncology Histologic Variability and Diverse Oncologic Outcomes of Prostate  Sarcomas Mooyoung Sohn, Taekmin Kwon, In Gab Jeong, Sungwoo Hong1, Dalsan You, Jun Hyuk Hong,  Hanjong Ahn, Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 1Department of Urology, Dankook University  College of Medicine, Cheonan, Korea Purpose:  Primary prostate sarcomas are a rare type of prostate cancer that account  for less than 0.1% of primary prostate malignancies.",Non-OADS,/arxiv_data1/oa_pdf/b0/34/kju-55-797.PMC4265713.pdf
"Keywords:  Liposarcoma; Prostate; Rhabdomyosarcoma; Sarcoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 4 August, 2014 accepted 11 September, 2014 Corresponding Author: Choung-Soo Kim Department of Urology, Asan  Medical Center, University of Ulsan College of Medicine, 88  Olympic-ro 43-gil, Songpa-gu,  Seoul 138-736, KoreaTEL: +82-2-3010-3734 FAX: +82-2-477-8928 E-mail: cskim@amc.seoul.kr INTRODUCTION Soft tissue sarcomas make up less than 1% of all cancers,  and less than 5% of these lesi ons occur in the genitourinary  tract [1-3].",Non-OADS,/arxiv_data1/oa_pdf/b0/34/kju-55-797.PMC4265713.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 802 Korean J Urol 2014;55:802-807http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.802&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.802 Original Article - Urological Oncology Location of Positive Surgical Margin and Its Association With  Biochemical Recurrence Rate Do Not Differ Significantly in Four Different Types of Radical Prostatectomy Yoon Seok Suh, Hyeon Jun Jang, Wan Song, Hye Won Lee, Hye Seung Kim1, Hwang Gyun Jeon,  Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, Hyun Moo Lee Department of Urology, Samsung Medical Center, S ungkyunkwan University School of Medicine, Seoul, 1Biostatistics and Clinical  Epidemiology Center, Samsung Medical Center, Sungkyunk wan University School of Medicine, Seoul, Korea Purpose:  To analyze the location of the positive  surgical margin (PSM) and its associa- tion with the biochemical recurrence (BCR) rate in cases of radical prostatectomy (RP) according to the type of surgery.",Non-OADS,/arxiv_data1/oa_pdf/90/7c/kju-55-802.PMC4265714.pdf
"Keywords:  Operative surgical procedures; Prostate; Prostate neoplasms;  Prostatectomy;  Recurrence This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 June, 2014 accepted 20 October, 2014 Corresponding Author: Hyun Moo Lee Department of Urology, Samsung  Medical Center, Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul  135-710, KoreaTEL: +82-2-3410-6543 FAX: +82-2-3410-6992 E-mail: besthml@medimail.co.kr INTRODUCTION Radical prostatectomy (RP) is the standard of care among  the treatment options for patien ts with clinically localized  prostate cancer, especially in men with a life expectancy ＞ 10 years [1].",Non-OADS,/arxiv_data1/oa_pdf/90/7c/kju-55-802.PMC4265714.pdf
"3.0.3 (R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org/).",Non-OADS,/arxiv_data1/oa_pdf/90/7c/kju-55-802.PMC4265714.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 808 Korean J Urol 2014;55:808-813http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.808&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.808 Original Article - Laparoscopy/Robotics Comparison of Perioperative Outcomes of Robotic Versus  Laparoscopic Partial Nephrectomy for Complex Renal Tumors (RENAL Nephrometry Score of 7 or Higher) Hyeon Jun Jang, Wan Song, Yoon Seok Suh, U Seok Jeong, Hwang Gyun Jeon, Byong Chang Jeong,  Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Seong Il Seo Department of Urology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Purpose:  To compare the perioperative outcomes  of laparoscopic partial nephrectomy  (LPN) and robotic part ial nephrectomy (RPN) for moderately or highly complex tumors  (RENAL nephrometry score ≥7).",Non-OADS,/arxiv_data1/oa_pdf/8e/e4/kju-55-808.PMC4265715.pdf
"Keywords:  Laparoscopy; Nephrectomy; Renal cell carcinoma; Robotics This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 8 July, 2014 accepted 6 October, 2014 Corresponding Author: Seong Il SeoDepartment of Urology, Samsung  Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul  135-710, Korea TEL: +82-2-3410-3556FAX: +82-2-3410-6981 E-mail: siseo@skku.edu INTRODUCTION  Partial nephrectomy currently represents the gold stand- ard of care for clinical T1 renal masses, because it can pro-vide oncologic outcomes equivale nt to those of radical neph- rectomy [1,2].",Non-OADS,/arxiv_data1/oa_pdf/8e/e4/kju-55-808.PMC4265715.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 814 Korean J Urol 2014;55:814-820http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.814&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.814 Original Article - Lower Urinary Tract Dysfunction Impact of Metabolic Syndrome on Response to Medical Treatment  of Benign Prostatic Hyperplasia Ali Cyrus, Ali Kabir1, Davood Goodarzi, Afsaneh Talaei2, Ali Moradi3, Mohammad Rafiee4,  Mehrdad Moghimi5, Elham Shahbazi6, Elaheh Farmani6 Department of Urology, Arak University of Medical Sciences, Arak, 1Minimally Invasive Surgery Research Center, Iran University of  Medical Sciences, and Department of Epidemiology, Faculty of Pub lic Health, Shahid Beheshti University of Medical Sciences, Teh ran,  2Department of Endocrinology, Arak Un iversity of Medical Sciences, Arak, 3Asadabad Health and Treatment Network, Hamedan  University of Medical Sciences, Hamadan, and Department of Epidem iology, Faculty of Public Health , Shahid Beheshti University o f  Medical Sciences, Tehran, 4Department of Statistics, Arak University of Medical Sciences, Arak, 5Department of Surgery, Shahid Beheshti  University of Medical Sciences, Tehran, 6Arak University of Medical Sciences, Arak, Iran Purpose:  To investigate the effect of metabolic syndrome (MetS) on the response to med- ical therapy of benign prosta tic hyperplasia (BPH) after a 3-month period of treatment.",Non-OADS,/arxiv_data1/oa_pdf/a8/9e/kju-55-814.PMC4265716.pdf
"Keywords:  Finasteride; Lower urinary tract symptoms; Metabolic syndrome X;  Prazosin; Prostatic hyperplasia This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 July, 2014 accepted 28 October, 2014 Corresponding Author: Ali Kabir Nikan Health Researchers  Institute, Unit 9, No.",Non-OADS,/arxiv_data1/oa_pdf/a8/9e/kju-55-814.PMC4265716.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 821 Korean J Urol 2014;55:821-827http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.821&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.821 Original Article - Female Urology Does Preoperative Urodynamic Testing Improve Surgical  Outcomes in Patients Undergoing the Transobturator Tape Procedure for Stress Urinary Incontinence?",Non-OADS,/arxiv_data1/oa_pdf/6c/00/kju-55-821.PMC4265717.pdf
"Keywords:  Urinary incontinence; Urodynamics This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 22 April, 2014 accepted 15 October, 2014 Corresponding Author: Abhinav Agarwal Department of Urology, Institute  of Medical Sciences, Banaras Hindu University, A-11, Swastik  Tower, Lanka, Varanasi, Uttar  Pradesh 221005, IndiaTEL: +91-542-2309559 FAX: +91-542-2367568 E-mail: abhinav2611@gmail.com INTRODUCTION Changes in the pelvic floor alongside the urethral anatomy  occur with aging, which can result in stress urinary incon-tinence (SUI).",Non-OADS,/arxiv_data1/oa_pdf/6c/00/kju-55-821.PMC4265717.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 828 Korean J Urol 2014;55:828-833http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.828&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.828 Original Article - Pediatric Urology Efficacy, Tolerability, and Safety of Oxybutynin Chloride in  Pediatric Neurogenic Bladder With Spinal Dysraphism: A Retrospective, Multicenter, Observational Study Jung Hoon Lee, Kyoung Rok Kim, Yong Seung Lee1, Sang Won Han1, Kun Suk Kim2, Sang Hoon Song2,  Minki Baek3, Kwanjin Park4 Department of Urology, Seoul National University College of Medicine, Seoul, 1Department of Urology, Urological Science Institute, Yonsei  University College of Medicine, Seoul, 2Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  3Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 4Division of Pediatric Urology,  Department of Urology, Seoul National University Childrens' Hosp ital, Seoul National University College of Medicine, Seoul, Kor ea Purpose:  Anticholinergics are a key element in treating neurogenic detrusor over- activity, but only limited data are availabl e in the pediatric population, thus limiting  the application to children even for oxybutyn in chloride (OC), a prototype drug.",Non-OADS,/arxiv_data1/oa_pdf/fb/fd/kju-55-828.PMC4265718.pdf
"Keywords:  Child; Neurogenic urinary bladder; Oxybutynin This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 29 August, 2014 accepted 15 October, 2014 Corresponding Author: Kwanjin Park Department of Urology, Seoul National University College of  Medicine, 103 Daehak-ro,  Jongno-gu, Seoul 110-799, KoreaTEL: +82-2-2072-0695 FAX: +82-2-742-4665 E-mail: urodori@naver.com INTRODUCTION About 0.6 to 4 newborn children per 1,000 suffer from spinal  dysraphism (SD).",Non-OADS,/arxiv_data1/oa_pdf/fb/fd/kju-55-828.PMC4265718.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 834 Korean J Urol 2014;55:834-840http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.834&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.834 Original Article - Basic and Translational Research Tumor-Specific Immunity Induced by Cryoablation in a Murine  Renal Cell Carcinoma Model Hyung Keun Kim, Jong Hyun Pyun, Seok Cho, Sung Gu Kang, Jeong Gu Lee, Je Jong Kim, Jun Cheon,  Hong Seok Park1, Seok Ho Kang Department of Urology, Kore a University Anam Hospital, 1Korea University Guro Hospital, Seoul, Korea Purpose:  To evaluate tumor-specific immunity  and define the me chanisms involved  in the cryoimmunologic response, we compared  the tumor control efficacy and immuno- logic responses of cryoablation with those of  surgical excision in a tumor rechallenge  model.",Non-OADS,/arxiv_data1/oa_pdf/76/22/kju-55-834.PMC4265719.pdf
"Keywords:  Animal models; Cryosurgery; Immunity; Renal cell carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 29 September, 2014 accepted 23 October, 2014 Corresponding Author: Seok Ho Kang Department of Urology, Korea  University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul  136-705, Korea TEL: +82-2-920-5367FAX: +82-2-928-7864 E-mail: mdksh@korea.ac.kr INTRODUCTION Historical evidence demonstrates that renal cell carcino- ma (RCC) is immunogenic; this knowledge has stimulated intensive efforts to harness th e immune system to improve  the outcomes of patients with RCC, especially for those with advanced disease.",Non-OADS,/arxiv_data1/oa_pdf/76/22/kju-55-834.PMC4265719.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 841 Korean J Urol 2014;55:841-843http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.841&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.841 Case Report Reconstruction of an Amputated Glans Penis With a Buccal Mucosal  Graft: Case Report of a Novel Technique Hamdy Aboutaleb Urology Department, Minoufiya University, Ga mal Abdel-Nasser Street, Minoufiya, Egypt Penile amputation is a rare catastrophe and a serious complication of circumcision.",Non-OADS,/arxiv_data1/oa_pdf/2b/7e/kju-55-841.PMC4265720.pdf
"Keywords:  Amputation; Mouth mucosa; Penis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 5 February, 2014 accepted 3 April, 2014 Corresponding Author: Hamdy Aboutaleb Urology Department, Minoufiya  University, Gamal Abdel-Nasser Street, Minoufiya, Egypt TEL: +20-48-2221416 FAX: +20-48-22326810E-mail: hamdyabotaleb@yahoo.",Non-OADS,/arxiv_data1/oa_pdf/2b/7e/kju-55-841.PMC4265720.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 844 Korean J Urol 2014;55:844-846http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 2.844&domain=pdf&date_stamp=2014-12-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.12.844 Case Report Radiofrequency-Treated Recurrence of Urothelial Carcinoma of the  Upper Urinary Tract After Nephroureterectomy Roberto Molina, Manuel Álvarez, Jesús Capilla1, Álvaro Páez Departments of Urology and 1Radiology, Fuenlabrada Universitary Hospital, Madrid, Spain Local recurrence after radical nephroureter ectomy (RNU) owing to urothelial carcino- ma of the upper urinary tract is rare.",Non-OADS,/arxiv_data1/oa_pdf/e9/ac/kju-55-844.PMC4265721.pdf
"Keywords:  Local neoplasm recurrence; Radiofreque ncy catheter ablation; Transitional  cell carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 February, 2014 accepted 9 April, 2014 Corresponding Author: Roberto MolinaDepartment of Urology,  Fuenlabrada Universitary  Hospital, Camino Del Molino 2 Fuenlabrada, Madrid 28942,  Spain TEL: +34-91-600-6000FAX: +34-91-574-9172 E-mail: robersescu@hotmail.com INTRODUCTION Urothelial carcinomas of the upper urinary tract make up  approximately 10% of kidney tumors.",Non-OADS,/arxiv_data1/oa_pdf/e9/ac/kju-55-844.PMC4265721.pdf
This is an open- access article dis tributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/dd/thnov05p0001.PMC4265744.pdf
This is an open- access article distributed under the t erms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/05/05/thnov05p0012.PMC4265745.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fa/62/thnov05p0023.PMC4265746.pdf
This i s an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/c3/thnov05p0043.PMC4265747.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8f/51/thnov05p0062.PMC4265748.pdf
http://www.thno.org/v0 5p0062s1.pdf   Acknowledgements   This work is supported by the National Science  Fund for Distinguished Young Scholars (Grant No.,Non-OADS,/arxiv_data1/oa_pdf/8f/51/thnov05p0062.PMC4265748.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/66/0b/thnov05p0071.PMC4265749.pdf
Probe sequences were checked for  non- specif ic annealing sites using Basic Local Alig n- ment Search Tool (http://blast.ncbi.nlm.nih.gov/   Blast.cgi).,OADS,/arxiv_data1/oa_pdf/66/0b/thnov05p0071.PMC4265749.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/de/07/thnov05p0086.PMC4265750.pdf
This is an open- access a rticle distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/79/thnov05p0097.PMC4265751.pdf
http://www.thno.org/v05p0097s1.mp4  Additional File 2:   Supplementary Video 2: CEUS  imaging of 2 lymph  vessels connected to one lymph node.,Non-OADS,/arxiv_data1/oa_pdf/2f/79/thnov05p0097.PMC4265751.pdf
http://www.thno.org/v05p0097s 2.mp4  Additional File 3:   Supplementary Video 3: CEUS of mRNA -loaded m i- crob ubbles 6  min after mRNA -loaded microbubble  injection.,Non-OADS,/arxiv_data1/oa_pdf/2f/79/thnov05p0097.PMC4265751.pdf
http://www.thno.org/v05p0097s 3.mp4 Additional File 4:   Supplementary Video 4: Burst destruction of intra n- odal microbubbles.,Non-OADS,/arxiv_data1/oa_pdf/2f/79/thnov05p0097.PMC4265751.pdf
http://www.thno.org/v05p0097s 4.mp4  Additional File 5:   Figure s S1-S2.,Non-OADS,/arxiv_data1/oa_pdf/2f/79/thnov05p0097.PMC4265751.pdf
"http://www.thno.org/v05p0097s 5.pdf  Acknowledgements   Heleen Dewitte is a doctoral fellow of the Inst i- tute for the Promotion of Innovation through Science  and Technology in Flanders, Belgium  (IWT- Vlaanderen).",Non-OADS,/arxiv_data1/oa_pdf/2f/79/thnov05p0097.PMC4265751.pdf
"The emmetropization mechanism can be stimulated to Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > Received 10 September 2014 | Accepted 6 December 2014 | Published 9 December 2014© 2014 Molecular Vision 1643Scleral gene expression during recovery from myopia compared  with expression during myopia development in tree shrew Lin Guo, Michael R. Frost, John T. Siegwart Jr., Thomas T. Norton Department of Vision Sciences, School of Optometry, University of Alabama at Birmingham, Birmingham, AL Purpose:  During postnatal refractive development, the sclera receives retinally generated signals that regulate its bio - chemical properties.",Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1644produce increased axial elongation and myopia in animal  models by placing a concave (minus-power) lens in front  of an emmetropizing eye.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1645unrestricted vision for 2 (REC-2) or 4 (REC-4) days.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1646animals in this laboratory showed that the axial differences  measured with the Lenstar were similar to those measured  with A-scan ultrasound (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1647Table  1.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
"Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1648Gene symbol Protein name Location CYR61 Protein CYR61 Extracellular FBLN1 Fibulin 1 Extracellular NOV Protein NOV homolog Extracellular SPARC Secreted protein acidic and rich in cysteine Extracellular SPP1 Osteopontin Extracellular THBS1 Thrombospondin 1 Extracellular THBS2 Thrombospondin 2 Extracellular TNC Tenascin C Extracellular WISP1 WNT1 inducible signaling pathway protein 1 Extracellular MPs / TIMPs ADAMTS5 ADAM metallopeptidase with thrombospondin motif, 5 Extracellular MMP2 Matrix metallopeptidase 2 Extracellular MMP14 Matrix metallopeptidase 14 Cell surface TIMP1 TIMP metallopeptidase inhibitor 1 Extracellular TIMP2 TIMP metallopeptidase inhibitor 2 Extracellular TIMP3 TIMP metallopeptidase inhibitor 3 Extracellular",Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
"Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1649The myopia in the ML-11 group was −5.1±0.2 D; measured  with the lens in place, the treated eyes were slightly myopic  (−0.3±0.3 D) compared with their fellow control eyes, and all  treated eyes were within 1 D of the control eyes.",Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
"Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1650variability in expression across animals within each group  was low, as evidenced by the small SEM values.",Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1651 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1652The similar recovery patterns seen in Figure 5D (REC-2)  and Figure 5E (REC-4) are compared in Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1653the ML-4 pattern (Figure 5B).,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1654 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1655REC-4 group.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1656eyes may be considered to be a STOP signature for the 55  genes that we examined.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
"Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  1657rate and STOP one where the elongation rate decelerated,  then STAY is a condition of maintained axial elongation  rate.",Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  16589.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
Molecular Vision  2014; 20:1643-1659 <http://www.molvis.org/molvis/v 20/1643 > © 2014 Molecular Vision  165939.,Non-OADS,/arxiv_data1/oa_pdf/ff/1f/mv-v20-1643.PMC4265769.pdf
"Moreover, both  membrane structures are enriched in F-actin [ 6], which acts Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > Received 14 August  | Accepted 9 December 2014 | Published 12 December 2014© 2014 Molecular Vision 1660PTBP-dependent PSD-95 and CamKIIα alternative splicing in the  lens Peter Frederikse,1,2 Anoop Nandanoor,1 Chinnaswamy Kasinathan1 1Department of Oral Biology, Rutgers SDM, Newark, NJ; 2Department of Pharmacology & Physiology, Rutgers BHS Purpose:  Parallels described between neurons and lens fiber cells include detailed similarities in sub-cellular struc - tures that increasingly show shared expression of genes involved in the construction and function of these structures  in neurons.",Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
"Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > © 2014 Molecular Vision  1661a scaffold in dendritic spines that determines spine size and  shape, and underlies its functions [ 14,18,19].",Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
"Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > © 2014 Molecular Vision  1662purified for DNA sequencing (Rutgers Molecular Resource  Facility, Newark, NJ).",Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > © 2014 Molecular Vision  1663exon-specific primers.,Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > © 2014 Molecular Vision  1664membrane protrusions [ 6] lead us to speculate that PSD-95  interactions with the dendritic spine cytoskeleton may also  have parallels in the lens.,Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > © 2014 Molecular Vision  1665is expressed in mammalian lenses.,Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > © 2014 Molecular Vision  166618.,Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
Molecular Vision  2014; 20:1660-1667 <http://www.molvis.org/molvis/v 20/1660 > © 2014 Molecular Vision  166744.,Non-OADS,/arxiv_data1/oa_pdf/9d/e6/mv-v20-1660.PMC4265770.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/81/84/srep07471.PMC4265772.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7447 | DOI: 10.1038/srep07447 5",Non-OADS,/arxiv_data1/oa_pdf/6d/b0/srep07447.PMC4265773.pdf
The resulting pyrosequencing reads were filtered according to barcode and primer sequences using a combination of tools from Mothur (version 1.25.0; http://www.mothur.org) and custom Perl scripts.,OADS,/arxiv_data1/oa_pdf/cb/99/srep07485.PMC4265774.pdf
"A heatmap was generated on the basis of the relative abundance of OTUs using R (version 2.15; The R Project for Statistical Computing,http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/cb/99/srep07485.PMC4265774.pdf
Taxonomy-based analyses were performed by classifying each sequence using the Na ı¨ve Bayesian Classifier program of the Michigan State University Center for Microbial Ecology Ribosomal Database Project (RDP) database (http://rdp.cme.msu.,OADS,/arxiv_data1/oa_pdf/cb/99/srep07485.PMC4265774.pdf
"The characterization of microorganismal features differentiating the faecal microbiota specific to different toxigenic types wasperformed using linear discriminant analysis (LDA) effect size (LEfSe) method (http://huttenhower.sph.harvard.edu/lefse/) for biomarker discovery, which emphasizes both statistical significance and biological relevance 55.",Non-OADS,/arxiv_data1/oa_pdf/cb/99/srep07485.PMC4265774.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Ling, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/cb/99/srep07485.PMC4265774.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/srep07478.PMC4265775.pdf
All authors read and approve the final manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b9/e7/srep07481.PMC4265776.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/f5/srep07489.PMC4265777.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7489 | DOI: 10.1038/srep07489 9",Non-OADS,/arxiv_data1/oa_pdf/ad/f5/srep07489.PMC4265777.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e4/e1/srep07484.PMC4265778.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7484 | DOI: 10.1038/srep07484 6",Non-OADS,/arxiv_data1/oa_pdf/e4/e1/srep07484.PMC4265778.pdf
"Fluid secretion  is a Na+/K+ ATPase dependent process involving bicarbonate  and lactate transport accompanied by localized osmotic fluid Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > Received 11 August 2014 | Accepted 9 December 2014 | Published 12 December 2014© 2014 Molecular Vision 1668Loss of ion transporters and increased unfolded protein response  in Fuchs’ dystrophy Supriya S. Jalimarada, Diego G. Ogando, Joseph A. Bonanno School of Optometry, Indiana University, Bloomington, IN Purpose:  Fuchs’ endothelial corneal dystrophy (FECD), which affects approximately 5% of the population over 40 in the  U.S.A., is a major cause of corneal transplantation.",Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1669transfer [ 1].,Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
"Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1670UPR pathways, e.g., PERK, ATF6, and IRE1, are being tested  as pharmacological targets for cancer, obesity, and metabolic,  inflammatory, and neurodegenerative disorders [ 28,32].",Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
"Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1671Scientific, Whatman, MA).",Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1672and control groups.,Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1673had lower expression levels.,Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1674the COL8A2 Q455K knock-in mouse model of early onset  FECD [ 35].,Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1675summarizing the mechanisms that could contribute to the  occurrence of the clinical symptoms observed in FECD.,Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
"Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1676expression of pNBCe1 and NHE and MCT1, 2, and 4 in FECD  have not been determined previously.",Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
"Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1677In conclusion, simultaneous determination in the same  set of samples indicates that apart from UPR, endothelial ion  transport, which regulates pump function, is also inhibited  in FECD.",Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Molecular Vision  2014; 20:1668-1679 <http://www.molvis.org/molvis/v 20/1668 > © 2014 Molecular Vision  1678(Harboyan syndrome).,Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Molecular Vision  ####; ###:1668-1679 <http://www.molvis.org/molvis/v ###/#### > © Copyright Year Copyright Holder  1679Fuchs endothelial dystrophy of the cornea.,Non-OADS,/arxiv_data1/oa_pdf/da/df/mv-v20-1668.PMC4265779.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/de/srep07480.PMC4265780.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7480 | DOI: 10.1038/srep07480 5",Non-OADS,/arxiv_data1/oa_pdf/d3/de/srep07480.PMC4265780.pdf
contributed equally to the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b7/05/srep07472.PMC4265781.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7472 | DOI: 10.1038/srep07472 6",Non-OADS,/arxiv_data1/oa_pdf/b7/05/srep07472.PMC4265781.pdf
"We have developed a web-server, which would be helpful in identification of structural domains (http://vis.sculab.org/ ,huayongpan/cgi-bin/ domainAssignment.cgi).",OADS,/arxiv_data1/oa_pdf/6e/b9/srep07476.PMC4265785.pdf
"Finally, we have developed a webserver, which would be helpful in identification of structural domains (http://vis.sculab.org/ ,huayongpan/cgi-bin/domainAssignment.cgi).",Non-OADS,/arxiv_data1/oa_pdf/6e/b9/srep07476.PMC4265785.pdf
"Here, we only attain the half of Benchmark_2 and Benchmark_3 from a website pdomain (http://pdomains.sdsc.",OADS,/arxiv_data1/oa_pdf/6e/b9/srep07476.PMC4265785.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6e/b9/srep07476.PMC4265785.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7476 | DOI: 10.1038/srep07476 7",Non-OADS,/arxiv_data1/oa_pdf/6e/b9/srep07476.PMC4265785.pdf
"& Reader, J. and NIST ASD Team, http://physics.nist.",OADS,/arxiv_data1/oa_pdf/0b/1e/srep07488.PMC4265786.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7488 | DOI: 10.1038/srep07488 5",Non-OADS,/arxiv_data1/oa_pdf/0b/1e/srep07488.PMC4265786.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7475 | DOI: 10.1038/srep07475 8",Non-OADS,/arxiv_data1/oa_pdf/bb/4b/srep07475.PMC4265787.pdf
(2000) and can be downloaded from http://www.landcover.org/data/ landcover/index.shtml This figure was produced using ArcGIS 10.1.,OADS,/arxiv_data1/oa_pdf/d3/de/srep07483.PMC4265788.pdf
These data can be obtained freely fromhttp://www.ntsg.umt.edu/project/mod16.,OADS,/arxiv_data1/oa_pdf/d3/de/srep07483.PMC4265788.pdf
Global land cover classification product at1 km resolution developed by the University of Maryland was used to assist inextracting the latitudinal evolution of WUE for each biome (http://glcfapp.glcf.,OADS,/arxiv_data1/oa_pdf/d3/de/srep07483.PMC4265788.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/de/srep07483.PMC4265788.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7483 | DOI: 10.1038/srep07483 11",Non-OADS,/arxiv_data1/oa_pdf/d3/de/srep07483.PMC4265788.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Figure 6 |Simulated dynamic range of signal power for 40-Gbaud (160-Gbit/s) hexadecimal addition/subtraction using a silicon-organic hybrid slot waveguide.www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7491 | DOI: 10.1038/srep07491 5",Non-OADS,/arxiv_data1/oa_pdf/2c/e9/srep07491.PMC4265790.pdf
"1F; http://www.flycircuit.tw/; Chiang et al.,2011).",Non-OADS,/arxiv_data1/oa_pdf/0b/79/cne0522-3795.PMC4265792.pdf
"Identification of M6-LNs From among the 3,000 single neurons with all proc- esses restricted to the medulla that are found in theFlyCircuit image database (http://www.flycircuit.tw/; Chiang et al., 2011), we visually identified 155 neurons having arborizations restricted to the M6 stratum inevery sample brain (Supp.",OADS,/arxiv_data1/oa_pdf/0b/79/cne0522-3795.PMC4265792.pdf
"Legend: NHP = nonhuman primate; TNF = Tumor necrosis factor; IL = InterleukinTable 1: The 2014 outbreak: Report of Ebola  cases by country (data as of November 12, 2014) Continent / CountryTotal cases Laboratory  confirmedDeaths  (mortality %) Africa Guinea 1,878 1,612 1,142 (60.8) Liberia 6,822 2,553 2,836 (41.6) Mali 4 2 1 (25.0) Nigeria 20 19 8 (40.0) Senegal 1 1 0 (n/a) Sierra Leone 5,368 4,523 1,169 (21.8) Europe Spain 1 1 0 (n/a) North America United States 4 4 1 (25.0) Totals 14,098 8,715 5,157 (36.6) Note: According to the CDC, a national Ebola outbreak is considered to have come to an end at 42 days (or two times the duration of the 21-day incubation period for EBOV) from the time the last patient in isolation becomes laboratory-negative for the virus.Source: CDC (http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html)",Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.cdc.gov/vhf/ebola/resources/outbreak-table.,OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
2014;  Available from: http://apps.who.int/iris/bitstream/10665/131974/1/ roadmapsitrep1_eng.pdf?ua=1).,OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.euronews.com/2014/10/27/spanish- nursing-assistant-s-husband-who-overcame-ebola-leaves-hospital/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.iaia.org/conferences/iaia13/ proceedings/Final%20papers%20review%20process%2013/Emerging%20 Infectious%20Diseases%20and%20Impact%20Assessments.pdf?AspxAu toDetectCookieSupport=1.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.who.int/mediacentre/news/ebola/25- august-2014/en/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.e-ir.info/2014/07/26/ the-ebola-outbreak-in-guinea-liberia-and-sierra-leone/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.bbc.com/news/world-africa-29436851.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.theguardian.com/global-development/2014/ Nov/12/mali-ebola-outbreak-second-death.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.reuters.com/article/2014/11/12/ us-health-ebola-mali-idUSKCN0IW12C20141112.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.nytimes.com/2014/09/13/world/africa/us-scientists-see-long-fight-against-ebola.html.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.nytimes.com/2014/10/15/world/africa/ebola- epidemic-who-west-africa.html?_r=0.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
